Disease_category,Disease,Protein,Protein_definition,method,nsnp,OR [95% CI],Pvalue,QTL_type
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,ADGRE5,Adhesion G protein-coupled receptor E5,Inverse variance weighted,8,0.6 [0.45-0.8],0.000509754441859868,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,CD5,T-cell surface glycoprotein CD5,Inverse variance weighted,6,2.32 [1.4-3.84],0.00107440221311262,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,CST3,Cystatin-C,Inverse variance weighted,10,1.56 [1.19-2.03],0.00121536652711042,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,UMOD,Uromodulin,Inverse variance weighted,29,1.23 [1.08-1.39],0.00125768598298425,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,SLAMF8,SLAM family member 8,Inverse variance weighted,25,1.16 [1.06-1.27],0.00173818468003603,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,CD48,CD48 antigen,Inverse variance weighted,18,0.8 [0.7-0.92],0.00185913811968886,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,FOLR1,Folate receptor alpha,Inverse variance weighted,5,2.49 [1.4-4.45],0.00198149176406178,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,TMPRSS11D,Transmembrane protease serine 11D,Inverse variance weighted,3,0.32 [0.15-0.67],0.00253036759760997,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,MMP9,Matrix metalloproteinase-9,Inverse variance weighted,2,0.41 [0.23-0.75],0.00344687376582691,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,MMP3,Stromelysin-1,Inverse variance weighted,34,1.35 [1.09-1.67],0.00532243324117212,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,GP2,Pancreatic secretory granule membrane major glycoprotein GP2,Inverse variance weighted,6,0.62 [0.44-0.87],0.0056620627660907,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,DKK3,Dickkopf-related protein 3,Inverse variance weighted,13,0.76 [0.63-0.92],0.00585926893829544,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,CPXM2,Inactive carboxypeptidase-like protein X2,Inverse variance weighted,22,0.76 [0.61-0.93],0.00942918636327896,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,MSMB,Beta-microseminoprotein,Inverse variance weighted,64,0.86 [0.77-0.97],0.00975264839241771,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,ICAM5,Intercellular adhesion molecule 5,Inverse variance weighted,33,1.21 [1.04-1.39],0.0112935144370079,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,LCN2,Neutrophil gelatinase-associated lipocalin,Wald ratio,1,0.04 [0-0.5],0.0122338140820422,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,CCL7,C-C motif chemokine 7,Inverse variance weighted,3,0.19 [0.05-0.71],0.0137848883603661,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,SPINK1,Serine protease inhibitor Kazal-type 1,Inverse variance weighted,23,0.82 [0.71-0.96],0.01399521617308,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,VMO1,Vitelline membrane outer layer protein 1 homolog,Inverse variance weighted,34,1.15 [1.03-1.29],0.0149414859341895,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,CD4,T-cell surface glycoprotein CD4,Inverse variance weighted,5,0.74 [0.58-0.95],0.0186284476074999,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,LEFTY2,Left-right determination factor 2,Inverse variance weighted,36,0.87 [0.77-0.98],0.018652498304057,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,CPB1,Carboxypeptidase B,Wald ratio,1,2.65 [1.17-5.99],0.0193276068899418,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,SPINT1,Kunitz-type protease inhibitor 1,Inverse variance weighted,7,1.52 [1.07-2.17],0.0195196074182935,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,TNFRSF4,Tumor necrosis factor receptor superfamily member 4,Inverse variance weighted,5,0.57 [0.35-0.92],0.0213274308570583,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,BOC,Brother of CDO,Inverse variance weighted,6,1.53 [1.06-2.21],0.0220039115497723,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,MYBPC2,"Myosin-binding protein C, fast-type",Wald ratio,1,14.55 [1.46-144.56],0.0223069260871664,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,CD40,Tumor necrosis factor receptor superfamily member 5,Inverse variance weighted,10,0.76 [0.6-0.96],0.0229707341685371,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,CRELD2,Protein disulfide isomerase CRELD2,Inverse variance weighted,15,0.79 [0.65-0.97],0.0237422725351759,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,CTSS,Cathepsin S,Inverse variance weighted,23,1.23 [1.03-1.48],0.0237793700224311,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,F3,Tissue factor,Inverse variance weighted,11,1.45 [1.05-2.01],0.0241123749990205,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,AMBP,Protein AMBP,Inverse variance weighted,3,1.96 [1.08-3.55],0.0258943694208706,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,COCH,Cochlin,Inverse variance weighted,17,1.17 [1.02-1.34],0.0267847884134344,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,CYTL1,Cytokine-like protein 1,Inverse variance weighted,7,1.18 [1.02-1.36],0.0277876889228853,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,IGFBP2,Insulin-like growth factor-binding protein 2,Inverse variance weighted,2,3.34 [1.14-9.82],0.0283974881145989,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,IFNGR1,Interferon gamma receptor 1,Inverse variance weighted,4,1.7 [1.06-2.72],0.0285577996493832,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,CDH3,Cadherin-3,Inverse variance weighted,2,3.13 [1.12-8.73],0.0293350214839663,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,CST5,Cystatin-D,Inverse variance weighted,37,0.87 [0.77-0.99],0.0303589011237205,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,IGSF8,Immunoglobulin superfamily member 8,Inverse variance weighted,2,0.51 [0.28-0.94],0.0308109021890827,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,PTPRN2,Receptor-type tyrosine-protein phosphatase N2,Inverse variance weighted,5,1.68 [1.05-2.69],0.0319736161518739,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,COL9A1,Collagen alpha-1(IX) chain,Inverse variance weighted,8,0.72 [0.54-0.97],0.0323789344117264,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,RETN,Resistin,Inverse variance weighted,9,0.82 [0.68-0.99],0.0349299278962474,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,UNC5D,Netrin receptor UNC5D,Wald ratio,1,1028.53 [1.63-648061.69],0.0349444416773621,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,PSAP,Prosaposin,Inverse variance weighted,5,1.52 [1.03-2.26],0.0352255043619973,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,INSL5,Insulin-like peptide INSL5,Inverse variance weighted,3,0.6 [0.38-0.97],0.0354202570378244,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,APOA4,Apolipoprotein A-IV,Wald ratio,1,8.77 [1.16-66.4],0.0355733501634755,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,OCLN,Occludin,Inverse variance weighted,2,2.05 [1.05-4.03],0.0359555978783856,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,FCRL6,Fc receptor-like protein 6,Inverse variance weighted,32,0.88 [0.77-0.99],0.0363724319475488,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,KLK6,Kallikrein-6,Inverse variance weighted,4,1.61 [1.03-2.51],0.036694423378372,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,HYOU1,Hypoxia up-regulated protein 1,Inverse variance weighted,6,1.6 [1.02-2.49],0.0386641790024597,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,PSG1,Pregnancy-specific beta-1-glycoprotein 1,Inverse variance weighted,55,0.92 [0.85-1],0.0408179369151591,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,CR1,Complement receptor type 1,Inverse variance weighted,21,1.17 [1.01-1.37],0.0408870800870427,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,EGFL7,Epidermal growth factor-like protein 7,Inverse variance weighted,8,0.71 [0.51-0.99],0.0412486522149207,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,PKD2,Polycystin-2,Inverse variance weighted,3,2.86 [1.03-7.94],0.0445161865967798,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,THBS2,Thrombospondin-2,Inverse variance weighted,16,0.82 [0.68-1],0.0446265861857722,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,MSTN,Growth/differentiation factor 8,Inverse variance weighted,2,1.75 [1.01-3.04],0.0451215301296814,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,NUDT5,ADP-sugar pyrophosphatase,Wald ratio,1,4.81 [1.03-22.42],0.0453234122280909,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,ASGR2,Asialoglycoprotein receptor 2,Inverse variance weighted,12,1.29 [1-1.65],0.0460913542861888,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,BMPER,BMP-binding endothelial regulator protein,Inverse variance weighted,7,1.4 [1-1.97],0.0475338069638891,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,LY9,T-lymphocyte surface antigen Ly-9,Inverse variance weighted,24,0.81 [0.66-1],0.0488404102191662,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,S100P,Protein S100-P,Inverse variance weighted,2,3.34 [1-11.2],0.050407285936541,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,CAMKK1,Calcium/calmodulin-dependent protein kinase kinase 1,Inverse variance weighted,3,1.36 [1-1.86],0.0505200084211589,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,ACP6,Lysophosphatidic acid phosphatase type 6,Inverse variance weighted,40,1.13 [1-1.29],0.0513446302091684,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,MIA,Melanoma-derived growth regulatory protein,Inverse variance weighted,27,1.13 [1-1.27],0.0521708381221251,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,TEX101,Testis-expressed protein 101,Inverse variance weighted,4,0.69 [0.47-1.01],0.0536742193481378,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,CXCL9,C-X-C motif chemokine 9,Inverse variance weighted,2,1.81 [0.99-3.32],0.0544655651087601,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,P4HB,Protein disulfide-isomerase,Inverse variance weighted,2,0.26 [0.07-1.03],0.0550458754019601,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,PLA2G7,Platelet-activating factor acetylhydrolase,Inverse variance weighted,2,0.11 [0.01-1.05],0.0551744612400914,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,RIDA,2-iminobutanoate/2-iminopropanoate deaminase,Inverse variance weighted,7,1.32 [0.99-1.75],0.0567067026042882,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,ANGPTL7,Angiopoietin-related protein 7,Inverse variance weighted,11,0.78 [0.61-1.01],0.0586140559071808,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,CD14,Monocyte differentiation antigen CD14,Inverse variance weighted,13,0.78 [0.6-1.01],0.0586623888955843,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,NRP1,Neuropilin-1,Inverse variance weighted,12,0.79 [0.62-1.01],0.059065908664061,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",Inverse variance weighted,18,0.85 [0.72-1.01],0.0620899838407302,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,PRELP,Prolargin,Inverse variance weighted,9,1.28 [0.98-1.66],0.0681856552662383,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,INSL4,Early placenta insulin-like peptide,Inverse variance weighted,2,0.6 [0.35-1.04],0.0688000718642648,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,TCN2,Transcobalamin-2,Inverse variance weighted,34,0.89 [0.78-1.01],0.0689786146484615,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,ADAMTS16,A disintegrin and metalloproteinase with thrombospondin motifs 16,Inverse variance weighted,10,1.44 [0.97-2.13],0.0692333147535391,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,HSDL2,Hydroxysteroid dehydrogenase-like protein 2,Inverse variance weighted,27,1.19 [0.99-1.43],0.070633861174165,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,GPC1,Glypican-1,Inverse variance weighted,17,0.81 [0.64-1.02],0.0707584220895981,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,TNFRSF10B,Tumor necrosis factor receptor superfamily member 10B,Inverse variance weighted,15,0.81 [0.65-1.02],0.0708371181006808,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,RBP7,Retinoid-binding protein 7,Inverse variance weighted,8,0.57 [0.31-1.05],0.0721514668454971,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,TCL1A,T-cell leukemia/lymphoma protein 1A,Inverse variance weighted,11,1.27 [0.98-1.65],0.0728666124265523,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,MSR1,Macrophage scavenger receptor types I and II,Inverse variance weighted,8,0.77 [0.57-1.03],0.074550522422268,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,CD34,Hematopoietic progenitor cell antigen CD34,Wald ratio,1,3.95 [0.87-17.9],0.07459138203962,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,MB,Myoglobin,Wald ratio,1,8.5 [0.8-90.1],0.075689193991119,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,PRND,Prion-like protein doppel,Inverse variance weighted,9,0.78 [0.6-1.03],0.0761030701486986,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,TNFRSF11A,Tumor necrosis factor receptor superfamily member 11A,Inverse variance weighted,25,0.84 [0.7-1.02],0.0764549703797953,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,SCG2,Secretogranin-2,Wald ratio,1,0.18 [0.03-1.21],0.0780322436434547,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,OSM,Oncostatin-M,Wald ratio,1,3.12 [0.88-11.08],0.078241309953441,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,ADM,Pro-adrenomedullin,Inverse variance weighted,2,2.1 [0.91-4.86],0.0809482128938045,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,APOA2,Apolipoprotein A-II,Wald ratio,1,0.3 [0.08-1.16],0.0820938219203228,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,TNFRSF9,Tumor necrosis factor receptor superfamily member 9,Wald ratio,1,7.82 [0.77-79.45],0.082102155235357,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,NOMO1,Nodal modulator 1,Inverse variance weighted,2,1.65 [0.94-2.92],0.0824026514815889,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,KAZALD1,Kazal-type serine protease inhibitor domain-containing protein 1,Inverse variance weighted,21,1.08 [0.99-1.18],0.083641805608261,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,CDH2,Cadherin-2,Inverse variance weighted,3,0.4 [0.14-1.13],0.0838070424804074,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,FAM20A,Pseudokinase FAM20A,Inverse variance weighted,14,1.22 [0.97-1.52],0.0844695834987906,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,CCL20,C-C motif chemokine 20,Inverse variance weighted,2,2.44 [0.88-6.73],0.0860941919711042,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,MFGE8,Lactadherin,Inverse variance weighted,11,0.8 [0.62-1.03],0.086623212699249,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,CLEC3B,Tetranectin,Inverse variance weighted,7,0.73 [0.5-1.05],0.0874344626912078,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,DLK1,Protein delta homolog 1,Inverse variance weighted,25,1.14 [0.98-1.34],0.0874813946941363,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,KLK13,Kallikrein-13,Inverse variance weighted,11,0.85 [0.71-1.02],0.0878127484810328,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,SHISA5,Protein shisa-5,Inverse variance weighted,5,2.72 [0.86-8.61],0.0882317340725156,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,SLURP1,Secreted Ly-6/uPAR-related protein 1,Inverse variance weighted,22,0.84 [0.68-1.03],0.0883098200609616,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,TIMD4,T-cell immunoglobulin and mucin domain-containing protein 4,Inverse variance weighted,13,0.76 [0.56-1.04],0.0886665988978001,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,ESM1,Endothelial cell-specific molecule 1,Inverse variance weighted,4,0.68 [0.43-1.06],0.0887893539427895,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,AREG,Amphiregulin,Inverse variance weighted,3,1.64 [0.93-2.92],0.0893244029485851,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,SLAMF6,SLAM family member 6,Inverse variance weighted,2,0.63 [0.37-1.08],0.0927556601632104,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,TNFRSF13B,Tumor necrosis factor receptor superfamily member 13B,Inverse variance weighted,5,1.41 [0.94-2.12],0.0933950538371427,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,PENK,Proenkephalin-A,Inverse variance weighted,19,1.25 [0.96-1.62],0.0958369960582247,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,C1QTNF9,Complement C1q and tumor necrosis factor-related protein 9A,Inverse variance weighted,33,1.08 [0.98-1.19],0.0999291322728793,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,GDNF,Glial cell line-derived neurotrophic factor,Inverse variance weighted,12,0.79 [0.6-1.05],0.101058203865985,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,SCARB2,Lysosome membrane protein 2,Inverse variance weighted,7,1.32 [0.95-1.83],0.101848884792314,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,EFNA1,Ephrin-A1,Inverse variance weighted,11,1.23 [0.96-1.58],0.103184588556913,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,ANGPTL4,Angiopoietin-related protein 4,Inverse variance weighted,7,0.77 [0.56-1.06],0.104760530230466,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,SPON1,Spondin-1,Inverse variance weighted,21,1.21 [0.96-1.54],0.107111230746802,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,SBSN,Suprabasin,Inverse variance weighted,17,1.14 [0.97-1.34],0.108048898662848,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Inverse variance weighted,18,1.28 [0.94-1.73],0.11296900646768,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,CCL23,C-C motif chemokine 23,Inverse variance weighted,17,1.14 [0.97-1.33],0.113378056614442,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,MMP1,Interstitial collagenase,Inverse variance weighted,31,0.88 [0.75-1.03],0.113715777449381,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,CTHRC1,Collagen triple helix repeat-containing protein 1,Inverse variance weighted,3,2.71 [0.79-9.31],0.113752469834974,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,SEMA3F,Semaphorin-3F,Inverse variance weighted,15,1.52 [0.9-2.56],0.114468557613622,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,LYVE1,Lymphatic vessel endothelial hyaluronic acid receptor 1,Inverse variance weighted,4,1.44 [0.91-2.26],0.115409430364757,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,NPDC1,Neural proliferation differentiation and control protein 1,Inverse variance weighted,2,0.58 [0.29-1.14],0.115828692254797,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,SEL1L,Protein sel-1 homolog 1,Wald ratio,1,1.27 [0.94-1.71],0.116570478662565,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,LRIG3,Leucine-rich repeats and immunoglobulin-like domains protein 3,Wald ratio,1,2.72 [0.78-9.46],0.116640585161479,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,STC1,Stanniocalcin-1,Inverse variance weighted,2,2.83 [0.77-10.45],0.118899095121285,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,ADAMTSL2,ADAMTS-like protein 2,Inverse variance weighted,4,0.62 [0.34-1.13],0.119618115338269,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,NFASC,Neurofascin,Inverse variance weighted,15,1.19 [0.96-1.47],0.119777569429082,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,PALM,Paralemmin-1,Inverse variance weighted,6,1.42 [0.91-2.21],0.120310717271181,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,SFRP1,Secreted frizzled-related protein 1,Inverse variance weighted,13,0.73 [0.49-1.09],0.120406920337704,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,VASN,Vasorin,Inverse variance weighted,14,0.88 [0.75-1.03],0.12097770746922,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,SIGLEC6,Sialic acid-binding Ig-like lectin 6,Inverse variance weighted,17,0.88 [0.76-1.03],0.122471119005973,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,MMP12,Macrophage metalloelastase,Inverse variance weighted,18,0.9 [0.79-1.03],0.123758019540741,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,FAM3B,Protein FAM3B,Inverse variance weighted,18,0.89 [0.77-1.03],0.123820297065936,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,MAMDC2,MAM domain-containing protein 2,Inverse variance weighted,5,0.73 [0.5-1.09],0.124032692861491,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,SEZ6L,Seizure 6-like protein,Inverse variance weighted,8,0.77 [0.56-1.07],0.124647029619729,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,NOS1,"Nitric oxide synthase, brain",Inverse variance weighted,2,0.63 [0.35-1.14],0.125372158121675,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,IFNAR1,Interferon alpha/beta receptor 1,Inverse variance weighted,17,1.15 [0.96-1.38],0.125432269630391,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,SIGLEC10,Sialic acid-binding Ig-like lectin 10,Inverse variance weighted,14,1.13 [0.97-1.31],0.126195812944939,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,HNMT,Histamine N-methyltransferase,Inverse variance weighted,27,0.88 [0.76-1.04],0.126559668515784,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,TREML2,Trem-like transcript 2 protein,Inverse variance weighted,9,0.8 [0.61-1.06],0.1271883661109,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,NCS1,Neuronal calcium sensor 1,Inverse variance weighted,3,0.6 [0.31-1.16],0.128833995335278,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,CCL22,C-C motif chemokine 22,Inverse variance weighted,6,0.73 [0.49-1.1],0.129418354708168,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,SUSD5,Sushi domain-containing protein 5,Inverse variance weighted,22,1.14 [0.96-1.36],0.131995031395181,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,KIF1C,Kinesin-like protein KIF1C,Wald ratio,1,7.37 [0.54-99.82],0.13292479424696,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,VSIG2,V-set and immunoglobulin domain-containing protein 2,Inverse variance weighted,5,1.34 [0.91-1.98],0.133771621608836,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,CCL27,C-C motif chemokine 27,Inverse variance weighted,4,1.31 [0.92-1.88],0.134218506653839,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,TNFRSF1A,Tumor necrosis factor receptor superfamily member 1A,Wald ratio,1,0.36 [0.09-1.38],0.134670381269663,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,GFRA1,GDNF family receptor alpha-1,Inverse variance weighted,7,1.28 [0.92-1.78],0.135966047394841,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,IGFBP4,Insulin-like growth factor-binding protein 4,Wald ratio,1,4.88 [0.61-39.26],0.13624955131718,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,QPCT,Glutaminyl-peptide cyclotransferase,Inverse variance weighted,12,0.87 [0.73-1.04],0.137274808055083,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,USP28,Ubiquitin carboxyl-terminal hydrolase 28,Inverse variance weighted,2,2.08 [0.79-5.52],0.139893578170958,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,LTBP2,Latent-transforming growth factor beta-binding protein 2,Inverse variance weighted,7,0.66 [0.38-1.15],0.14128039935527,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,PCDH1,Protocadherin-1,Wald ratio,1,0.44 [0.15-1.32],0.145231889614457,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,SERPINB6,Serpin B6,Inverse variance weighted,4,0.72 [0.46-1.12],0.145751006911498,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,GPR37,Prosaposin receptor GPR37,Inverse variance weighted,36,1.11 [0.96-1.27],0.146960280221347,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,CHCHD6,MICOS complex subunit MIC25,Inverse variance weighted,4,0.77 [0.54-1.1],0.147783294782254,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,ADA2,Adenosine deaminase 2,Inverse variance weighted,8,1.24 [0.93-1.65],0.148234722715274,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,SPINK5,Serine protease inhibitor Kazal-type 5,Inverse variance weighted,22,0.88 [0.74-1.05],0.150590887734294,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,WFDC1,WAP four-disulfide core domain protein 1,Inverse variance weighted,6,1.21 [0.93-1.56],0.151494926181115,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,EFCAB14,EF-hand calcium-binding domain-containing protein 14,Inverse variance weighted,3,0.46 [0.16-1.33],0.152041847249334,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,IL16,Pro-interleukin-16,Inverse variance weighted,16,1.16 [0.95-1.43],0.152668658034258,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,CD248,Endosialin,Inverse variance weighted,2,0.2 [0.02-1.81],0.152766336593362,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,TNC,Tenascin,Inverse variance weighted,12,0.81 [0.6-1.08],0.156031230612126,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,HRC,Sarcoplasmic reticulum histidine-rich calcium-binding protein,Inverse variance weighted,3,1.62 [0.83-3.18],0.16015235610433,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,PAM,Peptidyl-glycine alpha-amidating monooxygenase,Inverse variance weighted,24,0.91 [0.8-1.04],0.16391729744765,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,REG4,Regenerating islet-derived protein 4,Inverse variance weighted,6,1.3 [0.9-1.89],0.165863615716108,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,B4GALT1,"Beta-1,4-galactosyltransferase 1",Inverse variance weighted,6,1.31 [0.89-1.92],0.168477762268097,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,IL17D,Interleukin-17D,Inverse variance weighted,15,1.18 [0.93-1.48],0.168697471134931,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,LPCAT2,Lysophosphatidylcholine acyltransferase 2,Inverse variance weighted,5,0.72 [0.45-1.15],0.169271652340942,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,IGFBPL1,Insulin-like growth factor-binding protein-like 1,Inverse variance weighted,20,0.9 [0.78-1.05],0.173306484987856,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,AIF1L,Allograft inflammatory factor 1-like,Inverse variance weighted,10,0.76 [0.51-1.13],0.173370117106994,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,GRPEL1,"GrpE protein homolog 1, mitochondrial",Wald ratio,1,3.12 [0.6-16.3],0.177100664283597,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,GUCA2A,Guanylin,Inverse variance weighted,9,0.74 [0.47-1.15],0.177764839867577,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,LAMP3,Lysosome-associated membrane glycoprotein 3,Inverse variance weighted,8,0.79 [0.56-1.12],0.178721976043488,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,CCN5,CCN family member 5,Inverse variance weighted,8,1.6 [0.8-3.19],0.181055163553691,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,REG3A,Regenerating islet-derived protein 3-alpha,Inverse variance weighted,10,1.22 [0.91-1.62],0.183292895707231,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,CSF1,Macrophage colony-stimulating factor 1,Inverse variance weighted,5,0.77 [0.52-1.13],0.184476254237477,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,PNLIPRP1,Inactive pancreatic lipase-related protein 1,Inverse variance weighted,7,0.67 [0.37-1.21],0.184606198095609,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,ACAN,Aggrecan core protein,Inverse variance weighted,3,0.57 [0.24-1.32],0.185862069702561,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,CD38,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1,Inverse variance weighted,16,1.44 [0.84-2.48],0.185916817049105,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,CLEC14A,C-type lectin domain family 14 member A,Wald ratio,1,0.49 [0.17-1.42],0.18746434679716,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,CPA2,Carboxypeptidase A2,Inverse variance weighted,17,0.85 [0.67-1.08],0.187756044587201,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,TNFRSF11B,Tumor necrosis factor receptor superfamily member 11B,Inverse variance weighted,10,0.8 [0.58-1.12],0.19242881433114,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,IGF2R,Cation-independent mannose-6-phosphate receptor,Inverse variance weighted,21,1.14 [0.93-1.4],0.193696357590142,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,DSC2,Desmocollin-2,Inverse variance weighted,9,0.82 [0.61-1.11],0.194838817104767,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,SUSD4,Sushi domain-containing protein 4,Inverse variance weighted,15,1.24 [0.9-1.7],0.194890583668617,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,C7,Complement component C7,Inverse variance weighted,38,1.07 [0.96-1.19],0.195517555255833,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,AGT,Angiotensinogen,Inverse variance weighted,14,0.89 [0.74-1.06],0.198333774665795,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,CD300LF,CMRF35-like molecule 1,Inverse variance weighted,29,0.92 [0.81-1.04],0.198814794929949,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,ART3,Ecto-ADP-ribosyltransferase 3,Inverse variance weighted,10,1.22 [0.9-1.65],0.200849047786014,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,F7,Coagulation factor VII,Inverse variance weighted,21,1.15 [0.93-1.43],0.202083477277289,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,FCN1,Ficolin-1,Inverse variance weighted,28,0.89 [0.74-1.07],0.202731906490372,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,FNDC1,Fibronectin type III domain-containing protein 1,Inverse variance weighted,20,1.15 [0.93-1.43],0.202974792043042,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,COL3A1,Collagen alpha-1(III) chain,Wald ratio,1,0.25 [0.03-2.14],0.203394727456302,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,KLK15,Kallikrein-15,Inverse variance weighted,20,0.94 [0.86-1.03],0.205132149201773,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,PRG2,Bone marrow proteoglycan,Wald ratio,1,2.09 [0.67-6.55],0.206636219767817,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,CD22,B-cell receptor CD22,Inverse variance weighted,6,1.23 [0.89-1.69],0.207062350739425,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,CD164,Sialomucin core protein 24,Inverse variance weighted,3,1.41 [0.82-2.43],0.209039506234377,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,ADAM8,Disintegrin and metalloproteinase domain-containing protein 8,Inverse variance weighted,16,1.17 [0.92-1.48],0.211249145509139,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,NRP2,Neuropilin-2,Inverse variance weighted,11,0.82 [0.59-1.12],0.211636357648675,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,ADAMTS1,A disintegrin and metalloproteinase with thrombospondin motifs 1,Wald ratio,1,4.81 [0.41-56.9],0.212278455242053,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,SEZ6,Seizure protein 6 homolog,Inverse variance weighted,2,0.4 [0.09-1.7],0.212640450325229,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,EPS8L2,Epidermal growth factor receptor kinase substrate 8-like protein 2,Inverse variance weighted,10,0.82 [0.59-1.12],0.214182173432344,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,LILRB2,Leukocyte immunoglobulin-like receptor subfamily B member 2,Inverse variance weighted,25,0.94 [0.85-1.04],0.214468693628497,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,CNTN5,Contactin-5,Inverse variance weighted,28,1.1 [0.95-1.28],0.216290572113761,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,CD80,T-lymphocyte activation antigen CD80,Inverse variance weighted,16,0.89 [0.75-1.07],0.216957802538477,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,SFRP4,Secreted frizzled-related protein 4,Inverse variance weighted,3,0.78 [0.53-1.16],0.220184888315852,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,APOH,Beta-2-glycoprotein 1,Inverse variance weighted,17,0.89 [0.74-1.07],0.220245869234376,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,TGFBR3,Transforming growth factor beta receptor type 3,Inverse variance weighted,6,1.68 [0.73-3.88],0.22152476312721,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,SERPINF1,Pigment epithelium-derived factor,Inverse variance weighted,14,1.19 [0.9-1.59],0.222889765734219,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,CST6,Cystatin-M,Inverse variance weighted,2,0.76 [0.49-1.18],0.223724345238586,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,FGA,Fibrinogen alpha chain,Inverse variance weighted,7,1.39 [0.82-2.38],0.223840378061382,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,SCN4B,Sodium channel subunit beta-4,Inverse variance weighted,24,1.09 [0.95-1.25],0.225095384228772,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,TNFRSF17,Tumor necrosis factor receptor superfamily member 17,Inverse variance weighted,3,1.38 [0.82-2.31],0.226413106406875,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,OGN,Mimecan,Inverse variance weighted,30,1.13 [0.93-1.37],0.227559771602728,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,CCER2,Coiled-coil domain-containing glutamate-rich protein 2,Wald ratio,1,1.2 [0.89-1.62],0.228946512337687,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,ERBB2,Receptor tyrosine-protein kinase erbB-2,Inverse variance weighted,10,0.85 [0.66-1.11],0.230090635672254,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,KRT5,"Keratin, type II cytoskeletal 5",Wald ratio,1,0.58 [0.24-1.41],0.230202078329766,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,CD300E,CMRF35-like molecule 2,Inverse variance weighted,21,1.13 [0.93-1.37],0.230662120856885,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,LILRA5,Leukocyte immunoglobulin-like receptor subfamily A member 5,Inverse variance weighted,7,0.71 [0.4-1.24],0.230869124571343,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,STX8,Syntaxin-8,Wald ratio,1,0.53 [0.19-1.5],0.232755834283466,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,GPR158,Probable G-protein coupled receptor 158,Wald ratio,1,2.35 [0.58-9.56],0.233915168762367,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,FGF21,Fibroblast growth factor 21,Inverse variance weighted,2,0.67 [0.34-1.3],0.234790326721958,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,ANXA5,Annexin A5,Inverse variance weighted,2,1.66 [0.72-3.83],0.235786373734342,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,FABP3,"Fatty acid-binding protein, heart",Inverse variance weighted,4,0.64 [0.3-1.34],0.23610853271191,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,FLRT2,Leucine-rich repeat transmembrane protein FLRT2,Inverse variance weighted,19,1.16 [0.91-1.47],0.236316068826811,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,NEO1,Neogenin,Wald ratio,1,0.5 [0.16-1.59],0.23828719418822,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,MRC1,Macrophage mannose receptor 1,Inverse variance weighted,7,0.69 [0.37-1.29],0.239933936436548,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,IFI30,Gamma-interferon-inducible lysosomal thiol reductase,Inverse variance weighted,13,0.88 [0.72-1.09],0.243216227450022,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,OBP2B,Odorant-binding protein 2b,Inverse variance weighted,20,1.13 [0.92-1.37],0.244266265257582,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,IL10RB,Interleukin-10 receptor subunit beta,Inverse variance weighted,25,0.92 [0.79-1.06],0.249413392442892,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,CALB2,Calretinin,Wald ratio,1,2.32 [0.55-9.73],0.250581005681597,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,BCAM,Basal cell adhesion molecule,Inverse variance weighted,12,1.19 [0.88-1.62],0.250804356247653,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,KLK10,Kallikrein-10,Inverse variance weighted,15,1.14 [0.91-1.43],0.251158306412625,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,CTSB,Cathepsin B,Inverse variance weighted,26,1.1 [0.93-1.31],0.251572012514018,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,CILP,Cartilage intermediate layer protein 1,Inverse variance weighted,8,0.84 [0.62-1.13],0.25174980061629,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,CXCL16,C-X-C motif chemokine 16,Inverse variance weighted,8,1.31 [0.83-2.07],0.25191858403485,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,ITGAV,Integrin alpha-V,Inverse variance weighted,5,1.46 [0.76-2.79],0.253159140823884,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,PDCD1,Programmed cell death protein 1,Inverse variance weighted,9,1.44 [0.77-2.69],0.253418114553737,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,IL18BP,Interleukin-18-binding protein,Inverse variance weighted,3,0.7 [0.38-1.29],0.255022486694753,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,SERPING1,Plasma protease C1 inhibitor,Inverse variance weighted,9,0.84 [0.63-1.13],0.255677599015253,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,GIPC2,PDZ domain-containing protein GIPC2,Inverse variance weighted,16,0.87 [0.68-1.11],0.257763109295993,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,NBL1,Neuroblastoma suppressor of tumorigenicity 1,Inverse variance weighted,2,0.62 [0.27-1.42],0.258109201578967,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,TACSTD2,Tumor-associated calcium signal transducer 2,Inverse variance weighted,22,0.91 [0.78-1.07],0.266760776124472,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,ST3GAL1,"CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 1",Inverse variance weighted,3,0.82 [0.58-1.16],0.267032798249677,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,CD244,Natural killer cell receptor 2B4,Inverse variance weighted,10,1.11 [0.92-1.35],0.268064539815581,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,CEACAM21,Carcinoembryonic antigen-related cell adhesion molecule 21,Inverse variance weighted,43,1.05 [0.96-1.14],0.269090555480723,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,FST,Follistatin,Inverse variance weighted,4,1.36 [0.79-2.36],0.270470150746976,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,CXCL13,C-X-C motif chemokine 13,Wald ratio,1,2.48 [0.49-12.46],0.270799507270998,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,LY6D,Lymphocyte antigen 6D,Inverse variance weighted,22,0.91 [0.76-1.08],0.273230622877135,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,TIMP4,Metalloproteinase inhibitor 4,Inverse variance weighted,17,1.14 [0.9-1.46],0.273354459107495,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,TNFRSF12A,Tumor necrosis factor receptor superfamily member 12A,Inverse variance weighted,4,0.64 [0.29-1.42],0.273460707187648,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,CD7,T-cell antigen CD7,Inverse variance weighted,8,1.11 [0.92-1.34],0.274365889350712,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,SPRR3,Small proline-rich protein 3,Inverse variance weighted,11,1.18 [0.88-1.57],0.275128009340936,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,PCDH7,Protocadherin-7,Inverse variance weighted,3,0.67 [0.33-1.37],0.276787549574841,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Wald ratio,1,0.5 [0.14-1.75],0.277192845326242,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,CRHBP,Corticotropin-releasing factor-binding protein,Inverse variance weighted,28,0.91 [0.78-1.08],0.277723082419025,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,SPINT2,Kunitz-type protease inhibitor 2,Inverse variance weighted,4,1.29 [0.82-2.03],0.278077348568975,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,SPOCK1,Testican-1,Inverse variance weighted,6,0.76 [0.47-1.24],0.278259331698407,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,PRSS27,Serine protease 27,Inverse variance weighted,5,0.83 [0.6-1.16],0.278558404860661,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,PLXNB2,Plexin-B2,Inverse variance weighted,27,1.06 [0.96-1.17],0.279504775590722,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,CLEC1A,C-type lectin domain family 1 member A,Inverse variance weighted,13,1.14 [0.9-1.44],0.27973883581303,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,MATN2,Matrilin-2,Inverse variance weighted,18,1.17 [0.88-1.54],0.2815663027706,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,SPINK6,Serine protease inhibitor Kazal-type 6,Inverse variance weighted,12,0.81 [0.55-1.19],0.28288911506293,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,PCSK9,Proprotein convertase subtilisin/kexin type 9,Inverse variance weighted,5,1.11 [0.92-1.34],0.28302368071112,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,CTSL,Cathepsin L1,Wald ratio,1,0.35 [0.05-2.39],0.283378376546872,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,ROBO4,Roundabout homolog 4,Wald ratio,1,1.73 [0.63-4.72],0.284542772870666,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,CD274,Programmed cell death 1 ligand 1,Inverse variance weighted,22,1.14 [0.9-1.44],0.285021227035792,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,SORCS2,VPS10 domain-containing receptor SorCS2,Inverse variance weighted,21,1.13 [0.91-1.4],0.285355947812642,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,ANGPT2,Angiopoietin-2,Inverse variance weighted,4,1.26 [0.83-1.91],0.285911474107218,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,F11R,Junctional adhesion molecule A,Wald ratio,1,0.45 [0.11-1.95],0.286739834454949,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,REG1B,Lithostathine-1-beta,Inverse variance weighted,18,1.13 [0.9-1.41],0.289758071933298,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,SIGLEC5,Sialic acid-binding Ig-like lectin 5,Inverse variance weighted,30,0.95 [0.86-1.05],0.290299306641994,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,DCBLD2,"Discoidin, CUB and LCCL domain-containing protein 2",Inverse variance weighted,10,1.17 [0.87-1.58],0.290629292569606,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,PRSS22,Brain-specific serine protease 4,Inverse variance weighted,7,1.16 [0.88-1.52],0.292311134350653,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,SEPTIN8,Septin-8,Inverse variance weighted,2,0.71 [0.38-1.34],0.293869115427152,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,SCGB1A1,Uteroglobin,Inverse variance weighted,12,1.15 [0.89-1.48],0.294453193541163,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,INHBB,Inhibin beta B chain,Inverse variance weighted,10,0.89 [0.71-1.11],0.297271415741829,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,KRT19,"Keratin, type I cytoskeletal 19",Wald ratio,1,0.72 [0.38-1.34],0.298025237715682,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,MATN3,Matrilin-3,Inverse variance weighted,28,0.9 [0.74-1.1],0.300058274828449,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,CD300LG,CMRF35-like molecule 9,Inverse variance weighted,6,1.21 [0.84-1.74],0.300716905155214,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,CCL25,C-C motif chemokine 25,Inverse variance weighted,26,0.92 [0.79-1.08],0.301676406886209,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,ITGBL1,Integrin beta-like protein 1,Inverse variance weighted,23,1.12 [0.9-1.41],0.303245633567384,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,CHCHD10,"Coiled-coil-helix-coiled-coil-helix domain-containing protein 10, mitochondrial",Inverse variance weighted,2,0.66 [0.3-1.46],0.303764012497612,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,KLRD1,Natural killer cells antigen CD94,Inverse variance weighted,16,0.91 [0.75-1.09],0.306116280279111,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,BTN3A2,Butyrophilin subfamily 3 member A2,Inverse variance weighted,4,1.26 [0.81-1.98],0.307187612912948,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,PCDHB15,Protocadherin beta-15,Inverse variance weighted,29,1.08 [0.93-1.25],0.307349881183036,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,MAPK9,Mitogen-activated protein kinase 9,Inverse variance weighted,2,1.46 [0.71-3.01],0.307831159942594,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,MXRA8,Matrix remodeling-associated protein 8,Wald ratio,1,0.53 [0.16-1.79],0.310626391511086,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,FAM3C,Protein FAM3C,Inverse variance weighted,2,2.17 [0.48-9.73],0.313270305559635,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,AMOTL2,Angiomotin-like protein 2,Wald ratio,1,2.12 [0.49-9.26],0.316482745311306,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,REN,Renin,Inverse variance weighted,4,1.18 [0.85-1.63],0.318656564399086,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,CNTNAP2,Contactin-associated protein-like 2,Inverse variance weighted,31,1.09 [0.92-1.28],0.319611037061095,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,JAM2,Junctional adhesion molecule B,Inverse variance weighted,2,2.02 [0.5-8.09],0.320420844661833,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,VSTM1,V-set and transmembrane domain-containing protein 1,Inverse variance weighted,26,1.06 [0.94-1.19],0.320837147874105,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,GPNMB,Transmembrane glycoprotein NMB,Inverse variance weighted,19,1.04 [0.96-1.14],0.321236690490303,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,CYB5R2,NADH-cytochrome b5 reductase 2,Inverse variance weighted,14,0.88 [0.69-1.13],0.329880150947337,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,MUC13,Mucin-13,Inverse variance weighted,9,1.19 [0.84-1.69],0.330317724763561,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,ADGRE2,Adhesion G protein-coupled receptor E2,Inverse variance weighted,13,1.14 [0.87-1.49],0.3315669949447,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,PAXX,Protein PAXX,Inverse variance weighted,3,0.77 [0.46-1.3],0.332103228447896,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,PPP1R14D,Protein phosphatase 1 regulatory subunit 14D,Wald ratio,1,2.05 [0.48-8.74],0.334387281345377,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,GFER,FAD-linked sulfhydryl oxidase ALR,Wald ratio,1,0.57 [0.18-1.79],0.336493988848178,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,PLA2G10,Group 10 secretory phospholipase A2,Inverse variance weighted,7,1.28 [0.77-2.12],0.336500333731464,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,C1QTNF5,Complement C1q tumor necrosis factor-related protein 5,Wald ratio,1,1.39 [0.71-2.75],0.337953133602731,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,SPINK2,Serine protease inhibitor Kazal-type 2,Inverse variance weighted,21,1.12 [0.89-1.4],0.338590368756536,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,CD160,CD160 antigen,Inverse variance weighted,11,0.9 [0.72-1.12],0.340003367187595,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,SERPINA3,Alpha-1-antichymotrypsin,Inverse variance weighted,10,1.12 [0.89-1.41],0.341786420222976,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,TGFA,Protransforming growth factor alpha,Inverse variance weighted,2,1.43 [0.68-3.02],0.343550655854336,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,HSPB6,Heat shock protein beta-6,Wald ratio,1,0.34 [0.04-3.18],0.344772559075169,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,SLAMF1,Signaling lymphocytic activation molecule,Inverse variance weighted,2,0.56 [0.17-1.88],0.346598923980628,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,APBB1IP,Amyloid beta A4 precursor protein-binding family B member 1-interacting protein,Inverse variance weighted,3,0.82 [0.54-1.24],0.346936744235359,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,RNASET2,Ribonuclease T2,Inverse variance weighted,14,1.1 [0.9-1.33],0.348026438094366,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,TPSAB1,Tryptase alpha/beta-1,Inverse variance weighted,44,0.97 [0.9-1.04],0.348117205882374,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,ANGPTL3,Angiopoietin-related protein 3,Inverse variance weighted,10,0.88 [0.67-1.15],0.34882875815821,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,HIP1R,Huntingtin-interacting protein 1-related protein,Wald ratio,1,1.6 [0.6-4.27],0.348879368312611,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,CPA4,Carboxypeptidase A4,Inverse variance weighted,21,1.08 [0.92-1.28],0.350012631424296,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,ACY3,N-acyl-aromatic-L-amino acid amidohydrolase,Inverse variance weighted,15,0.86 [0.62-1.18],0.350179236282518,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,PILRB,Paired immunoglobulin-like type 2 receptor beta,Inverse variance weighted,49,1.04 [0.96-1.13],0.352692207860271,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,CLMP,CXADR-like membrane protein,Inverse variance weighted,12,1.12 [0.88-1.43],0.355719084962122,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,ZBTB17,Zinc finger and BTB domain-containing protein 17,Wald ratio,1,0.41 [0.06-2.74],0.355751470654131,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,DSG2,Desmoglein-2,Inverse variance weighted,11,1.15 [0.86-1.54],0.356991113120626,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,IL32,Interleukin-32,Inverse variance weighted,11,1.16 [0.85-1.59],0.35706648646525,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,VEGFB,Vascular endothelial growth factor B,Inverse variance weighted,5,0.78 [0.46-1.32],0.357571463010014,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,GHRL,Appetite-regulating hormone,Inverse variance weighted,3,0.92 [0.76-1.1],0.358337393653003,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,SIGLEC1,Sialoadhesin,Inverse variance weighted,20,0.88 [0.67-1.15],0.358721558645063,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,CCL3,C-C motif chemokine 3,Inverse variance weighted,9,0.88 [0.68-1.15],0.358726847930184,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,SCGB3A1,Secretoglobin family 3A member 1,Inverse variance weighted,2,0.73 [0.37-1.43],0.361126238057456,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,EGLN1,Egl nine homolog 1,Inverse variance weighted,3,0.69 [0.31-1.53],0.3617568149915,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,TNFRSF6B,Tumor necrosis factor receptor superfamily member 6B,Inverse variance weighted,22,1.12 [0.87-1.44],0.361765122927478,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,S100A11,Protein S100-A11,Wald ratio,1,1.33 [0.72-2.47],0.361972484490925,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,FAS,Tumor necrosis factor receptor superfamily member 6,Inverse variance weighted,9,1.14 [0.86-1.5],0.363998891687799,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,DRAXIN,Draxin,Inverse variance weighted,13,1.09 [0.91-1.31],0.364637703823761,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,SMOC2,SPARC-related modular calcium-binding protein 2,Inverse variance weighted,17,1.1 [0.9-1.35],0.365170734464568,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,TGFBR1,TGF-beta receptor type-1,Wald ratio,1,2.25 [0.39-12.94],0.365549649175729,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,PRTG,Protogenin,Inverse variance weighted,19,1.08 [0.92-1.26],0.365695546157542,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,C4BPB,C4b-binding protein beta chain,Inverse variance weighted,8,1.18 [0.83-1.67],0.367393375889314,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,ATOX1,Copper transport protein ATOX1,Wald ratio,1,0.57 [0.16-1.96],0.368055818273023,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,ADAM12,Disintegrin and metalloproteinase domain-containing protein 12,Inverse variance weighted,4,1.22 [0.79-1.86],0.36819156377128,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,AMY2B,Alpha-amylase 2B,Inverse variance weighted,26,0.92 [0.78-1.1],0.372605609605701,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,RTBDN,Retbindin,Inverse variance weighted,3,0.8 [0.49-1.31],0.375479622095761,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,TDGF1,Teratocarcinoma-derived growth factor 1,Inverse variance weighted,50,0.97 [0.9-1.04],0.376269983315115,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,RLN2,Prorelaxin H2,Inverse variance weighted,4,1.3 [0.72-2.33],0.382641125746631,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,CALCB,Calcitonin gene-related peptide 2,Inverse variance weighted,7,0.78 [0.44-1.37],0.383272135258262,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,IGLC2,Immunoglobulin lambda constant 2,Inverse variance weighted,4,0.83 [0.54-1.27],0.384258831493859,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,PRSS2,Trypsin-2,Inverse variance weighted,3,1.57 [0.57-4.32],0.385260189530778,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,HAVCR2,Hepatitis A virus cellular receptor 2,Inverse variance weighted,6,1.06 [0.93-1.21],0.38544135417239,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,EPHA2,Ephrin type-A receptor 2,Inverse variance weighted,3,1.75 [0.49-6.24],0.385846486057864,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,CD46,Membrane cofactor protein,Wald ratio,1,0.64 [0.24-1.75],0.388171676677387,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,TGFB1,Transforming growth factor beta-1 proprotein,Inverse variance weighted,5,0.87 [0.64-1.19],0.388315363284996,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,FDX1,"Adrenodoxin, mitochondrial",Wald ratio,1,2.1 [0.39-11.3],0.388709463734219,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,CHGA,Chromogranin-A,Inverse variance weighted,3,1.31 [0.71-2.43],0.389614848389407,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,LAG3,Lymphocyte activation gene 3 protein,Inverse variance weighted,4,1.22 [0.77-1.93],0.389978588645081,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,KLK4,Kallikrein-4,Inverse variance weighted,17,1.09 [0.9-1.32],0.390703299512071,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,LGALS9,Galectin-9,Inverse variance weighted,26,1.09 [0.89-1.34],0.392467718780235,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,IFNLR1,Interferon lambda receptor 1,Inverse variance weighted,8,1.1 [0.88-1.38],0.39508006281395,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,NXPH3,Neurexophilin-3,Inverse variance weighted,11,1.12 [0.87-1.44],0.395459351770186,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,SOST,Sclerostin,Wald ratio,1,0.5 [0.1-2.51],0.395465206292222,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,CCL16,C-C motif chemokine 16,Inverse variance weighted,19,0.95 [0.83-1.08],0.395708037678437,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,LRG1,Leucine-rich alpha-2-glycoprotein,Inverse variance weighted,26,0.89 [0.69-1.16],0.396394479820067,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,ADGRB3,Adhesion G protein-coupled receptor B3,Inverse variance weighted,50,1.04 [0.95-1.15],0.397194628529385,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,VSNL1,Visinin-like protein 1,Inverse variance weighted,8,0.68 [0.27-1.69],0.403615976978995,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,ACVRL1,Serine/threonine-protein kinase receptor R3,Inverse variance weighted,10,1.1 [0.88-1.36],0.40445539050702,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,KIAA0319,Dyslexia-associated protein KIAA0319,Inverse variance weighted,14,0.91 [0.74-1.13],0.404999073153796,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,SCARA5,Scavenger receptor class A member 5,Inverse variance weighted,10,1.12 [0.86-1.46],0.405074809277188,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,FGF5,Fibroblast growth factor 5,Inverse variance weighted,36,1.07 [0.92-1.24],0.405265180177616,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,CST1,Cystatin-SN,Inverse variance weighted,25,0.94 [0.8-1.09],0.407436731802151,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,AOC3,Membrane primary amine oxidase,Inverse variance weighted,18,0.93 [0.79-1.1],0.408396725231183,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,COL15A1,Collagen alpha-1(XV) chain,Inverse variance weighted,8,1.2 [0.78-1.84],0.410115686556177,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,CD1C,T-cell surface glycoprotein CD1c,Inverse variance weighted,3,0.66 [0.25-1.78],0.410889022698894,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,HYAL1,Hyaluronidase-1,Inverse variance weighted,5,1.23 [0.75-2.03],0.411318636050666,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,CTSV,Cathepsin L2,Inverse variance weighted,11,1.14 [0.83-1.57],0.41132451965382,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,HGF,Hepatocyte growth factor,Inverse variance weighted,2,0.65 [0.24-1.8],0.411890793038358,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,FCRL2,Fc receptor-like protein 2,Inverse variance weighted,36,0.94 [0.8-1.1],0.412121655079093,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,TXNDC15,Thioredoxin domain-containing protein 15,Inverse variance weighted,27,1.05 [0.93-1.19],0.412650076285821,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Inverse variance weighted,6,1.19 [0.78-1.8],0.414602030798972,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,PHLDB1,Pleckstrin homology-like domain family B member 1,Wald ratio,1,2.35 [0.3-18.29],0.416077125281637,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,RGMB,RGM domain family member B,Inverse variance weighted,9,0.82 [0.5-1.33],0.416673722189414,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,IL2RA,Interleukin-2 receptor subunit alpha,Inverse variance weighted,11,1.19 [0.78-1.81],0.416736501791646,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,ENDOU,Poly(U)-specific endoribonuclease,Inverse variance weighted,14,0.9 [0.71-1.16],0.419184050841465,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,TNFRSF19,Tumor necrosis factor receptor superfamily member 19,Inverse variance weighted,8,0.89 [0.66-1.19],0.421680081990838,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,SCARF2,Scavenger receptor class F member 2,Inverse variance weighted,12,1.13 [0.84-1.52],0.430244148498644,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,NOTCH1,Neurogenic locus notch homolog protein 1,Inverse variance weighted,4,1.45 [0.58-3.63],0.430438814471064,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,NTproBNP,N-terminal prohormone of brain natriuretic peptide,Inverse variance weighted,9,0.89 [0.67-1.19],0.433354774058381,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,MCFD2,Multiple coagulation factor deficiency protein 2,Inverse variance weighted,2,1.27 [0.7-2.29],0.434329955821396,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,ADAMTS15,A disintegrin and metalloproteinase with thrombospondin motifs 15,Inverse variance weighted,3,1.4 [0.6-3.25],0.43440689477422,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,HPGDS,Hematopoietic prostaglandin D synthase,Inverse variance weighted,19,1.05 [0.93-1.19],0.436142799200149,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,TINAGL1,Tubulointerstitial nephritis antigen-like,Inverse variance weighted,3,0.65 [0.22-1.92],0.436875161473309,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,CRTAM,Cytotoxic and regulatory T-cell molecule,Inverse variance weighted,15,1.09 [0.88-1.34],0.437960509928813,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,TGFBR2,TGF-beta receptor type-2,Inverse variance weighted,3,0.54 [0.11-2.59],0.439319428352266,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,TNFRSF10A,Tumor necrosis factor receptor superfamily member 10A,Inverse variance weighted,25,1.07 [0.9-1.27],0.439702646424014,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,GPHA2,Glycoprotein hormone alpha-2,Inverse variance weighted,3,0.85 [0.56-1.28],0.440071150466767,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,PKD1,Polycystin-1,Inverse variance weighted,12,1.12 [0.84-1.51],0.440246723133016,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,CD70,CD70 antigen,Inverse variance weighted,28,0.95 [0.82-1.09],0.440789062260385,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,MSLN,Mesothelin,Inverse variance weighted,25,1.07 [0.9-1.27],0.441203251431408,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,IL6R,Interleukin-6 receptor subunit alpha,Inverse variance weighted,56,1.04 [0.95-1.14],0.441888699593168,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,GPIHBP1,Glycosylphosphatidylinositol-anchored high density lipoprotein-binding protein 1,Inverse variance weighted,10,1.12 [0.84-1.47],0.441940699650821,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,BCHE,Cholinesterase,Inverse variance weighted,30,1.1 [0.86-1.4],0.445487991213942,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,PON1,Serum paraoxonase/arylesterase 1,Inverse variance weighted,41,1.04 [0.95-1.13],0.445677636371011,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,SULT2A1,Bile salt sulfotransferase,Inverse variance weighted,4,0.89 [0.66-1.2],0.446402065073048,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,GFAP,Glial fibrillary acidic protein,Inverse variance weighted,4,0.74 [0.34-1.61],0.447527361447877,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,NCR1,Natural cytotoxicity triggering receptor 1,Inverse variance weighted,6,0.9 [0.69-1.18],0.45468701612286,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,NPHS1,Nephrin,Inverse variance weighted,20,0.93 [0.76-1.13],0.457003611722527,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,IGFBP6,Insulin-like growth factor-binding protein 6,Inverse variance weighted,2,1.4 [0.58-3.4],0.457113312330753,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,CA14,Carbonic anhydrase 14,Inverse variance weighted,8,0.95 [0.83-1.09],0.457545621196281,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,AHNAK2,Protein AHNAK2,Inverse variance weighted,4,0.86 [0.59-1.27],0.459291528022705,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,XCL1,Lymphotactin,Inverse variance weighted,31,1.06 [0.91-1.23],0.460476068668821,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,FSHB,Follitropin subunit beta,Inverse variance weighted,2,1.52 [0.5-4.65],0.46053810666914,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,NHLRC3,NHL repeat-containing protein 3,Inverse variance weighted,8,1.16 [0.78-1.72],0.463334729082014,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,RARRES1,Retinoic acid receptor responder protein 1,Inverse variance weighted,28,1.06 [0.9-1.25],0.463851903632268,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,TIGIT,T-cell immunoreceptor with Ig and ITIM domains,Wald ratio,1,0.67 [0.23-1.96],0.464188539602398,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,MAN1A2,"Mannosyl-oligosaccharide 1,2-alpha-mannosidase IB",Inverse variance weighted,11,1.13 [0.81-1.59],0.467884966690861,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,MMP7,Matrilysin,Inverse variance weighted,13,0.92 [0.72-1.16],0.470230974517938,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,C1QA,Complement C1q subcomponent subunit A,Inverse variance weighted,15,1.1 [0.85-1.41],0.470371232056431,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,GPR15L,Protein GPR15L,Inverse variance weighted,9,0.9 [0.68-1.2],0.471775841573444,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,MZB1,Marginal zone B- and B1-cell-specific protein,Wald ratio,1,0.41 [0.04-4.6],0.471921081030642,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,PLAUR,Urokinase plasminogen activator surface receptor,Inverse variance weighted,2,1.33 [0.61-2.89],0.471927484782789,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,LILRA2,Leukocyte immunoglobulin-like receptor subfamily A member 2,Inverse variance weighted,14,1.12 [0.82-1.53],0.472553274898304,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,TPK1,Thiamin pyrophosphokinase 1,Inverse variance weighted,19,1.07 [0.89-1.29],0.476470277366167,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,WFIKKN2,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 2",Inverse variance weighted,29,0.93 [0.78-1.13],0.47703036494755,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,CST7,Cystatin-F,Inverse variance weighted,39,0.95 [0.83-1.09],0.477391613630048,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,EFHD1,EF-hand domain-containing protein D1,Inverse variance weighted,9,0.86 [0.57-1.31],0.478208154587542,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,HJV,Hemojuvelin,Wald ratio,1,1.19 [0.73-1.95],0.478542122067165,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,RARRES2,Retinoic acid receptor responder protein 2,Inverse variance weighted,2,1.17 [0.76-1.81],0.480812581255844,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,MMP13,Collagenase 3,Inverse variance weighted,2,1.85 [0.33-10.26],0.481278734185962,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,DSG4,Desmoglein-4,Wald ratio,1,2.59 [0.18-37.26],0.483403901528504,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,SCARF1,Scavenger receptor class F member 1,Inverse variance weighted,11,1.1 [0.84-1.46],0.484026320461831,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,IL18R1,Interleukin-18 receptor 1,Inverse variance weighted,46,0.96 [0.86-1.07],0.487478658413561,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,RNASE6,Ribonuclease K6,Inverse variance weighted,15,1.06 [0.9-1.26],0.487699750121828,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,CD300C,CMRF35-like molecule 6,Inverse variance weighted,12,1.06 [0.9-1.25],0.488386766406771,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,EPHB4,Ephrin type-B receptor 4,Wald ratio,1,1.22 [0.69-2.17],0.490658004252744,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,SIGLEC8,Sialic acid-binding Ig-like lectin 8,Inverse variance weighted,21,0.95 [0.83-1.09],0.492031459581294,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,LRP11,Low-density lipoprotein receptor-related protein 11,Inverse variance weighted,33,1.06 [0.9-1.26],0.494523594275187,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,MYOC,Myocilin,Inverse variance weighted,21,1.09 [0.85-1.42],0.494598656221322,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,SPINK4,Serine protease inhibitor Kazal-type 4,Inverse variance weighted,29,1.04 [0.92-1.18],0.49548016178702,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,ALCAM,CD166 antigen,Inverse variance weighted,6,1.22 [0.69-2.13],0.495737337040171,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,ERBB4,Receptor tyrosine-protein kinase erbB-4,Inverse variance weighted,7,1.12 [0.8-1.57],0.495836297551992,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,DLL1,Delta-like protein 1,Inverse variance weighted,7,1.18 [0.73-1.91],0.497504135466608,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,AKAP12,A-kinase anchor protein 12,Wald ratio,1,2.42 [0.19-31.28],0.499315529862552,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,FCAMR,High affinity immunoglobulin alpha and immunoglobulin mu Fc receptor,Inverse variance weighted,30,1.07 [0.87-1.33],0.500685369812973,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,ADGRE1,Adhesion G protein-coupled receptor E1,Inverse variance weighted,14,1.07 [0.88-1.31],0.501577388268347,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,DBI,Acyl-CoA-binding protein,Inverse variance weighted,9,0.9 [0.65-1.24],0.504769355808907,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,SLITRK1,SLIT and NTRK-like protein 1,Wald ratio,1,0.75 [0.33-1.73],0.506457099745047,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,MILR1,Allergin-1,Inverse variance weighted,33,0.97 [0.88-1.07],0.507483527384201,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,CD300A,CMRF35-like molecule 8,Inverse variance weighted,5,1.11 [0.81-1.54],0.507725611535593,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,MAD1L1,Mitotic spindle assembly checkpoint protein MAD1,Inverse variance weighted,4,0.79 [0.39-1.59],0.508460598166179,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,STC2,Stanniocalcin-2,Inverse variance weighted,3,0.72 [0.27-1.93],0.50908940372122,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,IGSF3,Immunoglobulin superfamily member 3,Inverse variance weighted,2,0.62 [0.15-2.57],0.510199931334001,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,VCAM1,Vascular cell adhesion protein 1,Inverse variance weighted,2,0.69 [0.23-2.08],0.512443151170867,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,SLC39A5,Zinc transporter ZIP5,Inverse variance weighted,2,0.74 [0.31-1.81],0.513937333141094,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,CA5A,"Carbonic anhydrase 5A, mitochondrial",Inverse variance weighted,26,1.1 [0.82-1.47],0.514112879306719,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,BCL2,Apoptosis regulator Bcl-2,Inverse variance weighted,2,1.91 [0.27-13.49],0.515209523951616,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,RSPO1,R-spondin-1,Inverse variance weighted,5,0.89 [0.62-1.28],0.515478552697163,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,CEACAM20,Carcinoembryonic antigen-related cell adhesion molecule 20,Inverse variance weighted,2,0.78 [0.37-1.64],0.516454974154203,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,CKAP4,Cytoskeleton-associated protein 4,Inverse variance weighted,10,1.12 [0.8-1.56],0.516598492228536,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,PVR,Poliovirus receptor,Inverse variance weighted,27,0.96 [0.85-1.08],0.5207284905553,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,PTPRF,Receptor-type tyrosine-protein phosphatase F,Inverse variance weighted,2,1.42 [0.48-4.21],0.521835772655164,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,TNFRSF13C,Tumor necrosis factor receptor superfamily member 13C,Inverse variance weighted,23,1.06 [0.89-1.26],0.524622567881088,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,LGALS4,Galectin-4,Inverse variance weighted,4,1.2 [0.69-2.07],0.524703767893218,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,COLEC12,Collectin-12,Inverse variance weighted,11,1.17 [0.72-1.91],0.5252868637497,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,GCHFR,GTP cyclohydrolase 1 feedback regulatory protein,Wald ratio,1,1.42 [0.48-4.16],0.527454993298716,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,LAIR2,Leukocyte-associated immunoglobulin-like receptor 2,Inverse variance weighted,32,1.04 [0.91-1.2],0.527979426080388,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,CD83,CD83 antigen,Inverse variance weighted,5,0.87 [0.55-1.35],0.52858423828247,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,GGT5,Glutathione hydrolase 5 proenzyme,Inverse variance weighted,22,0.94 [0.78-1.14],0.530944354253595,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,CXCL17,C-X-C motif chemokine 17,Inverse variance weighted,2,0.7 [0.22-2.16],0.53246925392838,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,CRIP2,Cysteine-rich protein 2,Inverse variance weighted,5,0.79 [0.38-1.64],0.534007527874572,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,TFPI2,Tissue factor pathway inhibitor 2,Inverse variance weighted,8,1.13 [0.77-1.67],0.536806153055446,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,FABP4,"Fatty acid-binding protein, adipocyte",Wald ratio,1,1.39 [0.48-4.01],0.539210068120008,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,IL17RB,Interleukin-17 receptor B,Inverse variance weighted,36,0.96 [0.86-1.08],0.539494598381553,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,IL1RN,Interleukin-1 receptor antagonist protein,Inverse variance weighted,10,0.9 [0.65-1.25],0.539951209432111,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,PYY,Peptide YY,Inverse variance weighted,6,0.88 [0.6-1.31],0.540650539126113,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,NPPB,Natriuretic peptides B,Inverse variance weighted,3,0.86 [0.53-1.39],0.541109811016422,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,IL15,Interleukin-15,Wald ratio,1,0.11 [0-142.36],0.542100129820074,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,BMP10,Bone morphogenetic protein 10,Inverse variance weighted,10,0.93 [0.72-1.19],0.544263943433012,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,CTRL,Chymotrypsin-like protease CTRL-1,Inverse variance weighted,2,0.71 [0.23-2.17],0.544516907397722,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,ANXA10,Annexin A10,Wald ratio,1,0.59 [0.1-3.31],0.545240092339576,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,CD200,OX-2 membrane glycoprotein,Inverse variance weighted,6,1.13 [0.76-1.69],0.545858843661064,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,MEP1B,Meprin A subunit beta,Inverse variance weighted,46,1.03 [0.94-1.13],0.546652795198783,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,ARHGEF5,Rho guanine nucleotide exchange factor 5,Inverse variance weighted,19,0.95 [0.8-1.13],0.547325107842303,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,ANG,Angiogenin,Inverse variance weighted,19,1.06 [0.87-1.3],0.54815604496592,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,AGR2,Anterior gradient protein 2 homolog,Wald ratio,1,1.28 [0.57-2.91],0.548591968956763,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,ICAM1,Intercellular adhesion molecule 1,Inverse variance weighted,28,0.95 [0.8-1.12],0.548752714122971,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,NPTXR,Neuronal pentraxin receptor,Inverse variance weighted,11,1.03 [0.92-1.16],0.550104685147177,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,IGFBP1,Insulin-like growth factor-binding protein 1,Wald ratio,1,0.55 [0.08-3.95],0.552027025177925,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,MFAP4,Microfibril-associated glycoprotein 4,Inverse variance weighted,4,1.12 [0.77-1.64],0.555594735553516,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,IL12RB1,Interleukin-12 receptor subunit beta-1,Inverse variance weighted,13,0.93 [0.74-1.18],0.556800624415631,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,HMBS,Porphobilinogen deaminase,Inverse variance weighted,5,0.86 [0.53-1.4],0.557223107182865,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,PRRT3,Proline-rich transmembrane protein 3,Inverse variance weighted,4,1.12 [0.76-1.67],0.558818594083091,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,ACE,Angiotensin-converting enzyme,Inverse variance weighted,26,1.06 [0.88-1.27],0.560231872730551,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,CRELD1,Protein disulfide isomerase CRELD1,Inverse variance weighted,34,1.05 [0.88-1.26],0.562836485183194,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,GRN,Progranulin,Inverse variance weighted,7,1.09 [0.81-1.47],0.564243195567064,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,TMSB10,Thymosin beta-10,Wald ratio,1,1.57 [0.34-7.25],0.564763783837765,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,CSPG4,Chondroitin sulfate proteoglycan 4,Inverse variance weighted,5,1.18 [0.67-2.09],0.566532336964973,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,IL1RL1,Interleukin-1 receptor-like 1,Inverse variance weighted,44,0.95 [0.81-1.12],0.567584125231228,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,SIRPB1,Signal-regulatory protein beta-1,Inverse variance weighted,27,1.05 [0.9-1.22],0.57056552199765,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,GDF15,Growth/differentiation factor 15,Inverse variance weighted,12,1.16 [0.7-1.92],0.570635357495092,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,FGF23,Fibroblast growth factor 23,Inverse variance weighted,2,1.64 [0.29-9.19],0.571529587616502,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,TFF3,Trefoil factor 3,Inverse variance weighted,5,0.87 [0.54-1.4],0.571771489005853,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,CDH1,Cadherin-1,Wald ratio,1,1.73 [0.26-11.61],0.573119547239425,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,EPPK1,Epiplakin,Inverse variance weighted,33,0.96 [0.84-1.1],0.573789062690422,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,CLGN,Calmegin,Inverse variance weighted,23,1.04 [0.9-1.21],0.574756638894031,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,SERPINB8,Serpin B8,Inverse variance weighted,28,1.03 [0.93-1.14],0.57555398552524,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,COL6A3,Collagen alpha-3(VI) chain,Inverse variance weighted,2,0.64 [0.14-3.04],0.576331730217984,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,DSG3,Desmoglein-3,Inverse variance weighted,7,0.89 [0.57-1.37],0.581250987496853,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,EPHB6,Ephrin type-B receptor 6,Inverse variance weighted,9,1.1 [0.79-1.52],0.58166979003734,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,TNFSF13,Tumor necrosis factor ligand superfamily member 13,Inverse variance weighted,10,1.08 [0.82-1.43],0.582595284909452,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,ISM1,Isthmin-1,Inverse variance weighted,10,1.09 [0.8-1.48],0.583301372474099,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,MCAM,Cell surface glycoprotein MUC18,Wald ratio,1,0.83 [0.43-1.61],0.584327293665437,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,ADAMTS4,A disintegrin and metalloproteinase with thrombospondin motifs 4,Wald ratio,1,1.23 [0.58-2.59],0.584822775533159,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,MERTK,Tyrosine-protein kinase Mer,Inverse variance weighted,11,1.09 [0.8-1.5],0.585973360604695,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,MDK,Midkine,Inverse variance weighted,4,1.17 [0.66-2.08],0.58890265106983,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,INHBC,Inhibin beta C chain,Inverse variance weighted,29,0.96 [0.85-1.1],0.589139178347412,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,PALM2,Paralemmin-2,Inverse variance weighted,8,1.1 [0.77-1.58],0.589663653548447,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,CD8A,T-cell surface glycoprotein CD8 alpha chain,Inverse variance weighted,9,1.11 [0.75-1.64],0.592671145358735,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,ST6GAL1,"Beta-galactoside alpha-2,6-sialyltransferase 1",Inverse variance weighted,8,0.91 [0.64-1.29],0.593603017093881,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,LECT2,Leukocyte cell-derived chemotaxin-2,Inverse variance weighted,44,0.96 [0.83-1.12],0.594710104389624,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,MAP2,Microtubule-associated protein 2,Wald ratio,1,2 [0.15-26.6],0.599759690767764,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,CX3CL1,Fractalkine,Inverse variance weighted,9,0.9 [0.6-1.34],0.599778542900762,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,ADIPOQ,Adiponectin,Inverse variance weighted,13,0.92 [0.69-1.24],0.601931000338612,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,RSPO3,R-spondin-3,Inverse variance weighted,6,0.89 [0.56-1.4],0.60221529888376,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,SPON2,Spondin-2,Inverse variance weighted,4,0.9 [0.62-1.32],0.602709471292032,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,TGOLN2,Trans-Golgi network integral membrane protein 2,Inverse variance weighted,32,0.96 [0.84-1.11],0.60288363190889,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,CAPG,Macrophage-capping protein,Inverse variance weighted,33,1.05 [0.88-1.26],0.603327848877466,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,LAYN,Layilin,Inverse variance weighted,20,0.93 [0.73-1.21],0.604151347659044,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,ICAM2,Intercellular adhesion molecule 2,Inverse variance weighted,2,1.44 [0.36-5.65],0.605049356716095,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,DPT,Dermatopontin,Inverse variance weighted,21,0.94 [0.75-1.19],0.605078290759624,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,PGA4,Pepsin A-4,Inverse variance weighted,2,1.36 [0.42-4.42],0.60603761197023,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,OSCAR,Osteoclast-associated immunoglobulin-like receptor,Inverse variance weighted,24,1.03 [0.92-1.16],0.606693860124502,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,AHNAK,Neuroblast differentiation-associated protein AHNAK,Inverse variance weighted,3,1.2 [0.6-2.41],0.607116888304934,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,TPMT,Thiopurine S-methyltransferase,Inverse variance weighted,10,1.05 [0.86-1.29],0.607773869131012,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,CLEC5A,C-type lectin domain family 5 member A,Inverse variance weighted,8,0.93 [0.7-1.23],0.609939180466712,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,NELL1,Protein kinase C-binding protein NELL1,Inverse variance weighted,10,1.07 [0.83-1.37],0.611100418505572,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,KLRK1,NKG2-D type II integral membrane protein,Inverse variance weighted,19,1.05 [0.87-1.28],0.612498796026412,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,CPA1,Carboxypeptidase A1,Inverse variance weighted,2,1.15 [0.67-1.96],0.612639180862668,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,RTN4R,Reticulon-4 receptor,Inverse variance weighted,15,0.95 [0.78-1.16],0.613508028602872,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,GRP,Gastrin-releasing peptide,Inverse variance weighted,12,0.95 [0.79-1.15],0.61609843161849,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,ULBP2,UL16-binding protein 2,Inverse variance weighted,25,1.04 [0.9-1.2],0.617773953920216,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,TG,Thyroglobulin,Inverse variance weighted,2,1.28 [0.48-3.41],0.619912953020468,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,VCAN,Versican core protein,Inverse variance weighted,31,0.96 [0.83-1.12],0.619973058739837,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,PRAP1,Proline-rich acidic protein 1,Inverse variance weighted,7,1.09 [0.77-1.53],0.624919589309049,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,VIT,Vitrin,Inverse variance weighted,25,1.03 [0.91-1.18],0.625352569615784,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,MEPE,Matrix extracellular phosphoglycoprotein,Inverse variance weighted,3,0.86 [0.47-1.58],0.62661869944895,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,PLIN3,Perilipin-3,Wald ratio,1,0.74 [0.22-2.5],0.626787022716205,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,NECTIN4,Nectin-4,Inverse variance weighted,7,1.07 [0.82-1.39],0.628761702040863,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,GM2A,Ganglioside GM2 activator,Inverse variance weighted,24,0.96 [0.83-1.12],0.629498649028139,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,SPARCL1,SPARC-like protein 1,Inverse variance weighted,35,0.97 [0.85-1.11],0.630312868462565,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,SORBS1,Sorbin and SH3 domain-containing protein 1,Inverse variance weighted,2,2.05 [0.11-37.97],0.630481487847392,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,GFRA2,GDNF family receptor alpha-2,Inverse variance weighted,21,0.95 [0.78-1.16],0.63139559932236,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,ITIH3,Inter-alpha-trypsin inhibitor heavy chain H3,Inverse variance weighted,20,1.08 [0.79-1.46],0.631438599185027,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,CRIM1,Cysteine-rich motor neuron 1 protein,Inverse variance weighted,7,1.12 [0.71-1.75],0.631531095583068,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,MMP10,Stromelysin-2,Inverse variance weighted,22,1.06 [0.84-1.34],0.632719802286933,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,FGFR4,Fibroblast growth factor receptor 4,Inverse variance weighted,42,0.97 [0.87-1.09],0.632825844926168,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,DTNB,Dystrobrevin beta,Inverse variance weighted,2,1.59 [0.23-10.83],0.633646843631662,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,CSTB,Cystatin-B,Inverse variance weighted,28,1.04 [0.88-1.24],0.633813148453655,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,IL12B,Interleukin-12 subunit beta,Inverse variance weighted,24,1.04 [0.88-1.24],0.63482376551755,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,EPO,Erythropoietin,Inverse variance weighted,5,0.78 [0.28-2.17],0.635183442223872,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,F2R,Proteinase-activated receptor 1,Inverse variance weighted,2,0.64 [0.1-4.12],0.636219159854722,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,ORM1,Alpha-1-acid glycoprotein 1,Inverse variance weighted,17,0.95 [0.75-1.19],0.636240742748324,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,PLA2G1B,Phospholipase A2,Wald ratio,1,1.45 [0.31-6.74],0.637583718564572,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,EPHA1,Ephrin type-A receptor 1,Inverse variance weighted,8,0.93 [0.67-1.27],0.638223190322258,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,VAMP5,Vesicle-associated membrane protein 5,Wald ratio,1,1.66 [0.2-13.59],0.63854246775139,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,PTN,Pleiotrophin,Inverse variance weighted,4,1.2 [0.56-2.53],0.640506784737487,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,CHGB,Secretogranin-1,Inverse variance weighted,27,1.04 [0.89-1.21],0.64220077736142,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,PEAR1,Platelet endothelial aggregation receptor 1,Inverse variance weighted,9,1.09 [0.76-1.56],0.64441315737237,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,COL5A1,Collagen alpha-1(V) chain,Inverse variance weighted,8,0.91 [0.62-1.35],0.645546761579306,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,LUZP2,Leucine zipper protein 2,Inverse variance weighted,8,0.92 [0.64-1.32],0.645569819093292,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,LBP,Lipopolysaccharide-binding protein,Inverse variance weighted,21,0.97 [0.86-1.1],0.646550164008856,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,CLEC7A,C-type lectin domain family 7 member A,Inverse variance weighted,25,1.03 [0.92-1.15],0.646670631481781,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,CCL21,C-C motif chemokine 21,Inverse variance weighted,4,1.17 [0.59-2.31],0.649737942603911,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,NPC2,NPC intracellular cholesterol transporter 2,Inverse variance weighted,10,1.08 [0.78-1.5],0.65073192061349,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,FGL1,Fibrinogen-like protein 1,Inverse variance weighted,30,0.96 [0.81-1.14],0.65271842499315,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,PTPRC,Receptor-type tyrosine-protein phosphatase C,Inverse variance weighted,8,1.19 [0.56-2.54],0.654843254335898,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,IL18,Interleukin-18,Inverse variance weighted,16,1.13 [0.65-1.96],0.656175158379395,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,TFRC,Transferrin receptor protein 1,Inverse variance weighted,28,0.95 [0.78-1.17],0.657266655264386,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,PTPRR,Receptor-type tyrosine-protein phosphatase R,Inverse variance weighted,4,0.81 [0.32-2.06],0.658421385295013,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,VWA1,von Willebrand factor A domain-containing protein 1,Inverse variance weighted,6,1.04 [0.88-1.22],0.659322334068396,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,HSPA2,Heat shock-related 70 kDa protein 2,Inverse variance weighted,3,1.27 [0.44-3.7],0.660047891623695,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,SDC1,Syndecan-1,Inverse variance weighted,2,1.27 [0.43-3.78],0.662892773671761,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,CD86,T-lymphocyte activation antigen CD86,Inverse variance weighted,5,1.11 [0.69-1.8],0.663253994484733,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,CANT1,Soluble calcium-activated nucleotidase 1,Inverse variance weighted,2,1.23 [0.48-3.11],0.665636070363615,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,LSP1,Lymphocyte-specific protein 1,Inverse variance weighted,6,1.18 [0.56-2.48],0.665681388245676,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,ADAM22,Disintegrin and metalloproteinase domain-containing protein 22,Inverse variance weighted,40,1.03 [0.91-1.17],0.666688789448071,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,VWC2,Brorin,Inverse variance weighted,22,1.05 [0.84-1.31],0.667097690409562,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,ADAMTSL4,ADAMTS-like protein 4,Inverse variance weighted,12,1.06 [0.83-1.35],0.667581691802321,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,CD33,Myeloid cell surface antigen CD33,Inverse variance weighted,36,1.02 [0.93-1.11],0.669702455234973,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,LIFR,Leukemia inhibitory factor receptor,Inverse variance weighted,4,1.09 [0.74-1.61],0.6701647837087,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,IL19,Interleukin-19,Inverse variance weighted,11,0.95 [0.73-1.23],0.670193276721334,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,ANGPTL1,Angiopoietin-related protein 1,Inverse variance weighted,14,1.04 [0.86-1.27],0.674333978861679,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,DCTPP1,dCTP pyrophosphatase 1,Wald ratio,1,1.53 [0.21-11.14],0.67504228793222,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,EDDM3B,Epididymal secretory protein E3-beta,Inverse variance weighted,3,0.85 [0.38-1.86],0.675945850470406,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,KIR2DL2,Killer cell immunoglobulin-like receptor 2DL2,Inverse variance weighted,16,0.91 [0.59-1.41],0.682230756877624,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,IL15RA,Interleukin-15 receptor subunit alpha,Inverse variance weighted,14,1.05 [0.82-1.35],0.683550539851742,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,AMY2A,Pancreatic alpha-amylase,Inverse variance weighted,25,0.96 [0.81-1.15],0.683800663124564,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,EFEMP1,EGF-containing fibulin-like extracellular matrix protein 1,Inverse variance weighted,6,0.9 [0.55-1.48],0.685483675868897,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,CDNF,Cerebral dopamine neurotrophic factor,Inverse variance weighted,12,0.96 [0.78-1.18],0.686219330413555,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,SPP1,Osteopontin,Inverse variance weighted,8,0.88 [0.47-1.65],0.689265294280079,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,YAP1,Transcriptional coactivator YAP1,Wald ratio,1,0.75 [0.18-3.09],0.689792127534516,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,CLIC5,Chloride intracellular channel protein 5,Inverse variance weighted,2,0.87 [0.44-1.73],0.690217417209668,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,TAFA5,Chemokine-like protein TAFA-5,Inverse variance weighted,10,0.94 [0.7-1.27],0.69513312338783,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,CALCA,Calcitonin,Inverse variance weighted,5,0.87 [0.44-1.73],0.695327828179887,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,AXL,Tyrosine-protein kinase receptor UFO,Inverse variance weighted,8,0.94 [0.68-1.29],0.696060787178221,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,CTRB1,Chymotrypsinogen B,Inverse variance weighted,27,1.04 [0.87-1.23],0.696201048319602,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,SMOC1,SPARC-related modular calcium-binding protein 1,Inverse variance weighted,15,0.95 [0.72-1.25],0.696600738055531,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,CRH,Corticoliberin,Inverse variance weighted,11,0.95 [0.74-1.22],0.696723895836291,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,STAB2,Stabilin-2,Inverse variance weighted,20,1.03 [0.87-1.23],0.697879946992035,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,CD27,CD27 antigen,Inverse variance weighted,9,1.07 [0.77-1.48],0.698128036612523,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,LPL,Lipoprotein lipase,Inverse variance weighted,14,0.95 [0.74-1.22],0.698394575676454,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,CD28,T-cell-specific surface glycoprotein CD28,Inverse variance weighted,5,1.09 [0.7-1.7],0.699531331133633,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,ELN,Elastin,Inverse variance weighted,2,0.8 [0.25-2.54],0.700171423536132,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,ADAM9,Disintegrin and metalloproteinase domain-containing protein 9,Inverse variance weighted,11,0.9 [0.51-1.57],0.701234947548899,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,MEGF9,Multiple epidermal growth factor-like domains protein 9,Inverse variance weighted,11,1.06 [0.8-1.4],0.701783413069018,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,CFD,Complement factor D,Inverse variance weighted,11,0.95 [0.71-1.26],0.70298454673343,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,IL22RA1,Interleukin-22 receptor subunit alpha-1,Inverse variance weighted,7,0.91 [0.55-1.5],0.704602032911797,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,LAIR1,Leukocyte-associated immunoglobulin-like receptor 1,Inverse variance weighted,16,0.95 [0.75-1.21],0.704825612282611,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,PRTN3,Myeloblastin,Inverse variance weighted,21,1.06 [0.79-1.41],0.707434980565113,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,CCL14,C-C motif chemokine 14,Inverse variance weighted,12,1.03 [0.87-1.22],0.708159539242492,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,CFHR2,Complement factor H-related protein 2,Inverse variance weighted,63,1.02 [0.94-1.1],0.70863485063435,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,CCN3,CCN family member 3,Inverse variance weighted,19,0.95 [0.71-1.26],0.711475274886491,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,COL1A1,Collagen alpha-1(I) chain,Wald ratio,1,0.69 [0.1-4.83],0.712604778565274,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,LTBR,Tumor necrosis factor receptor superfamily member 3,Inverse variance weighted,6,1.05 [0.8-1.38],0.713247751460204,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,CCL17,C-C motif chemokine 17,Inverse variance weighted,9,1.06 [0.76-1.49],0.715749902260163,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,VGF,Neurosecretory protein VGF,Wald ratio,1,0.64 [0.06-7.08],0.716013649237732,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,FCER1A,High affinity immunoglobulin epsilon receptor subunit alpha,Inverse variance weighted,6,1.16 [0.51-2.64],0.716626225603543,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,IL36G,Interleukin-36 gamma,Inverse variance weighted,2,0.8 [0.24-2.66],0.71906218898899,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,LTBP3,Latent-transforming growth factor beta-binding protein 3,Inverse variance weighted,17,1.04 [0.85-1.26],0.719310841294036,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,CCN4,CCN family member 4,Inverse variance weighted,27,1.03 [0.88-1.21],0.719801930886042,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,TNFRSF14,Tumor necrosis factor receptor superfamily member 14,Wald ratio,1,1.15 [0.54-2.46],0.722235904808962,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,PDCD1LG2,Programmed cell death 1 ligand 2,Inverse variance weighted,37,1.04 [0.84-1.28],0.723253096327064,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,ATRAID,All-trans retinoic acid-induced differentiation factor,Inverse variance weighted,8,0.95 [0.7-1.28],0.723416554638062,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,CCDC80,Coiled-coil domain-containing protein 80,Inverse variance weighted,3,1.31 [0.29-5.81],0.724216595994427,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,CBLIF,Cobalamin binding intrinsic factor,Inverse variance weighted,2,0.85 [0.34-2.12],0.725785070354467,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,VWC2L,von Willebrand factor C domain-containing protein 2-like,Wald ratio,1,0.84 [0.31-2.29],0.726951655420246,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,CA12,Carbonic anhydrase 12,Inverse variance weighted,13,1.04 [0.83-1.3],0.727052227848256,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,KIRREL2,Kin of IRRE-like protein 2,Inverse variance weighted,11,0.93 [0.64-1.37],0.727444485665911,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,FAM171B,Protein FAM171B,Inverse variance weighted,21,1.04 [0.84-1.29],0.730239014413461,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,CDH5,Cadherin-5,Inverse variance weighted,3,1.1 [0.65-1.85],0.730573991355343,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,TFF2,Trefoil factor 2,Inverse variance weighted,5,1.1 [0.65-1.86],0.730810646323691,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,PIGR,Polymeric immunoglobulin receptor,Inverse variance weighted,21,1.1 [0.63-1.93],0.732415718630907,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,CLPS,Colipase,Inverse variance weighted,39,1.03 [0.87-1.21],0.732700321220798,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,FCER2,Low affinity immunoglobulin epsilon Fc receptor,Inverse variance weighted,11,0.96 [0.76-1.21],0.734688971966906,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,LMOD1,Leiomodin-1,Inverse variance weighted,5,0.88 [0.42-1.84],0.735133704201665,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,ABL1,Tyrosine-protein kinase ABL1,Wald ratio,1,0.8 [0.21-3.03],0.737121991786609,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,ESAM,Endothelial cell-selective adhesion molecule,Inverse variance weighted,3,0.86 [0.34-2.13],0.737478465350358,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,LRIG1,Leucine-rich repeats and immunoglobulin-like domains protein 1,Inverse variance weighted,30,0.98 [0.85-1.12],0.738571605662127,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,IL6ST,Interleukin-6 receptor subunit beta,Inverse variance weighted,3,1.08 [0.67-1.75],0.740162745881031,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,THBD,Thrombomodulin,Inverse variance weighted,5,0.93 [0.59-1.45],0.74167106618158,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,ASGR1,Asialoglycoprotein receptor 1,Inverse variance weighted,2,0.92 [0.55-1.53],0.74189318516862,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,CGA,Glycoprotein hormones alpha chain,Wald ratio,1,1.53 [0.12-20.19],0.744448783464982,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,SUMF2,Inactive C-alpha-formylglycine-generating enzyme 2,Inverse variance weighted,42,0.97 [0.82-1.15],0.744695947188923,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,LAMB1,Laminin subunit beta-1,Inverse variance weighted,35,0.97 [0.82-1.15],0.745661088454526,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,EDIL3,EGF-like repeat and discoidin I-like domain-containing protein 3,Inverse variance weighted,3,1.16 [0.48-2.79],0.745705286266522,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,ACTA2,"Actin, aortic smooth muscle",Wald ratio,1,0.79 [0.18-3.39],0.746741842588731,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,SCG3,Secretogranin-3,Inverse variance weighted,32,0.97 [0.79-1.18],0.751684815062825,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,ENAH,Protein enabled homolog,Inverse variance weighted,2,1.2 [0.38-3.78],0.753847526742473,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,RBP2,Retinol-binding protein 2,Wald ratio,1,0.79 [0.19-3.39],0.754972656164525,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,COL4A1,Collagen alpha-1(IV) chain,Inverse variance weighted,3,0.88 [0.38-2.02],0.756278279876574,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,WIF1,Wnt inhibitory factor 1,Inverse variance weighted,2,1.11 [0.57-2.15],0.756924840599677,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,SCGB3A2,Secretoglobin family 3A member 2,Inverse variance weighted,5,1.05 [0.75-1.49],0.761441468714235,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,FABP5,Fatty acid-binding protein 5,Wald ratio,1,1.1 [0.59-2.08],0.762030300102032,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,BOLA1,BolA-like protein 1,Wald ratio,1,1.16 [0.43-3.12],0.763618386883563,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,IFNL1,Interferon lambda-1,Wald ratio,1,1.36 [0.18-10.18],0.763811034807545,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,PILRA,Paired immunoglobulin-like type 2 receptor alpha,Inverse variance weighted,46,1.01 [0.92-1.12],0.764107330336307,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,REG1A,Lithostathine-1-alpha,Inverse variance weighted,13,0.96 [0.75-1.24],0.764575449817333,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,BST2,Bone marrow stromal antigen 2,Inverse variance weighted,2,1.06 [0.72-1.58],0.764589336782522,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,LY96,Lymphocyte antigen 96,Inverse variance weighted,3,0.86 [0.33-2.24],0.764658254276489,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,PI3,Elafin,Inverse variance weighted,10,0.95 [0.65-1.37],0.765594515746074,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,EGFR,Epidermal growth factor receptor,Inverse variance weighted,7,0.9 [0.44-1.85],0.768989997012429,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,CXCL14,C-X-C motif chemokine 14,Wald ratio,1,1.31 [0.22-7.81],0.770143035339382,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,CD59,CD59 glycoprotein,Inverse variance weighted,4,1.08 [0.66-1.76],0.771935741015859,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,Inverse variance weighted,6,1.06 [0.7-1.61],0.774977942795042,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,CTSZ,Cathepsin Z,Inverse variance weighted,3,0.95 [0.68-1.33],0.775430606054644,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,BTN2A1,Butyrophilin subfamily 2 member A1,Wald ratio,1,0.87 [0.33-2.27],0.776728147210362,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,FAM3D,Protein FAM3D,Inverse variance weighted,17,1.05 [0.75-1.47],0.77698941425672,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,WNT9A,Protein Wnt-9a,Inverse variance weighted,3,0.91 [0.47-1.76],0.777596544264986,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,SLMAP,Sarcolemmal membrane-associated protein,Inverse variance weighted,2,1.17 [0.39-3.51],0.781384865661181,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,ADAM23,Disintegrin and metalloproteinase domain-containing protein 23,Inverse variance weighted,37,1.02 [0.89-1.17],0.784657511257444,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,CD55,Complement decay-accelerating factor,Inverse variance weighted,15,1.03 [0.82-1.3],0.784869740978156,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,CGREF1,Cell growth regulator with EF hand domain protein 1,Inverse variance weighted,29,0.98 [0.85-1.14],0.787166558024218,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,RNF149,E3 ubiquitin-protein ligase RNF149,Inverse variance weighted,5,0.96 [0.71-1.29],0.789716052042145,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,B3GNT7,"UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7",Inverse variance weighted,28,0.98 [0.85-1.13],0.789849290966338,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,C1QTNF1,Complement C1q tumor necrosis factor-related protein 1,Inverse variance weighted,7,1.02 [0.86-1.22],0.790077579431333,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,LGALS1,Galectin-1,Inverse variance weighted,6,1.04 [0.78-1.39],0.79192021650572,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,PRR4,Proline-rich protein 4,Inverse variance weighted,36,0.98 [0.86-1.12],0.795869906808541,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,HS3ST3B1,Heparan sulfate glucosamine 3-O-sulfotransferase 3B1,Inverse variance weighted,17,1.03 [0.85-1.24],0.796143304115872,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,PDGFRA,Platelet-derived growth factor receptor alpha,Inverse variance weighted,9,1.06 [0.7-1.59],0.797300151579493,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,RGMA,Repulsive guidance molecule A,Inverse variance weighted,12,0.97 [0.77-1.23],0.800882233583635,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,ADGRG1,Adhesion G-protein coupled receptor G1,Inverse variance weighted,5,1.14 [0.41-3.16],0.801532545424022,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,SLITRK6,SLIT and NTRK-like protein 6,Inverse variance weighted,14,1.02 [0.85-1.23],0.802196147395362,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,PODXL2,Podocalyxin-like protein 2,Inverse variance weighted,5,0.98 [0.83-1.16],0.804435182499494,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,DPY30,Protein dpy-30 homolog,Wald ratio,1,1.28 [0.17-9.73],0.808440692889536,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,OGFR,Opioid growth factor receptor,Inverse variance weighted,2,1.22 [0.23-6.51],0.811884358297055,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,SMPD3,Sphingomyelin phosphodiesterase 3,Wald ratio,1,0.79 [0.11-5.48],0.811944819953657,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,COL18A1,Collagen alpha-1(XVIII) chain,Inverse variance weighted,12,1.04 [0.74-1.46],0.813570847967893,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,EFNA4,Ephrin-A4,Inverse variance weighted,3,1.11 [0.47-2.64],0.814534180059531,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,ERMAP,Erythroid membrane-associated protein,Inverse variance weighted,2,1.12 [0.43-2.93],0.815415485717198,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,S100A4,Protein S100-A4,Inverse variance weighted,4,1.06 [0.63-1.8],0.81660417445562,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,CD72,B-cell differentiation antigen CD72,Inverse variance weighted,3,1.1 [0.48-2.52],0.817543264291287,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,OSMR,Oncostatin-M-specific receptor subunit beta,Inverse variance weighted,27,0.98 [0.83-1.16],0.817732773705474,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,KRT18,"Keratin, type I cytoskeletal 18",Wald ratio,1,1.25 [0.19-8.37],0.818029659430824,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,RNASE1,Ribonuclease pancreatic,Inverse variance weighted,4,0.96 [0.65-1.4],0.818111151350217,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,RELT,Tumor necrosis factor receptor superfamily member 19L,Inverse variance weighted,14,0.97 [0.76-1.25],0.820355169256092,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,KIR2DL3,Killer cell immunoglobulin-like receptor 2DL3,Inverse variance weighted,17,0.97 [0.72-1.3],0.82158270064447,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Inverse variance weighted,19,0.97 [0.76-1.25],0.82180890184454,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,FOLR2,Folate receptor beta,Inverse variance weighted,2,0.92 [0.45-1.89],0.825429344791518,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,DNMBP,Dynamin-binding protein,Inverse variance weighted,5,0.95 [0.61-1.48],0.832020022280714,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,FBLN2,Fibulin-2,Inverse variance weighted,11,1.03 [0.81-1.3],0.834400083825515,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,OPTC,Opticin,Inverse variance weighted,9,1.02 [0.84-1.25],0.836894782841464,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,CCL15,C-C motif chemokine 15,Inverse variance weighted,22,1.01 [0.91-1.12],0.83739481092926,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,THPO,Thrombopoietin,Inverse variance weighted,3,1.12 [0.38-3.28],0.837436492456457,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,TNFRSF21,Tumor necrosis factor receptor superfamily member 21,Inverse variance weighted,12,1.05 [0.68-1.6],0.837607779818366,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,FABP1,"Fatty acid-binding protein, liver",Inverse variance weighted,5,0.95 [0.57-1.58],0.840524031837696,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,EGFLAM,Pikachurin,Inverse variance weighted,19,1.01 [0.88-1.17],0.844149348521948,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,ICOSLG,ICOS ligand,Inverse variance weighted,12,1.06 [0.57-1.99],0.845168276998184,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,AGRN,Agrin,Inverse variance weighted,17,1.03 [0.75-1.41],0.849069736940168,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,CLEC10A,C-type lectin domain family 10 member A,Inverse variance weighted,18,1.01 [0.87-1.18],0.851219603359942,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,FABP9,Fatty acid-binding protein 9,Inverse variance weighted,4,1.07 [0.53-2.13],0.851953156816977,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,DTX3,Probable E3 ubiquitin-protein ligase DTX3,Inverse variance weighted,3,0.9 [0.27-2.93],0.85649531920024,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,CLEC4G,C-type lectin domain family 4 member G,Inverse variance weighted,6,0.97 [0.67-1.39],0.857526811180292,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,CCL18,C-C motif chemokine 18,Inverse variance weighted,15,1.01 [0.87-1.18],0.859560939245514,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,AGRP,Agouti-related protein,Inverse variance weighted,3,0.92 [0.37-2.31],0.861646851456631,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,LMNB2,Lamin-B2,Wald ratio,1,0.82 [0.09-7.33],0.862741235653657,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,CHI3L1,Chitinase-3-like protein 1,Inverse variance weighted,21,1.01 [0.89-1.16],0.863191105476799,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,VEGFA,Vascular endothelial growth factor A,Inverse variance weighted,28,1.01 [0.89-1.15],0.864812324793711,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,FGFR2,Fibroblast growth factor receptor 2,Inverse variance weighted,5,0.9 [0.26-3.09],0.865810849087105,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,TREM2,Triggering receptor expressed on myeloid cells 2,Inverse variance weighted,4,0.96 [0.57-1.62],0.869333042232286,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,RNASE4,Ribonuclease 4,Inverse variance weighted,11,1.02 [0.8-1.31],0.874072743189319,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,IL17C,Interleukin-17C,Inverse variance weighted,3,1.05 [0.55-2.02],0.874121289236535,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,RNASE10,Inactive ribonuclease-like protein 10,Inverse variance weighted,25,1.01 [0.91-1.12],0.87438084966169,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,IDI2,Isopentenyl-diphosphate delta-isomerase 2,Inverse variance weighted,9,1.02 [0.83-1.25],0.876843679385384,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,CLC,Galectin-10,Wald ratio,1,1.08 [0.41-2.86],0.877312352565131,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,CEACAM8,Carcinoembryonic antigen-related cell adhesion molecule 8,Wald ratio,1,0.94 [0.45-1.97],0.87790298652483,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,FSTL1,Follistatin-related protein 1,Inverse variance weighted,3,0.96 [0.55-1.67],0.879089248664947,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,PTH1R,Parathyroid hormone/parathyroid hormone-related peptide receptor,Inverse variance weighted,9,0.98 [0.75-1.27],0.880121168664937,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,SIRPA,Tyrosine-protein phosphatase non-receptor type substrate 1,Inverse variance weighted,44,1.01 [0.93-1.09],0.880958665501876,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,SDC4,Syndecan-4,Inverse variance weighted,8,0.97 [0.65-1.44],0.881744972848505,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,DNER,Delta and Notch-like epidermal growth factor-related receptor,Inverse variance weighted,12,1.02 [0.78-1.34],0.883301818542117,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,HAVCR1,Hepatitis A virus cellular receptor 1,Inverse variance weighted,27,1.01 [0.84-1.22],0.885244237595433,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,KLRF1,Killer cell lectin-like receptor subfamily F member 1,Inverse variance weighted,2,0.95 [0.48-1.9],0.8890068364094,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,KLK8,Kallikrein-8,Inverse variance weighted,12,1.02 [0.76-1.36],0.890673837638624,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,GAS6,Growth arrest-specific protein 6,Inverse variance weighted,9,1.03 [0.64-1.66],0.891166270977316,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,THY1,Thy-1 membrane glycoprotein,Inverse variance weighted,10,0.99 [0.82-1.19],0.892449083389295,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,SNCG,Gamma-synuclein,Inverse variance weighted,36,0.99 [0.86-1.14],0.892727646694747,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,KLRB1,Killer cell lectin-like receptor subfamily B member 1,Wald ratio,1,0.84 [0.07-9.94],0.893033554805547,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,BCL2L15,Bcl-2-like protein 15,Inverse variance weighted,5,1.03 [0.64-1.65],0.893771586437942,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,PDZK1,Na(+)/H(+) exchange regulatory cofactor NHE-RF3,Wald ratio,1,0.95 [0.43-2.11],0.895412556489679,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,ITGA11,Integrin alpha-11,Inverse variance weighted,8,0.98 [0.71-1.34],0.895987058554387,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,FCRLB,Fc receptor-like B,Inverse variance weighted,61,1.01 [0.89-1.14],0.897571534691164,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,EPHA4,Ephrin type-A receptor 4,Inverse variance weighted,4,0.96 [0.54-1.71],0.899662249321486,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,NOTCH2,Neurogenic locus notch homolog protein 2,Inverse variance weighted,7,1.04 [0.6-1.8],0.901726561289335,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,PGLYRP1,Peptidoglycan recognition protein 1,Inverse variance weighted,7,1.02 [0.71-1.48],0.903704342648207,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,NUCB2,Nucleobindin-2,Inverse variance weighted,24,0.99 [0.8-1.22],0.90458306691389,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,CXADR,Coxsackievirus and adenovirus receptor,Inverse variance weighted,2,0.9 [0.17-4.78],0.905114557588682,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,PTGDS,Prostaglandin-H2 D-isomerase,Inverse variance weighted,4,0.96 [0.45-2.03],0.905348291691639,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,FABP6,Gastrotropin,Wald ratio,1,0.96 [0.49-1.87],0.907904119123347,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,BGLAP,Osteocalcin,Inverse variance weighted,2,0.86 [0.06-12.18],0.908394885246985,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,EDN1,Endothelin-1,Inverse variance weighted,3,0.98 [0.66-1.45],0.911321568317798,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,CA3,Carbonic anhydrase 3,Inverse variance weighted,6,0.97 [0.57-1.65],0.912238522139391,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,FABP2,"Fatty acid-binding protein, intestinal",Inverse variance weighted,3,0.98 [0.67-1.43],0.912407702595583,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,PRG3,Proteoglycan 3,Inverse variance weighted,4,0.97 [0.56-1.68],0.915974267520616,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,PGF,Placenta growth factor,Inverse variance weighted,2,1.13 [0.12-10.26],0.916066633080473,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,GP1BA,Platelet glycoprotein Ib alpha chain,Inverse variance weighted,2,0.96 [0.42-2.2],0.916234523149065,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,SEZ6L2,Seizure 6-like protein 2,Inverse variance weighted,5,1.02 [0.67-1.55],0.917155122378247,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,WFDC2,WAP four-disulfide core domain protein 2,Inverse variance weighted,2,0.96 [0.42-2.2],0.918476388584039,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,SCRG1,Scrapie-responsive protein 1,Inverse variance weighted,3,0.94 [0.3-2.97],0.918598365239747,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,TNFAIP2,Tumor necrosis factor alpha-induced protein 2,Inverse variance weighted,3,0.97 [0.5-1.86],0.919337984663283,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,KLK14,Kallikrein-14,Inverse variance weighted,15,1.01 [0.77-1.33],0.919531591065364,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,TXNDC5,Thioredoxin domain-containing protein 5,Inverse variance weighted,3,0.97 [0.5-1.88],0.919685559693907,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,NPPC,C-type natriuretic peptide,Wald ratio,1,0.9 [0.11-7.57],0.919877171438409,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,SLAMF7,SLAM family member 7,Inverse variance weighted,20,1.01 [0.87-1.17],0.923902449937,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,LAMA4,Laminin subunit alpha-4,Inverse variance weighted,2,1.02 [0.62-1.7],0.926079969384804,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,ROR1,Inactive tyrosine-protein kinase transmembrane receptor ROR1,Inverse variance weighted,12,1.01 [0.81-1.27],0.926772795707482,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,CDCP1,CUB domain-containing protein 1,Inverse variance weighted,14,1.01 [0.77-1.34],0.927001853429805,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,TNFRSF1B,Tumor necrosis factor receptor superfamily member 1B,Inverse variance weighted,4,0.97 [0.53-1.79],0.927414666489327,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,FSTL3,Follistatin-related protein 3,Inverse variance weighted,4,1.03 [0.58-1.83],0.928195442271322,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,TCOF1,Treacle protein,Wald ratio,1,0.93 [0.16-5.48],0.932204246048019,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,PTPRZ1,Receptor-type tyrosine-protein phosphatase zeta,Inverse variance weighted,6,1.02 [0.7-1.48],0.934000954791521,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,PTK7,Inactive tyrosine-protein kinase 7,Wald ratio,1,0.93 [0.18-4.88],0.93583977800614,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,NRCAM,Neuronal cell adhesion molecule,Inverse variance weighted,15,1.01 [0.8-1.28],0.937530767459839,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,CHRDL2,Chordin-like protein 2,Inverse variance weighted,7,0.98 [0.61-1.58],0.938731584124121,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,TFF1,Trefoil factor 1,Inverse variance weighted,8,1.01 [0.74-1.39],0.940176878646097,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,DDAH1,"N(G),N(G)-dimethylarginine dimethylaminohydrolase 1",Inverse variance weighted,8,1.02 [0.58-1.8],0.940465492369242,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,CD276,CD276 antigen,Inverse variance weighted,20,1.01 [0.85-1.19],0.941625971096517,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,DKK4,Dickkopf-related protein 4,Inverse variance weighted,4,0.96 [0.35-2.64],0.941628127457709,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,TNFRSF10C,Tumor necrosis factor receptor superfamily member 10C,Inverse variance weighted,11,1.01 [0.76-1.34],0.942473914285443,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,PXN,Paxillin,Inverse variance weighted,26,1.01 [0.85-1.2],0.942791397642641,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,IL1R1,Interleukin-1 receptor type 1,Inverse variance weighted,7,0.98 [0.6-1.61],0.943524975460188,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,KITLG,Kit ligand,Wald ratio,1,1.07 [0.19-6.12],0.943690373991926,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,LRRC25,Leucine-rich repeat-containing protein 25,Inverse variance weighted,13,0.99 [0.72-1.36],0.94372263653756,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,PI16,Peptidase inhibitor 16,Inverse variance weighted,15,0.99 [0.77-1.27],0.945072680490327,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,IGF1R,Insulin-like growth factor 1 receptor,Inverse variance weighted,4,0.98 [0.48-1.98],0.946394820767959,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,ITGB6,Integrin beta-6,Inverse variance weighted,11,0.99 [0.73-1.34],0.947389937486139,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,CD79B,B-cell antigen receptor complex-associated protein beta chain,Inverse variance weighted,2,0.98 [0.58-1.67],0.947758852522185,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,PRSS8,Prostasin,Inverse variance weighted,5,0.97 [0.4-2.39],0.949743532246125,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,KLK11,Kallikrein-11,Inverse variance weighted,6,1.01 [0.84-1.21],0.950626095953688,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,PIK3IP1,Phosphoinositide-3-kinase-interacting protein 1,Inverse variance weighted,14,1.01 [0.78-1.3],0.950870396989332,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,TIMP2,Metalloproteinase inhibitor 2,Inverse variance weighted,2,0.98 [0.44-2.19],0.952496862690508,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,LCN15,Lipocalin-15,Inverse variance weighted,20,1 [0.86-1.15],0.953106299249422,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,PYDC1,Pyrin domain-containing protein 1,Inverse variance weighted,12,0.99 [0.74-1.33],0.954939211563725,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,GFRA3,GDNF family receptor alpha-3,Inverse variance weighted,2,0.97 [0.29-3.19],0.957181950554,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,LGALS3,Galectin-3,Inverse variance weighted,25,1 [0.84-1.2],0.95778011613488,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,MAPK13,Mitogen-activated protein kinase 13,Wald ratio,1,1.04 [0.2-5.34],0.960908798593678,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,GSN,Gelsolin,Inverse variance weighted,5,0.98 [0.5-1.95],0.961373001266152,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,NPY,Pro-neuropeptide Y,Inverse variance weighted,3,1.02 [0.46-2.24],0.961743532895856,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,TYRP1,"5,6-dihydroxyindole-2-carboxylic acid oxidase",Wald ratio,1,0.97 [0.31-3.08],0.961824399551557,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,CD302,CD302 antigen,Inverse variance weighted,9,0.99 [0.74-1.34],0.962937346972281,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,CDH15,Cadherin-15,Inverse variance weighted,18,1 [0.8-1.23],0.964144721238107,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,NECTIN2,Nectin-2,Inverse variance weighted,5,0.99 [0.62-1.57],0.964436574368275,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,MMP8,Neutrophil collagenase,Inverse variance weighted,17,1 [0.84-1.2],0.96476860383846,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,IL4R,Interleukin-4 receptor subunit alpha,Inverse variance weighted,10,1.01 [0.78-1.29],0.966662269728388,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,TNFRSF8,Tumor necrosis factor receptor superfamily member 8,Inverse variance weighted,5,0.99 [0.66-1.49],0.967319274369681,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,CALB1,Calbindin,Inverse variance weighted,2,0.98 [0.36-2.66],0.968582445704874,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,LILRB4,Leukocyte immunoglobulin-like receptor subfamily B member 4,Inverse variance weighted,14,0.99 [0.63-1.57],0.970562447439212,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,VWF,von Willebrand factor,Inverse variance weighted,2,0.99 [0.46-2.13],0.97075790567115,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,CD207,C-type lectin domain family 4 member K,Inverse variance weighted,21,1 [0.83-1.21],0.972316013391697,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,IGFBP7,Insulin-like growth factor-binding protein 7,Inverse variance weighted,19,1 [0.8-1.26],0.972959347892437,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,PON3,Serum paraoxonase/lactonase 3,Inverse variance weighted,16,1 [0.82-1.2],0.973176285607843,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,JAM3,Junctional adhesion molecule C,Inverse variance weighted,4,1.01 [0.53-1.92],0.975743474003373,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,WFDC12,WAP four-disulfide core domain protein 12,Inverse variance weighted,19,1 [0.84-1.2],0.976614144963223,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,BSG,Basigin,Wald ratio,1,0.99 [0.52-1.87],0.976703627085467,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,CA4,Carbonic anhydrase 4,Inverse variance weighted,12,1 [0.81-1.24],0.982384033618585,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,CDH6,Cadherin-6,Inverse variance weighted,29,1 [0.87-1.15],0.988049913779703,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,CTSE,Cathepsin E,Inverse variance weighted,14,1 [0.83-1.21],0.988074744753764,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,CEACAM19,Carcinoembryonic antigen-related cell adhesion molecule 19,Inverse variance weighted,3,1 [0.55-1.79],0.988307806350081,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,CA9,Carbonic anhydrase 9,Inverse variance weighted,3,1 [0.54-1.82],0.990207555823513,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,BAG3,BAG family molecular chaperone regulator 3,Inverse variance weighted,2,1.01 [0.2-5.04],0.990359416907872,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,PTPRS,Receptor-type tyrosine-protein phosphatase S,Inverse variance weighted,16,1 [0.84-1.2],0.990878176392128,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,CTSO,Cathepsin O,Inverse variance weighted,6,1 [0.67-1.5],0.991791317986403,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,DPP4,Dipeptidyl peptidase 4,Inverse variance weighted,9,1 [0.72-1.4],0.992781961817829,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,SNED1,"Sushi, nidogen and EGF-like domain-containing protein 1",Inverse variance weighted,8,1 [0.61-1.63],0.993473800233654,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,PSAPL1,Proactivator polypeptide-like 1,Inverse variance weighted,20,1 [0.87-1.15],0.996288241902751,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,CD58,Lymphocyte function-associated antigen 3,Inverse variance weighted,4,1 [0.66-1.51],0.997991258514779,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,NOTCH3,Neurogenic locus notch homolog protein 3,Inverse variance weighted,2,1 [0.42-2.38],0.998357407149214,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,CD74,HLA class II histocompatibility antigen gamma chain,Wald ratio,1,1 [0.13-7.69],0.998418587319514,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,PLA2G2A,"Phospholipase A2, membrane associated",Inverse variance weighted,19,1 [0.83-1.21],0.999623178991213,cis
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,TNFRSF14,Tumor necrosis factor receptor superfamily member 14,Wald ratio,1,118.2 [17.2-812.13],1.21390475843429e-06,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,SERPINA3,Alpha-1-antichymotrypsin,Inverse variance weighted,2,0.09 [0.03-0.36],0.000507127572898882,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,SEMA4C,Semaphorin-4C,Inverse variance weighted,3,5.38 [1.92-15.06],0.00133769259650147,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,NT5C1A,Cytosolic 5'-nucleotidase 1A,Inverse variance weighted,4,2.34 [1.37-3.98],0.0017683584927081,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,NCR1,Natural cytotoxicity triggering receptor 1,Inverse variance weighted,29,1.59 [1.17-2.16],0.00313989047305715,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,IGFBP4,Insulin-like growth factor-binding protein 4,Inverse variance weighted,3,5.1 [1.66-15.64],0.00437972396509014,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,SNRPB2,U2 small nuclear ribonucleoprotein B'',Inverse variance weighted,2,10.26 [2.01-52.51],0.00517182707318112,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,EPHB6,Ephrin type-B receptor 6,Inverse variance weighted,3,10.24 [1.94-53.97],0.00606142274889816,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,SOST,Sclerostin,Inverse variance weighted,31,1.46 [1.11-1.91],0.00639550140000551,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,ICAM2,Intercellular adhesion molecule 2,Inverse variance weighted,79,0.86 [0.77-0.96],0.00687560931434134,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,CPXM2,Inactive carboxypeptidase-like protein X2,Inverse variance weighted,26,0.76 [0.62-0.93],0.00841044394475334,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,CD163,Scavenger receptor cysteine-rich type 1 protein M130,Inverse variance weighted,38,1.42 [1.09-1.85],0.00970210583061188,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,SMTN,Smoothelin,Wald ratio,1,0.17 [0.04-0.65],0.00972496864855695,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,CDH2,Cadherin-2,Inverse variance weighted,21,0.64 [0.46-0.91],0.0123628157785217,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,LRP11,Low-density lipoprotein receptor-related protein 11,Inverse variance weighted,5,3.69 [1.3-10.51],0.0144689178769755,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,DNER,Delta and Notch-like epidermal growth factor-related receptor,Inverse variance weighted,18,1.7 [1.11-2.62],0.0154783348423854,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,AMBP,Protein AMBP,Inverse variance weighted,5,1.94 [1.13-3.31],0.0155427285389884,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,BCL2L15,Bcl-2-like protein 15,Inverse variance weighted,2,3.78 [1.26-11.28],0.017339491798559,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,CD40,Tumor necrosis factor receptor superfamily member 5,Inverse variance weighted,11,0.75 [0.59-0.95],0.0180481110747216,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,PI16,Peptidase inhibitor 16,Inverse variance weighted,22,1.3 [1.05-1.62],0.0184934761631022,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,EGFLAM,Pikachurin,Wald ratio,1,24.48 [1.66-359.92],0.0197234625426114,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,THPO,Thrombopoietin,Inverse variance weighted,12,0.6 [0.39-0.93],0.0207215132385401,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,MMP13,Collagenase 3,Wald ratio,1,0.11 [0.02-0.73],0.022771677699154,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,SCARB2,Lysosome membrane protein 2,Inverse variance weighted,10,2.13 [1.11-4.08],0.023100554409232,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,EGLN1,Egl nine homolog 1,Wald ratio,1,11.07 [1.38-88.52],0.0234007093904248,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,GDF15,Growth/differentiation factor 15,Wald ratio,1,0.05 [0-0.7],0.0256092144234069,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,WIF1,Wnt inhibitory factor 1,Inverse variance weighted,31,0.71 [0.52-0.96],0.0272829083936053,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,TEX101,Testis-expressed protein 101,Wald ratio,1,0.04 [0-0.7],0.0276346878225001,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,IGFBP7,Insulin-like growth factor-binding protein 7,Inverse variance weighted,4,0.36 [0.15-0.9],0.0279424654124339,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,LGALS7_LGALS7B,Galectin-7,Inverse variance weighted,15,1.93 [1.07-3.48],0.0280245770418454,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,FCAMR,High affinity immunoglobulin alpha and immunoglobulin mu Fc receptor,Inverse variance weighted,16,1.73 [1.06-2.82],0.0291782545563499,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,KLK10,Kallikrein-10,Wald ratio,1,0.08 [0.01-0.78],0.0300204073638757,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,CLEC1A,C-type lectin domain family 1 member A,Inverse variance weighted,7,0.82 [0.68-0.98],0.0301972368767209,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,CDH5,Cadherin-5,Inverse variance weighted,23,0.85 [0.74-0.98],0.0304486088568253,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,C1QTNF5,Complement C1q tumor necrosis factor-related protein 5,Inverse variance weighted,19,1.39 [1.03-1.86],0.0308513816502002,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,EPO,Erythropoietin,Inverse variance weighted,11,0.69 [0.49-0.97],0.0315387385638247,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,EDIL3,EGF-like repeat and discoidin I-like domain-containing protein 3,Inverse variance weighted,4,0.54 [0.31-0.96],0.0340942225242647,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,IDI2,Isopentenyl-diphosphate delta-isomerase 2,Inverse variance weighted,3,0.3 [0.1-0.92],0.0347061336866927,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,VWC2,Brorin,Inverse variance weighted,12,2.13 [1.05-4.3],0.0349365465928551,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,PRKAB1,5'-AMP-activated protein kinase subunit beta-1,Wald ratio,1,0.11 [0.01-0.87],0.0360339190479597,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,CD244,Natural killer cell receptor 2B4,Inverse variance weighted,18,1.49 [1.02-2.17],0.0366989464262085,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,MMP8,Neutrophil collagenase,Inverse variance weighted,10,1.6 [1.03-2.49],0.037597380149154,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,NGRN,Neugrin,Inverse variance weighted,4,2.32 [1.05-5.12],0.0378202480932667,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,F7,Coagulation factor VII,Inverse variance weighted,10,1.77 [1.03-3.04],0.0383107499135217,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,TPSAB1,Tryptase alpha/beta-1,Inverse variance weighted,23,0.58 [0.35-0.97],0.0384490624428599,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,TNFRSF10B,Tumor necrosis factor receptor superfamily member 10B,Inverse variance weighted,3,0.38 [0.15-0.95],0.0385018447015061,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,SPINK2,Serine protease inhibitor Kazal-type 2,Inverse variance weighted,17,1.61 [1.02-2.53],0.0388624809471974,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,FABP1,"Fatty acid-binding protein, liver",Inverse variance weighted,2,8.73 [1.11-68.44],0.0392701852281671,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,PRR4,Proline-rich protein 4,Inverse variance weighted,14,1.52 [1.02-2.27],0.0408144704804943,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,ITGA11,Integrin alpha-11,Inverse variance weighted,7,0.53 [0.28-0.98],0.0415344381725085,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,PGLYRP1,Peptidoglycan recognition protein 1,Inverse variance weighted,16,1.57 [1.02-2.43],0.0421411385191736,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,IL1RN,Interleukin-1 receptor antagonist protein,Inverse variance weighted,4,2.52 [1.03-6.17],0.0432274483678343,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,C1QTNF9,Complement C1q and tumor necrosis factor-related protein 9A,Inverse variance weighted,12,1.76 [1.01-3.04],0.0442679464855868,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,CD160,CD160 antigen,Inverse variance weighted,24,0.66 [0.44-0.99],0.0447109610025373,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,OSM,Oncostatin-M,Inverse variance weighted,6,1.74 [1.01-3],0.0451128236965275,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,OPTC,Opticin,Inverse variance weighted,16,1.59 [1.01-2.52],0.0461216916597164,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,SPINT2,Kunitz-type protease inhibitor 2,Inverse variance weighted,7,0.62 [0.39-0.99],0.0463639625632353,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,DLL1,Delta-like protein 1,Inverse variance weighted,6,5.36 [1.02-28.2],0.0477151525064751,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,LECT2,Leukocyte cell-derived chemotaxin-2,Inverse variance weighted,11,1.83 [1-3.35],0.0493161542435349,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,MYBPC2,"Myosin-binding protein C, fast-type",Inverse variance weighted,4,2.68 [0.99-7.23],0.0517021803267508,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,KAZALD1,Kazal-type serine protease inhibitor domain-containing protein 1,Inverse variance weighted,43,1.08 [1-1.17],0.051880547089242,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,ANGPTL1,Angiopoietin-related protein 1,Inverse variance weighted,7,0.57 [0.32-1.01],0.0525995336303802,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,CHI3L1,Chitinase-3-like protein 1,Inverse variance weighted,5,2.42 [0.99-5.92],0.0538334271222031,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,HSDL2,Hydroxysteroid dehydrogenase-like protein 2,Inverse variance weighted,29,1.2 [1-1.43],0.0542157799938055,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,CD248,Endosialin,Inverse variance weighted,17,0.65 [0.42-1.01],0.0548576308198614,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,CCL11,Eotaxin,Inverse variance weighted,11,1.33 [0.99-1.78],0.0557417287608871,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,CHCHD10,"Coiled-coil-helix-coiled-coil-helix domain-containing protein 10, mitochondrial",Inverse variance weighted,2,2.09 [0.98-4.46],0.0574042344584944,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,VAMP5,Vesicle-associated membrane protein 5,Wald ratio,1,0.14 [0.02-1.07],0.0581360525038939,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,PBXIP1,Pre-B-cell leukemia transcription factor-interacting protein 1,Wald ratio,1,0.15 [0.02-1.08],0.0596213656332687,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,IL32,Interleukin-32,Inverse variance weighted,9,1.64 [0.98-2.77],0.0612736202601408,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,MSTN,Growth/differentiation factor 8,Inverse variance weighted,11,1.84 [0.97-3.47],0.0614048417643823,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,DBI,Acyl-CoA-binding protein,Wald ratio,1,0.33 [0.1-1.08],0.0658667580107083,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",Inverse variance weighted,22,0.86 [0.73-1.01],0.0682513480904082,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,TNFRSF10C,Tumor necrosis factor receptor superfamily member 10C,Inverse variance weighted,59,0.88 [0.76-1.01],0.069051561772462,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,DNM3,Dynamin-3,Inverse variance weighted,11,0.73 [0.53-1.03],0.070316144692733,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,FAM3D,Protein FAM3D,Inverse variance weighted,38,1.19 [0.98-1.44],0.071631185980439,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,PSAP,Prosaposin,Inverse variance weighted,13,1.3 [0.98-1.74],0.0732099522105338,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,SCRG1,Scrapie-responsive protein 1,Inverse variance weighted,2,0.19 [0.03-1.2],0.077300291884903,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,CTSV,Cathepsin L2,Inverse variance weighted,34,1.23 [0.98-1.54],0.0790095229142885,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,PRELP,Prolargin,Inverse variance weighted,5,3.11 [0.87-11.15],0.0812599325589615,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,LRG1,Leucine-rich alpha-2-glycoprotein,Inverse variance weighted,4,2.6 [0.89-7.64],0.0818447142610079,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,KIRREL2,Kin of IRRE-like protein 2,Inverse variance weighted,19,0.85 [0.7-1.02],0.0818828088057258,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,CST6,Cystatin-M,Inverse variance weighted,26,1.45 [0.95-2.21],0.0818922161765853,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,ANGPTL7,Angiopoietin-related protein 7,Inverse variance weighted,7,0.34 [0.1-1.15],0.0819341530273308,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,LY9,T-lymphocyte surface antigen Ly-9,Inverse variance weighted,11,1.69 [0.93-3.07],0.0822802894103026,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,BMPER,BMP-binding endothelial regulator protein,Inverse variance weighted,4,2.16 [0.9-5.22],0.0853531701070486,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,EPPK1,Epiplakin,Inverse variance weighted,30,0.88 [0.76-1.02],0.0855582390887988,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,ITGB6,Integrin beta-6,Inverse variance weighted,16,0.68 [0.44-1.06],0.0866865780845121,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,CD99L2,CD99 antigen-like protein 2,Inverse variance weighted,8,1.52 [0.94-2.44],0.0880675947382103,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,MSLN,Mesothelin,Inverse variance weighted,11,1.52 [0.93-2.49],0.0926220251210841,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,SLURP1,Secreted Ly-6/uPAR-related protein 1,Inverse variance weighted,19,0.83 [0.66-1.03],0.0939580808199171,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,BNIP3L,BCL2/adenovirus E1B 19 kDa protein-interacting protein 3-like,Inverse variance weighted,2,0.19 [0.03-1.35],0.0965574618887923,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,LAMP3,Lysosome-associated membrane glycoprotein 3,Inverse variance weighted,13,0.65 [0.38-1.09],0.0988419151299954,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,KRT5,"Keratin, type II cytoskeletal 5",Inverse variance weighted,8,1.52 [0.92-2.51],0.100796015805843,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,S100P,Protein S100-P,Inverse variance weighted,4,1.78 [0.89-3.54],0.101876548952653,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,ADAMTSL2,ADAMTS-like protein 2,Inverse variance weighted,9,0.68 [0.42-1.08],0.103809197409982,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,GPIHBP1,Glycosylphosphatidylinositol-anchored high density lipoprotein-binding protein 1,Inverse variance weighted,14,1.23 [0.96-1.58],0.107129843732496,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,CEACAM19,Carcinoembryonic antigen-related cell adhesion molecule 19,Inverse variance weighted,5,1.82 [0.88-3.77],0.107463939353277,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,VASN,Vasorin,Inverse variance weighted,5,2.23 [0.84-5.95],0.108473773606773,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,VSIG4,V-set and immunoglobulin domain-containing protein 4,Inverse variance weighted,12,0.59 [0.31-1.13],0.110868934138535,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,MEP1B,Meprin A subunit beta,Inverse variance weighted,72,1.07 [0.98-1.17],0.113436120012781,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,SULT2A1,Bile salt sulfotransferase,Inverse variance weighted,3,0.44 [0.16-1.22],0.113565899958229,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,CCL23,C-C motif chemokine 23,Inverse variance weighted,23,1.13 [0.97-1.33],0.113690611578897,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,RSPO1,R-spondin-1,Inverse variance weighted,8,0.67 [0.4-1.1],0.114932418559009,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,RALY,RNA-binding protein Raly,Inverse variance weighted,2,2.71 [0.78-9.46],0.116760422964848,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,CGREF1,Cell growth regulator with EF hand domain protein 1,Inverse variance weighted,29,0.86 [0.72-1.04],0.117168627715005,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,FSTL1,Follistatin-related protein 1,Inverse variance weighted,12,0.56 [0.27-1.16],0.117388029450391,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,SCARA5,Scavenger receptor class A member 5,Wald ratio,1,3.9 [0.71-21.51],0.117855304883542,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,REG3A,Regenerating islet-derived protein 3-alpha,Inverse variance weighted,20,1.29 [0.94-1.76],0.11810059542609,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,PLA2G10,Group 10 secretory phospholipase A2,Inverse variance weighted,19,1.25 [0.94-1.65],0.118854446674121,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,ROR1,Inactive tyrosine-protein kinase transmembrane receptor ROR1,Inverse variance weighted,11,1.69 [0.87-3.28],0.119270493319924,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,TNFRSF9,Tumor necrosis factor receptor superfamily member 9,Inverse variance weighted,4,2.74 [0.77-9.78],0.121049821665501,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,EFNA1,Ephrin-A1,Inverse variance weighted,3,3.91 [0.69-21.97],0.122144853838761,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,SMOC2,SPARC-related modular calcium-binding protein 2,Inverse variance weighted,11,1.54 [0.89-2.65],0.12279967844326,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,GFRA1,GDNF family receptor alpha-1,Inverse variance weighted,10,1.29 [0.93-1.79],0.125578189591527,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,ITM2A,Integral membrane protein 2A,Inverse variance weighted,6,1.33 [0.92-1.91],0.129539266501173,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,BMP10,Bone morphogenetic protein 10,Inverse variance weighted,19,0.73 [0.48-1.1],0.12963166382579,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,PTN,Pleiotrophin,Inverse variance weighted,3,2.1 [0.8-5.49],0.130410384030378,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,RTBDN,Retbindin,Inverse variance weighted,2,2.47 [0.76-8.01],0.130716615106328,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,RARRES2,Retinoic acid receptor responder protein 2,Inverse variance weighted,2,0.37 [0.1-1.36],0.132544098401011,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,SLITRK6,SLIT and NTRK-like protein 6,Inverse variance weighted,16,0.68 [0.41-1.13],0.13333419185438,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,CDCP1,CUB domain-containing protein 1,Inverse variance weighted,9,1.51 [0.88-2.61],0.135428299717977,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,NUDT5,ADP-sugar pyrophosphatase,Wald ratio,1,0.23 [0.03-1.61],0.137868035999407,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,PRL,Prolactin,Inverse variance weighted,7,0.61 [0.32-1.17],0.13934400861803,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,MAMDC2,MAM domain-containing protein 2,Inverse variance weighted,22,0.81 [0.62-1.07],0.142125339945012,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,FAM3B,Protein FAM3B,Inverse variance weighted,26,0.9 [0.78-1.04],0.142466521921168,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,IGSF3,Immunoglobulin superfamily member 3,Inverse variance weighted,4,1.98 [0.79-4.92],0.14286395504703,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,FAM20A,Pseudokinase FAM20A,Inverse variance weighted,21,1.16 [0.95-1.42],0.147713031023018,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,PTPRR,Receptor-type tyrosine-protein phosphatase R,Wald ratio,1,0.37 [0.09-1.43],0.148333209302097,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,SIRPA,Tyrosine-protein phosphatase non-receptor type substrate 1,Wald ratio,1,5.84 [0.53-63.92],0.148455872056873,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,MRC1,Macrophage mannose receptor 1,Inverse variance weighted,17,0.73 [0.47-1.12],0.150055256400813,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,CCL20,C-C motif chemokine 20,Inverse variance weighted,6,1.56 [0.85-2.85],0.150110439187226,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,CD300LF,CMRF35-like molecule 1,Inverse variance weighted,34,0.91 [0.81-1.03],0.150444182698982,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,TFRC,Transferrin receptor protein 1,Inverse variance weighted,19,0.8 [0.59-1.09],0.151140600697836,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,ADAMTS1,A disintegrin and metalloproteinase with thrombospondin motifs 1,Inverse variance weighted,2,3.79 [0.61-23.49],0.152131761483012,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,CCN5,CCN family member 5,Inverse variance weighted,12,1.24 [0.92-1.68],0.152579197474112,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,NTproBNP,N-terminal prohormone of brain natriuretic peptide,Inverse variance weighted,11,1.6 [0.84-3.04],0.153361146409164,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,ADAM8,Disintegrin and metalloproteinase domain-containing protein 8,Inverse variance weighted,24,1.19 [0.94-1.51],0.153849867145212,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,SEZ6L2,Seizure 6-like protein 2,Inverse variance weighted,9,1.45 [0.87-2.42],0.154312984857424,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,SLAMF7,SLAM family member 7,Inverse variance weighted,16,0.76 [0.52-1.11],0.155022014196017,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,WNT9A,Protein Wnt-9a,Wald ratio,1,6.01 [0.51-71.4],0.155671172839968,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,APOA4,Apolipoprotein A-IV,Inverse variance weighted,4,5.67 [0.51-62.46],0.156679118032765,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,ASGR1,Asialoglycoprotein receptor 1,Inverse variance weighted,7,0.67 [0.38-1.17],0.158117620168738,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,DSG4,Desmoglein-4,Inverse variance weighted,55,1.18 [0.94-1.5],0.158334087179958,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,NPDC1,Neural proliferation differentiation and control protein 1,Inverse variance weighted,7,0.6 [0.3-1.22],0.158529202005898,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,CHRDL2,Chordin-like protein 2,Inverse variance weighted,9,1.95 [0.77-4.94],0.160100201652952,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,HNMT,Histamine N-methyltransferase,Inverse variance weighted,10,1.41 [0.87-2.28],0.161204388864223,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,OBP2B,Odorant-binding protein 2b,Inverse variance weighted,31,1.13 [0.95-1.34],0.161660342093684,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,HYAL1,Hyaluronidase-1,Inverse variance weighted,19,1.21 [0.93-1.57],0.163734671744365,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,LUZP2,Leucine zipper protein 2,Wald ratio,1,4.75 [0.53-42.78],0.164670031641773,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,THBD,Thrombomodulin,Inverse variance weighted,11,0.79 [0.57-1.1],0.164904815723345,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,CKAP4,Cytoskeleton-associated protein 4,Inverse variance weighted,6,0.63 [0.33-1.21],0.167632532073457,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,CTHRC1,Collagen triple helix repeat-containing protein 1,Inverse variance weighted,7,0.56 [0.24-1.28],0.168213245446149,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,PENK,Proenkephalin-A,Inverse variance weighted,15,1.33 [0.89-1.98],0.168609476060607,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,BOLA1,BolA-like protein 1,Inverse variance weighted,6,1.55 [0.83-2.9],0.168862670436235,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,HGF,Hepatocyte growth factor,Inverse variance weighted,5,0.56 [0.24-1.28],0.169051330590312,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,PRSS8,Prostasin,Inverse variance weighted,14,1.34 [0.88-2.04],0.169905398020518,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,PON1,Serum paraoxonase/arylesterase 1,Inverse variance weighted,28,1.22 [0.92-1.61],0.172330048607868,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,FCN1,Ficolin-1,Inverse variance weighted,50,0.89 [0.75-1.05],0.174012697652784,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,CEACAM8,Carcinoembryonic antigen-related cell adhesion molecule 8,Inverse variance weighted,22,1.21 [0.92-1.59],0.174893609758033,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,AGT,Angiotensinogen,Wald ratio,1,2.47 [0.67-9.1],0.175276444231088,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,CALCA,Calcitonin,Inverse variance weighted,13,0.69 [0.4-1.18],0.175835644689313,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,IL17RB,Interleukin-17 receptor B,Inverse variance weighted,23,0.75 [0.49-1.14],0.176234365599023,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,COCH,Cochlin,Inverse variance weighted,21,1.31 [0.88-1.95],0.176455201270382,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,PRTN3,Myeloblastin,Inverse variance weighted,20,1.29 [0.89-1.87],0.178013937860279,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,GFAP,Glial fibrillary acidic protein,Inverse variance weighted,14,0.76 [0.52-1.13],0.180243531504419,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,SIGLEC8,Sialic acid-binding Ig-like lectin 8,Inverse variance weighted,21,1.34 [0.87-2.07],0.180298155710105,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,ERBB2,Receptor tyrosine-protein kinase erbB-2,Inverse variance weighted,20,0.85 [0.67-1.08],0.180587308774294,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,HRC,Sarcoplasmic reticulum histidine-rich calcium-binding protein,Inverse variance weighted,7,0.66 [0.35-1.22],0.182549508519816,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,AXL,Tyrosine-protein kinase receptor UFO,Inverse variance weighted,15,1.27 [0.89-1.79],0.183346996126485,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,TNFRSF11A,Tumor necrosis factor receptor superfamily member 11A,Inverse variance weighted,35,0.88 [0.73-1.06],0.184514327170931,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,TCN2,Transcobalamin-2,Inverse variance weighted,24,1.13 [0.94-1.35],0.185558983747704,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,TNFRSF4,Tumor necrosis factor receptor superfamily member 4,Inverse variance weighted,10,2.04 [0.7-5.95],0.189849806503408,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,CD274,Programmed cell death 1 ligand 1,Inverse variance weighted,3,1.89 [0.72-4.92],0.194794006050048,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,ACY3,N-acyl-aromatic-L-amino acid amidohydrolase,Inverse variance weighted,13,0.7 [0.41-1.2],0.1950253246279,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,UMOD,Uromodulin,Inverse variance weighted,34,1.23 [0.9-1.67],0.195906647165756,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,NRCAM,Neuronal cell adhesion molecule,Inverse variance weighted,7,0.62 [0.3-1.29],0.197871479744396,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,PRTG,Protogenin,Inverse variance weighted,8,0.6 [0.28-1.3],0.199229794635536,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,PDGFRA,Platelet-derived growth factor receptor alpha,Inverse variance weighted,16,0.65 [0.34-1.25],0.199611903503314,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,IGFBPL1,Insulin-like growth factor-binding protein-like 1,Inverse variance weighted,4,2.34 [0.63-8.64],0.202277780829392,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,CA12,Carbonic anhydrase 12,Inverse variance weighted,9,1.56 [0.79-3.08],0.202345204726389,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,VCAM1,Vascular cell adhesion protein 1,Inverse variance weighted,9,1.6 [0.77-3.32],0.203157227787509,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,RGMB,RGM domain family member B,Inverse variance weighted,5,0.46 [0.14-1.51],0.203405062194344,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,CD276,CD276 antigen,Inverse variance weighted,24,0.83 [0.62-1.11],0.206868842076397,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,CST1,Cystatin-SN,Inverse variance weighted,12,1.37 [0.84-2.23],0.207221489406037,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,CLC,Galectin-10,Inverse variance weighted,14,1.36 [0.84-2.21],0.207978435287318,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,SMOC1,SPARC-related modular calcium-binding protein 1,Inverse variance weighted,13,0.7 [0.4-1.23],0.210939177191984,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,MEGF9,Multiple epidermal growth factor-like domains protein 9,Inverse variance weighted,22,1.2 [0.9-1.61],0.211573088742606,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,ADGRE2,Adhesion G protein-coupled receptor E2,Inverse variance weighted,6,0.49 [0.16-1.51],0.211688623441969,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,PCDH1,Protocadherin-1,Inverse variance weighted,4,1.46 [0.81-2.65],0.212414833458013,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,SEZ6,Seizure protein 6 homolog,Inverse variance weighted,2,0.4 [0.09-1.7],0.212640450325229,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,TNFRSF13B,Tumor necrosis factor receptor superfamily member 13B,Inverse variance weighted,13,1.31 [0.85-2.02],0.213143280670694,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,SLAMF8,SLAM family member 8,Inverse variance weighted,2,0.45 [0.13-1.6],0.215060324880438,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,KLRK1,NKG2-D type II integral membrane protein,Inverse variance weighted,9,0.75 [0.48-1.18],0.215792444445404,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,VSNL1,Visinin-like protein 1,Inverse variance weighted,9,0.82 [0.6-1.12],0.218583528717987,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,LGALS4,Galectin-4,Inverse variance weighted,15,1.25 [0.88-1.77],0.218678068587238,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,OGN,Mimecan,Inverse variance weighted,37,1.13 [0.93-1.37],0.219768483938663,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,CFC1,Cryptic protein,Inverse variance weighted,11,0.7 [0.39-1.24],0.220631482029721,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,MMP3,Stromelysin-1,Inverse variance weighted,4,2.17 [0.63-7.54],0.220646235569708,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,IMMT,MICOS complex subunit MIC60,Wald ratio,1,0.39 [0.08-1.77],0.221725592281106,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,RLN2,Prorelaxin H2,Inverse variance weighted,5,2.11 [0.64-6.97],0.222665401417287,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,NFASC,Neurofascin,Inverse variance weighted,6,0.55 [0.21-1.44],0.223033031887574,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,IL15RA,Interleukin-15 receptor subunit alpha,Wald ratio,1,3.47 [0.47-25.92],0.22471037551948,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,SEZ6L,Seizure 6-like protein,Inverse variance weighted,10,1.59 [0.75-3.36],0.226238212366259,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,AGRN,Agrin,Inverse variance weighted,14,1.53 [0.77-3.05],0.22791160244013,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,MERTK,Tyrosine-protein kinase Mer,Inverse variance weighted,28,1.22 [0.88-1.68],0.228792203581181,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,RNASE6,Ribonuclease K6,Inverse variance weighted,4,2.02 [0.64-6.37],0.231428154686783,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,TNFRSF1A,Tumor necrosis factor receptor superfamily member 1A,Inverse variance weighted,4,1.75 [0.7-4.37],0.232153425872306,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,AIF1L,Allograft inflammatory factor 1-like,Inverse variance weighted,12,0.8 [0.55-1.16],0.233476401895156,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,AMY1A_AMY1B_AMY1C,Alpha-amylase 1A_Alpha-amylase 1B_Alpha-amylase 1C,Inverse variance weighted,22,0.82 [0.59-1.14],0.233780766368919,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,CD33,Myeloid cell surface antigen CD33,Inverse variance weighted,4,2.02 [0.64-6.41],0.233900979577284,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,HJV,Hemojuvelin,Inverse variance weighted,2,2.49 [0.55-11.3],0.235822567746657,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,TREML2,Trem-like transcript 2 protein,Inverse variance weighted,10,1.66 [0.72-3.83],0.237173466721995,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,PRSS27,Serine protease 27,Inverse variance weighted,47,0.91 [0.77-1.07],0.237281011853424,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,SPINK6,Serine protease inhibitor Kazal-type 6,Wald ratio,1,3.5 [0.44-27.95],0.23758269604786,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,MAP2,Microtubule-associated protein 2,Inverse variance weighted,8,1.56 [0.74-3.27],0.238118369784934,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,BCL2L11,"Bcl-2-like protein 11, Isoform BimL ",Inverse variance weighted,17,0.84 [0.63-1.12],0.238823319966377,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,IFNAR1,Interferon alpha/beta receptor 1,Inverse variance weighted,19,1.13 [0.92-1.38],0.24067979644078,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,SLC39A14,Zinc transporter ZIP14,Inverse variance weighted,5,1.62 [0.72-3.62],0.241119733905837,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,FABP3,"Fatty acid-binding protein, heart",Inverse variance weighted,6,0.61 [0.26-1.4],0.241983796518398,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,KLK8,Kallikrein-8,Inverse variance weighted,5,0.62 [0.28-1.38],0.242456424499757,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,GP2,Pancreatic secretory granule membrane major glycoprotein GP2,Inverse variance weighted,21,0.88 [0.72-1.09],0.242582997810485,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,ESM1,Endothelial cell-specific molecule 1,Inverse variance weighted,21,0.76 [0.47-1.21],0.245804019122749,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,SMPD3,Sphingomyelin phosphodiesterase 3,Inverse variance weighted,3,0.34 [0.05-2.12],0.246688907440735,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,CGA,Glycoprotein hormones alpha chain,Inverse variance weighted,2,0.37 [0.07-2],0.247655542497347,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,FLT1,Vascular endothelial growth factor receptor 1,Inverse variance weighted,16,1.15 [0.91-1.45],0.24907573990371,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,ICAM1,Intercellular adhesion molecule 1,Inverse variance weighted,4,0.69 [0.36-1.3],0.250398741524809,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,KRT18,"Keratin, type I cytoskeletal 18",Inverse variance weighted,7,1.37 [0.8-2.34],0.254264170687986,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,SHISA5,Protein shisa-5,Inverse variance weighted,12,1.45 [0.77-2.75],0.25456424377984,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,GOLM2,Protein GOLM2,Inverse variance weighted,14,0.85 [0.64-1.13],0.254606776136993,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,IGF2R,Cation-independent mannose-6-phosphate receptor,Inverse variance weighted,19,1.3 [0.83-2.05],0.254957416769209,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,SPARCL1,SPARC-like protein 1,Inverse variance weighted,21,1.22 [0.87-1.7],0.257248223454665,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,TNFRSF17,Tumor necrosis factor receptor superfamily member 17,Inverse variance weighted,25,1.24 [0.85-1.8],0.259717286010241,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,GRPEL1,"GrpE protein homolog 1, mitochondrial",Inverse variance weighted,2,0.53 [0.18-1.59],0.259848500099714,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,PLA2G2A,"Phospholipase A2, membrane associated",Inverse variance weighted,3,1.73 [0.66-4.52],0.260261043970056,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,PCDHB15,Protocadherin beta-15,Inverse variance weighted,19,1.16 [0.89-1.51],0.262142887126935,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,TIMP4,Metalloproteinase inhibitor 4,Inverse variance weighted,6,0.65 [0.3-1.39],0.262453931745237,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,S100A11,Protein S100-A11,Wald ratio,1,0.38 [0.07-2.07],0.262555523316441,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,INHBB,Inhibin beta B chain,Inverse variance weighted,11,0.75 [0.45-1.24],0.262977755479965,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,BSG,Basigin,Inverse variance weighted,6,1.62 [0.7-3.75],0.26505052902468,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,CD72,B-cell differentiation antigen CD72,Inverse variance weighted,10,1.5 [0.73-3.08],0.265782547138899,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,CHGA,Chromogranin-A,Inverse variance weighted,5,1.54 [0.72-3.29],0.267080559087586,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,IL18R1,Interleukin-18 receptor 1,Inverse variance weighted,22,1.17 [0.89-1.55],0.26826033743509,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,CAPG,Macrophage-capping protein,Wald ratio,1,0.39 [0.08-2.06],0.269211025058976,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,NOTCH2,Neurogenic locus notch homolog protein 2,Inverse variance weighted,14,0.9 [0.74-1.09],0.270425947539603,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,CSPG4,Chondroitin sulfate proteoglycan 4,Inverse variance weighted,12,0.69 [0.35-1.34],0.27074480702545,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,TNC,Tenascin,Inverse variance weighted,57,0.91 [0.77-1.08],0.27106700590233,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,TPMT,Thiopurine S-methyltransferase,Inverse variance weighted,7,1.62 [0.69-3.82],0.271659028553526,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,KIR2DL2,Killer cell immunoglobulin-like receptor 2DL2,Inverse variance weighted,5,0.61 [0.25-1.47],0.273088589359642,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,LILRA5,Leukocyte immunoglobulin-like receptor subfamily A member 5,Inverse variance weighted,23,0.84 [0.62-1.14],0.274292062068541,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,NELL1,Protein kinase C-binding protein NELL1,Inverse variance weighted,33,1.16 [0.89-1.51],0.274306945066794,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,BOC,Brother of CDO,Inverse variance weighted,8,0.71 [0.38-1.32],0.274334627154989,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,PLA2G7,Platelet-activating factor acetylhydrolase,Inverse variance weighted,18,0.83 [0.6-1.16],0.276742330174268,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,CNTN5,Contactin-5,Inverse variance weighted,22,0.83 [0.6-1.16],0.277029626923936,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,SIGLEC10,Sialic acid-binding Ig-like lectin 10,Inverse variance weighted,8,1.68 [0.66-4.31],0.277103533010125,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,FAS,Tumor necrosis factor receptor superfamily member 6,Inverse variance weighted,12,1.16 [0.89-1.51],0.278033129520648,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,FABP4,"Fatty acid-binding protein, adipocyte",Wald ratio,1,0.54 [0.18-1.65],0.280299423644058,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,FGL1,Fibrinogen-like protein 1,Inverse variance weighted,7,1.79 [0.62-5.14],0.280590604261437,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,LCN15,Lipocalin-15,Inverse variance weighted,22,0.92 [0.8-1.07],0.280592390486878,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,AHNAK2,Protein AHNAK2,Inverse variance weighted,3,1.99 [0.57-6.95],0.280905788655983,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,MMP1,Interstitial collagenase,Inverse variance weighted,14,1.26 [0.83-1.92],0.281001570565423,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,MATN3,Matrilin-3,Inverse variance weighted,4,0.68 [0.34-1.37],0.28229034657297,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,TCOF1,Treacle protein,Wald ratio,1,0.32 [0.04-2.56],0.284429983668974,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,FGF21,Fibroblast growth factor 21,Inverse variance weighted,2,2.06 [0.54-7.85],0.287689922656038,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,PDZK1,Na(+)/H(+) exchange regulatory cofactor NHE-RF3,Inverse variance weighted,3,0.71 [0.37-1.34],0.287945071649046,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,FCER2,Low affinity immunoglobulin epsilon Fc receptor,Inverse variance weighted,29,1.22 [0.84-1.78],0.288730420500108,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,RNF149,E3 ubiquitin-protein ligase RNF149,Inverse variance weighted,6,1.53 [0.69-3.4],0.291102976846295,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,LGALS9,Galectin-9,Inverse variance weighted,36,1.11 [0.92-1.33],0.291518090731474,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,SIGLEC6,Sialic acid-binding Ig-like lectin 6,Inverse variance weighted,31,0.86 [0.65-1.14],0.291764499230235,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,PYDC1,Pyrin domain-containing protein 1,Inverse variance weighted,60,1.08 [0.94-1.24],0.292274704010965,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,TAFA5,Chemokine-like protein TAFA-5,Inverse variance weighted,5,2.01 [0.55-7.33],0.292630315090233,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,CX3CL1,Fractalkine,Inverse variance weighted,12,0.76 [0.45-1.28],0.29429533917952,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,TMPRSS11D,Transmembrane protease serine 11D,Wald ratio,1,0.35 [0.05-2.49],0.295100092459091,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,CPA2,Carboxypeptidase A2,Inverse variance weighted,10,1.41 [0.74-2.69],0.295636286910002,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,CD79B,B-cell antigen receptor complex-associated protein beta chain,Inverse variance weighted,21,1.22 [0.84-1.76],0.296428646423236,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,SNED1,"Sushi, nidogen and EGF-like domain-containing protein 1",Inverse variance weighted,4,0.63 [0.27-1.5],0.298298065095451,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,LRRC25,Leucine-rich repeat-containing protein 25,Inverse variance weighted,19,0.89 [0.71-1.11],0.298455022370751,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,CCN4,CCN family member 4,Inverse variance weighted,29,1.11 [0.91-1.34],0.299857170158403,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,ADA2,Adenosine deaminase 2,Inverse variance weighted,10,1.33 [0.77-2.29],0.306584093726488,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,MMP9,Matrix metalloproteinase-9,Inverse variance weighted,11,0.79 [0.5-1.24],0.308943210837684,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,CYTL1,Cytokine-like protein 1,Inverse variance weighted,3,3.53 [0.31-40.56],0.310485613998425,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,PNLIP,Pancreatic triacylglycerol lipase,Inverse variance weighted,17,0.82 [0.55-1.21],0.31256396661643,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,CSRP3,Cysteine and glycine-rich protein 3,Inverse variance weighted,3,0.6 [0.22-1.62],0.312632809535619,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,CRLF1,Cytokine receptor-like factor 1,Inverse variance weighted,15,0.78 [0.48-1.26],0.312952164775485,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,EFNA4,Ephrin-A4,Inverse variance weighted,2,1.98 [0.53-7.45],0.313000246912207,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,COL9A1,Collagen alpha-1(IX) chain,Inverse variance weighted,7,1.43 [0.71-2.87],0.315638684064579,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,LEFTY2,Left-right determination factor 2,Inverse variance weighted,7,0.61 [0.23-1.61],0.316664025196544,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,CD300C,CMRF35-like molecule 6,Inverse variance weighted,33,1.1 [0.91-1.33],0.318226801442227,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,IFI30,Gamma-interferon-inducible lysosomal thiol reductase,Inverse variance weighted,5,1.53 [0.66-3.54],0.320254291295967,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,VWA1,von Willebrand factor A domain-containing protein 1,Inverse variance weighted,5,0.65 [0.28-1.53],0.322104342273912,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,PXN,Paxillin,Inverse variance weighted,7,1.44 [0.7-2.99],0.322565257812076,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,AGR3,Anterior gradient protein 3,Inverse variance weighted,5,1.67 [0.6-4.63],0.324157896841222,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,PYY,Peptide YY,Inverse variance weighted,16,0.87 [0.65-1.15],0.326310271508111,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,BCAM,Basal cell adhesion molecule,Inverse variance weighted,22,0.9 [0.74-1.11],0.328134533333665,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,VEGFB,Vascular endothelial growth factor B,Inverse variance weighted,7,0.72 [0.37-1.4],0.330658222826334,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,KLRF1,Killer cell lectin-like receptor subfamily F member 1,Inverse variance weighted,20,1.22 [0.81-1.84],0.330802443322,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,TCL1A,T-cell leukemia/lymphoma protein 1A,Inverse variance weighted,31,1.18 [0.85-1.63],0.330892517845349,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,LCN2,Neutrophil gelatinase-associated lipocalin,Inverse variance weighted,21,1.24 [0.81-1.9],0.331798483634173,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,ADIPOQ,Adiponectin,Inverse variance weighted,25,0.86 [0.63-1.17],0.332214703699831,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,TNFRSF10A,Tumor necrosis factor receptor superfamily member 10A,Inverse variance weighted,3,0.59 [0.21-1.7],0.333071985887869,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,CTSE,Cathepsin E,Inverse variance weighted,8,0.7 [0.34-1.44],0.333474301133594,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,PPL,Periplakin,Inverse variance weighted,2,2.09 [0.47-9.29],0.334506626467988,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,GAS6,Growth arrest-specific protein 6,Inverse variance weighted,18,1.18 [0.84-1.65],0.335056330243148,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,DEFA1_DEFA1B,Neutrophil defensin 1,Inverse variance weighted,31,1.16 [0.86-1.55],0.335803728760657,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,ESAM,Endothelial cell-selective adhesion molecule,Inverse variance weighted,2,1.71 [0.57-5.06],0.336230712277164,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,CRELD2,Protein disulfide isomerase CRELD2,Inverse variance weighted,14,0.76 [0.43-1.34],0.340346856025112,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,RBFOX3,RNA binding protein fox-1 homolog 3,Inverse variance weighted,2,2.1 [0.46-9.67],0.341525019342466,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,IL22,Interleukin-22,Inverse variance weighted,4,0.59 [0.2-1.75],0.344140018213068,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,VMO1,Vitelline membrane outer layer protein 1 homolog,Inverse variance weighted,8,1.38 [0.7-2.74],0.352360728726866,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,IGF1R,Insulin-like growth factor 1 receptor,Inverse variance weighted,6,1.44 [0.66-3.14],0.353289684137639,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,APOH,Beta-2-glycoprotein 1,Inverse variance weighted,17,0.91 [0.75-1.11],0.353659880528049,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,SRPX,Sushi repeat-containing protein SRPX,Inverse variance weighted,2,2.03 [0.45-9.1],0.357317432799811,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,CD22,B-cell receptor CD22,Inverse variance weighted,25,1.19 [0.82-1.73],0.358649778936777,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,NDUFA5,NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 5,Wald ratio,1,0.26 [0.01-4.82],0.362148466817199,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,DPY30,Protein dpy-30 homolog,Wald ratio,1,2.3 [0.38-13.78],0.362653740463151,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,CILP,Cartilage intermediate layer protein 1,Inverse variance weighted,6,0.63 [0.24-1.69],0.363257100092863,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,COL15A1,Collagen alpha-1(XV) chain,Inverse variance weighted,10,1.23 [0.78-1.95],0.363267847618801,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,TGOLN2,Trans-Golgi network integral membrane protein 2,Inverse variance weighted,7,1.49 [0.63-3.5],0.363591402558118,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,COL5A1,Collagen alpha-1(V) chain,Inverse variance weighted,16,0.89 [0.69-1.15],0.364251068770426,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,HAVCR2,Hepatitis A virus cellular receptor 2,Inverse variance weighted,8,1.25 [0.77-2],0.36439407353728,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,BST2,Bone marrow stromal antigen 2,Inverse variance weighted,24,1.2 [0.81-1.79],0.364780658948393,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,TGFBR1,TGF-beta receptor type-1,Wald ratio,1,2.25 [0.39-12.94],0.365549649175729,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,RNASE1,Ribonuclease pancreatic,Inverse variance weighted,2,3.91 [0.2-75.03],0.366103214070849,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,SIGLEC1,Sialoadhesin,Inverse variance weighted,16,1.19 [0.81-1.75],0.366672398176979,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,CEACAM21,Carcinoembryonic antigen-related cell adhesion molecule 21,Inverse variance weighted,21,1.1 [0.9-1.34],0.367239587253452,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,IFNL1,Interferon lambda-1,Inverse variance weighted,8,0.76 [0.42-1.37],0.367461122991844,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,MB,Myoglobin,Inverse variance weighted,9,0.77 [0.43-1.36],0.368074938486302,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,SPP1,Osteopontin,Inverse variance weighted,13,0.75 [0.4-1.4],0.368128794895412,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,ADAM12,Disintegrin and metalloproteinase domain-containing protein 12,Inverse variance weighted,4,1.22 [0.79-1.86],0.36819156377128,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,PRG3,Proteoglycan 3,Inverse variance weighted,42,1.09 [0.9-1.33],0.368322981201943,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,CTRL,Chymotrypsin-like protease CTRL-1,Inverse variance weighted,35,0.92 [0.77-1.1],0.369993841951335,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,CDH6,Cadherin-6,Inverse variance weighted,5,1.49 [0.62-3.6],0.370037571362008,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,CD74,HLA class II histocompatibility antigen gamma chain,Inverse variance weighted,7,1.26 [0.76-2.11],0.370083868003423,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,CA3,Carbonic anhydrase 3,Inverse variance weighted,10,1.26 [0.76-2.11],0.370882458238677,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,PRRT3,Proline-rich transmembrane protein 3,Inverse variance weighted,5,1.52 [0.61-3.77],0.37123333660978,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,GP1BA,Platelet glycoprotein Ib alpha chain,Inverse variance weighted,24,1.22 [0.79-1.88],0.372523343275471,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,KLK6,Kallikrein-6,Inverse variance weighted,2,7.27 [0.09-570.16],0.372559789690034,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,LRIG3,Leucine-rich repeats and immunoglobulin-like domains protein 3,Wald ratio,1,2.38 [0.35-15.96],0.372917833087189,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,MCAM,Cell surface glycoprotein MUC18,Inverse variance weighted,11,0.84 [0.58-1.23],0.373978781720779,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,MSMB,Beta-microseminoprotein,Inverse variance weighted,52,0.95 [0.86-1.06],0.375946845675887,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,ISM1,Isthmin-1,Inverse variance weighted,2,0.57 [0.17-1.96],0.376317476381011,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,PTX3,Pentraxin-related protein PTX3,Inverse variance weighted,13,0.9 [0.7-1.14],0.376509422672674,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,ANGPT2,Angiopoietin-2,Inverse variance weighted,7,0.73 [0.37-1.46],0.37896894275941,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,CD70,CD70 antigen,Inverse variance weighted,11,0.8 [0.49-1.32],0.38042355882763,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,NXPH3,Neurexophilin-3,Inverse variance weighted,19,1.09 [0.9-1.33],0.380454014443634,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,MILR1,Allergin-1,Inverse variance weighted,43,0.96 [0.87-1.06],0.38065982042906,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,FUS,RNA-binding protein FUS,Wald ratio,1,0.43 [0.06-2.88],0.382021647261257,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,CD59,CD59 glycoprotein,Inverse variance weighted,4,0.67 [0.28-1.64],0.382742968097029,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,PLXNB2,Plexin-B2,Inverse variance weighted,12,0.74 [0.37-1.47],0.383229013736256,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,SCGB3A1,Secretoglobin family 3A member 1,Inverse variance weighted,26,0.91 [0.72-1.13],0.388224697286279,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,APBB1IP,Amyloid beta A4 precursor protein-binding family B member 1-interacting protein,Inverse variance weighted,2,2.61 [0.29-23.13],0.388325901451197,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,HPGDS,Hematopoietic prostaglandin D synthase,Inverse variance weighted,14,0.8 [0.48-1.33],0.391258592437537,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,MYL3,Myosin light chain 3,Inverse variance weighted,13,0.76 [0.41-1.42],0.392440402233498,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,FOLR1,Folate receptor alpha,Inverse variance weighted,6,1.94 [0.42-8.83],0.392875871139181,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,B4GALT1,"Beta-1,4-galactosyltransferase 1",Inverse variance weighted,12,0.84 [0.57-1.25],0.393120165788226,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,GFRA2,GDNF family receptor alpha-2,Inverse variance weighted,6,0.68 [0.29-1.64],0.394249720810527,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,LAMA4,Laminin subunit alpha-4,Inverse variance weighted,15,0.86 [0.61-1.21],0.394770289581365,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,ADGRG1,Adhesion G-protein coupled receptor G1,Inverse variance weighted,4,1.64 [0.53-5.11],0.394975856941821,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,GUCA2A,Guanylin,Inverse variance weighted,7,1.83 [0.46-7.34],0.395327583346458,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,KRT19,"Keratin, type I cytoskeletal 19",Inverse variance weighted,5,0.79 [0.45-1.37],0.396117615690733,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,IL10RB,Interleukin-10 receptor subunit beta,Inverse variance weighted,31,0.93 [0.8-1.09],0.396693215328915,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,PRSS2,Trypsin-2,Inverse variance weighted,17,0.86 [0.61-1.22],0.397697408109879,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,NOS1,"Nitric oxide synthase, brain",Wald ratio,1,1.86 [0.44-7.82],0.397882444473038,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,TFPI2,Tissue factor pathway inhibitor 2,Inverse variance weighted,15,1.21 [0.78-1.88],0.397956827881975,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,CXCL13,C-X-C motif chemokine 13,Wald ratio,1,0.44 [0.06-3.06],0.405000693248159,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,PLIN1,Perilipin-1,Wald ratio,1,0.45 [0.07-2.92],0.405639514546788,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,Inverse variance weighted,2,5.22 [0.11-256.92],0.406059555217049,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,FCER1A,High affinity immunoglobulin epsilon receptor subunit alpha,Inverse variance weighted,2,1.85 [0.43-7.88],0.408290683965222,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,PRSS22,Brain-specific serine protease 4,Inverse variance weighted,4,0.53 [0.12-2.41],0.410768235660478,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,FZD8,Frizzled-8,Wald ratio,1,2.31 [0.31-16.97],0.411306080442472,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,DIPK2B,Divergent protein kinase domain 2B,Inverse variance weighted,9,0.66 [0.25-1.77],0.412063278224168,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,SBSN,Suprabasin,Inverse variance weighted,10,1.62 [0.51-5.2],0.414010575100651,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,GPR15L,Protein GPR15L,Inverse variance weighted,13,0.89 [0.68-1.17],0.416281101983057,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,BAG3,BAG family molecular chaperone regulator 3,Inverse variance weighted,3,0.6 [0.17-2.08],0.417541864228934,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,PDCD1,Programmed cell death protein 1,Inverse variance weighted,16,0.8 [0.46-1.38],0.41774442110871,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,LMNB2,Lamin-B2,Inverse variance weighted,8,0.76 [0.4-1.47],0.420662956107896,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,PKD2,Polycystin-2,Inverse variance weighted,3,0.42 [0.05-3.47],0.422518283656885,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,ADAMTS15,A disintegrin and metalloproteinase with thrombospondin motifs 15,Inverse variance weighted,4,0.52 [0.11-2.57],0.423121463834583,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,PRG2,Bone marrow proteoglycan,Inverse variance weighted,39,1.09 [0.88-1.36],0.424830031059822,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,CSF1,Macrophage colony-stimulating factor 1,Inverse variance weighted,6,0.7 [0.3-1.67],0.425755214941467,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,CALB1,Calbindin,Inverse variance weighted,9,1.34 [0.65-2.77],0.42630918625141,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,C1QA,Complement C1q subcomponent subunit A,Inverse variance weighted,19,1.13 [0.83-1.54],0.427509171930431,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,IFNGR1,Interferon gamma receptor 1,Inverse variance weighted,7,1.33 [0.65-2.72],0.429850400931446,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,TNFSF13,Tumor necrosis factor ligand superfamily member 13,Inverse variance weighted,6,0.74 [0.34-1.57],0.430422714181751,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,JAM2,Junctional adhesion molecule B,Inverse variance weighted,6,0.69 [0.28-1.72],0.43202925798511,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,LILRA2,Leukocyte immunoglobulin-like receptor subfamily A member 2,Inverse variance weighted,11,1.27 [0.69-2.33],0.43566409221702,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,GFRA3,GDNF family receptor alpha-3,Inverse variance weighted,38,0.92 [0.74-1.14],0.436726846758215,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,SEMA3F,Semaphorin-3F,Inverse variance weighted,32,1.14 [0.82-1.58],0.438155612020623,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,CD28,T-cell-specific surface glycoprotein CD28,Inverse variance weighted,11,1.21 [0.74-1.99],0.44039409627635,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,SNCG,Gamma-synuclein,Inverse variance weighted,47,1.05 [0.92-1.2],0.443123210735641,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Wald ratio,1,0.59 [0.15-2.3],0.445407199055342,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,GHRL,Appetite-regulating hormone,Inverse variance weighted,14,0.78 [0.41-1.48],0.445968511045315,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,RELT,Tumor necrosis factor receptor superfamily member 19L,Inverse variance weighted,6,0.59 [0.15-2.28],0.446066313525956,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,VCAN,Versican core protein,Inverse variance weighted,30,0.9 [0.67-1.19],0.447515325410706,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,IL2RA,Interleukin-2 receptor subunit alpha,Inverse variance weighted,8,1.32 [0.65-2.69],0.448637582534028,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,IL12RB1,Interleukin-12 receptor subunit beta-1,Inverse variance weighted,9,0.79 [0.43-1.46],0.450294019344397,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,NRP2,Neuropilin-2,Inverse variance weighted,14,0.83 [0.51-1.35],0.451773818568916,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,EDA2R,Tumor necrosis factor receptor superfamily member 27,Inverse variance weighted,12,0.79 [0.43-1.45],0.452493976607189,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,VEGFA,Vascular endothelial growth factor A,Inverse variance weighted,15,0.84 [0.52-1.34],0.454991932895126,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,IL16,Pro-interleukin-16,Inverse variance weighted,6,1.42 [0.57-3.56],0.455929234356431,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,KLK15,Kallikrein-15,Inverse variance weighted,7,0.59 [0.15-2.37],0.456065613292664,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,PKD1,Polycystin-1,Inverse variance weighted,12,0.77 [0.4-1.52],0.456087598716308,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,GAST,Gastrin,Inverse variance weighted,9,1.2 [0.74-1.96],0.456187870704631,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,NUCB2,Nucleobindin-2,Inverse variance weighted,2,0.59 [0.14-2.39],0.456286031866875,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,RETN,Resistin,Inverse variance weighted,19,1.19 [0.75-1.88],0.457889085921477,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,EPHA1,Ephrin type-A receptor 1,Inverse variance weighted,2,0.48 [0.07-3.32],0.459961799498576,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,CDH15,Cadherin-15,Inverse variance weighted,4,0.6 [0.16-2.3],0.460421707244252,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,TGFBR2,TGF-beta receptor type-2,Inverse variance weighted,8,1.38 [0.58-3.26],0.461838961729139,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,CD4,T-cell surface glycoprotein CD4,Inverse variance weighted,6,0.73 [0.32-1.68],0.461944017137503,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,CBLIF,Cobalamin binding intrinsic factor,Inverse variance weighted,57,0.95 [0.84-1.08],0.462736560074934,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,STAB2,Stabilin-2,Inverse variance weighted,14,1.22 [0.72-2.06],0.462795715568745,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,CLGN,Calmegin,Inverse variance weighted,6,0.84 [0.52-1.35],0.462934902416778,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,CD93,Complement component C1q receptor,Inverse variance weighted,2,0.65 [0.21-2.03],0.463608034833239,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,DSG3,Desmoglein-3,Inverse variance weighted,27,0.89 [0.64-1.22],0.463711913728515,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,COL4A1,Collagen alpha-1(IV) chain,Inverse variance weighted,28,0.93 [0.76-1.14],0.465241062510047,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,XCL1,Lymphotactin,Inverse variance weighted,15,0.82 [0.49-1.39],0.465498427389434,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,CD99,CD99 antigen,Inverse variance weighted,4,1.5 [0.5-4.48],0.465690924299285,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,TACSTD2,Tumor-associated calcium signal transducer 2,Inverse variance weighted,13,0.84 [0.52-1.36],0.466353013125222,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,FUT3_FUT5,3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase FUT3_4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase FUT5,Inverse variance weighted,48,1.06 [0.9-1.25],0.468470293812561,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,LBR,Delta(14)-sterol reductase LBR,Inverse variance weighted,2,0.55 [0.11-2.79],0.46859831508572,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,LYVE1,Lymphatic vessel endothelial hyaluronic acid receptor 1,Inverse variance weighted,18,1.2 [0.73-1.99],0.471289105279228,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,MDK,Midkine,Inverse variance weighted,14,1.18 [0.75-1.87],0.472732306039137,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,KLK14,Kallikrein-14,Inverse variance weighted,15,0.84 [0.52-1.36],0.473214693032845,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,DCBLD2,"Discoidin, CUB and LCCL domain-containing protein 2",Inverse variance weighted,24,0.86 [0.58-1.29],0.475486165272469,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,SCARF2,Scavenger receptor class F member 2,Inverse variance weighted,6,1.37 [0.57-3.29],0.47581434078604,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,IL15,Interleukin-15,Inverse variance weighted,35,1.1 [0.85-1.42],0.478931649504741,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,TGFBR3,Transforming growth factor beta receptor type 3,Inverse variance weighted,19,0.89 [0.64-1.23],0.479350295870088,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,MZB1,Marginal zone B- and B1-cell-specific protein,Inverse variance weighted,18,1.14 [0.79-1.66],0.480298652410082,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,PSG1,Pregnancy-specific beta-1-glycoprotein 1,Inverse variance weighted,14,1.28 [0.64-2.56],0.482185422639876,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,MAN1A2,"Mannosyl-oligosaccharide 1,2-alpha-mannosidase IB",Inverse variance weighted,18,0.89 [0.65-1.23],0.486330251113934,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,ACE,Angiotensin-converting enzyme,Inverse variance weighted,27,1.07 [0.89-1.28],0.489964430316576,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,TNFRSF11B,Tumor necrosis factor receptor superfamily member 11B,Inverse variance weighted,25,0.9 [0.65-1.23],0.491817431212847,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,NPPC,C-type natriuretic peptide,Inverse variance weighted,3,2.92 [0.14-62.34],0.492942504873975,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,CD7,T-cell antigen CD7,Inverse variance weighted,12,1.07 [0.87-1.32],0.496860743424716,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,ADGRB3,Adhesion G protein-coupled receptor B3,Inverse variance weighted,43,1.04 [0.92-1.18],0.497167763378185,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,PTGDS,Prostaglandin-H2 D-isomerase,Inverse variance weighted,9,1.52 [0.45-5.19],0.499986112573722,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,APLP1,Amyloid-like protein 1,Inverse variance weighted,9,0.87 [0.57-1.32],0.501409044132819,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,LGALS3,Galectin-3,Inverse variance weighted,15,1.15 [0.77-1.73],0.501826209770452,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,ST3GAL1,"CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 1",Inverse variance weighted,3,1.32 [0.59-2.96],0.501903298625351,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,ATRAID,All-trans retinoic acid-induced differentiation factor,Inverse variance weighted,10,1.28 [0.62-2.63],0.502396059999239,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,MATN2,Matrilin-2,Inverse variance weighted,28,1.06 [0.9-1.24],0.502961818135849,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,IL19,Interleukin-19,Inverse variance weighted,10,0.91 [0.7-1.19],0.50531235443985,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,CEACAM20,Carcinoembryonic antigen-related cell adhesion molecule 20,Inverse variance weighted,2,0.46 [0.05-4.75],0.516793733009671,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,NDUFS6,"NADH dehydrogenase [ubiquinone] iron-sulfur protein 6, mitochondrial",Wald ratio,1,2.77 [0.13-60.09],0.516848906409198,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,SUMF2,Inactive C-alpha-formylglycine-generating enzyme 2,Inverse variance weighted,29,1.11 [0.81-1.53],0.518214790338322,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,PALM2,Paralemmin-2,Inverse variance weighted,9,1.12 [0.79-1.6],0.518328570252982,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,FCRL2,Fc receptor-like protein 2,Inverse variance weighted,30,1.13 [0.78-1.62],0.518346512067406,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,IGFBP2,Insulin-like growth factor-binding protein 2,Inverse variance weighted,11,0.75 [0.32-1.79],0.519727283027975,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,CRHBP,Corticotropin-releasing factor-binding protein,Inverse variance weighted,10,1.14 [0.76-1.7],0.521704097094182,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,DSC2,Desmocollin-2,Inverse variance weighted,16,0.9 [0.65-1.24],0.521845058096797,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,CTSS,Cathepsin S,Inverse variance weighted,7,1.32 [0.57-3.06],0.522162991640823,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,LY96,Lymphocyte antigen 96,Inverse variance weighted,16,0.86 [0.54-1.37],0.523582596871304,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,CD58,Lymphocyte function-associated antigen 3,Inverse variance weighted,6,1.15 [0.74-1.8],0.52545774955054,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,CCL25,C-C motif chemokine 25,Inverse variance weighted,22,1.08 [0.85-1.36],0.526257816835501,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,AHNAK,Neuroblast differentiation-associated protein AHNAK,Inverse variance weighted,3,1.45 [0.46-4.64],0.526871593690375,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,S100A4,Protein S100-A4,Inverse variance weighted,2,0.58 [0.1-3.18],0.527573152004221,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,CLMP,CXADR-like membrane protein,Inverse variance weighted,4,2.18 [0.19-24.53],0.52766024346132,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,CALCB,Calcitonin gene-related peptide 2,Inverse variance weighted,3,0.64 [0.16-2.53],0.528316415015188,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,ACP6,Lysophosphatidic acid phosphatase type 6,Inverse variance weighted,13,1.15 [0.74-1.79],0.530112467098543,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,SLC39A5,Zinc transporter ZIP5,Inverse variance weighted,13,1.17 [0.71-1.92],0.531673998007754,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,COL18A1,Collagen alpha-1(XVIII) chain,Inverse variance weighted,17,1.11 [0.81-1.52],0.532748134179619,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,HMBS,Porphobilinogen deaminase,Inverse variance weighted,2,0.56 [0.09-3.44],0.534154245444771,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,TPK1,Thiamin pyrophosphokinase 1,Inverse variance weighted,6,0.78 [0.35-1.71],0.534402619423886,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,ADGRG2,Adhesion G-protein coupled receptor G2,Inverse variance weighted,8,0.81 [0.41-1.58],0.534432841654616,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,CD48,CD48 antigen,Inverse variance weighted,14,1.2 [0.67-2.16],0.535438468013238,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,ELN,Elastin,Inverse variance weighted,10,1.21 [0.66-2.23],0.535824453818783,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,CFD,Complement factor D,Wald ratio,1,0.56 [0.09-3.58],0.536145608865433,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,CLEC3B,Tetranectin,Inverse variance weighted,2,0.6 [0.12-3],0.536307386654002,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,SERPINB8,Serpin B8,Inverse variance weighted,29,1.03 [0.93-1.15],0.537122038940591,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,EFEMP1,EGF-containing fibulin-like extracellular matrix protein 1,Inverse variance weighted,3,0.69 [0.21-2.25],0.539196494065483,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,LIFR,Leukemia inhibitory factor receptor,Inverse variance weighted,7,0.76 [0.32-1.83],0.539765440888247,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,ADAMTSL4,ADAMTS-like protein 4,Inverse variance weighted,6,0.84 [0.49-1.45],0.54108006695285,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,PREB,Prolactin regulatory element-binding protein,Wald ratio,1,1.99 [0.22-18.25],0.542226996491051,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,TFF1,Trefoil factor 1,Inverse variance weighted,14,0.92 [0.7-1.2],0.542697563936896,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,IGLC2,Immunoglobulin lambda constant 2,Inverse variance weighted,10,1.17 [0.7-1.96],0.546037962420455,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,PRAP1,Proline-rich acidic protein 1,Inverse variance weighted,8,1.11 [0.8-1.54],0.546993807680283,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,FNDC1,Fibronectin type III domain-containing protein 1,Inverse variance weighted,10,1.2 [0.66-2.2],0.547206661831805,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,CCL16,C-C motif chemokine 16,Inverse variance weighted,26,0.96 [0.85-1.09],0.547881751369345,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,CCL27,C-C motif chemokine 27,Inverse variance weighted,9,0.79 [0.37-1.7],0.547907889303655,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,ST6GAL1,"Beta-galactoside alpha-2,6-sialyltransferase 1",Inverse variance weighted,2,1.51 [0.39-5.75],0.548811442371241,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,CXADR,Coxsackievirus and adenovirus receptor,Inverse variance weighted,13,1.17 [0.7-1.97],0.550474263640972,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,REN,Renin,Inverse variance weighted,8,0.75 [0.29-1.92],0.551312569569049,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,MYLPF,"Myosin regulatory light chain 2, skeletal muscle isoform",Wald ratio,1,1.64 [0.32-8.49],0.552234739824029,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,CR1,Complement receptor type 1,Inverse variance weighted,15,1.15 [0.73-1.82],0.553407288706429,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,IL1RL1,Interleukin-1 receptor-like 1,Inverse variance weighted,27,1.16 [0.71-1.87],0.554451333439457,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,IGSF8,Immunoglobulin superfamily member 8,Inverse variance weighted,4,1.23 [0.62-2.47],0.554713700674536,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,RNASET2,Ribonuclease T2,Inverse variance weighted,10,1.15 [0.73-1.8],0.5554658908188,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,DPP4,Dipeptidyl peptidase 4,Inverse variance weighted,8,0.84 [0.47-1.51],0.555704492735094,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,STC2,Stanniocalcin-2,Inverse variance weighted,10,0.84 [0.46-1.52],0.556117801941784,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,SPOCK1,Testican-1,Inverse variance weighted,26,1.12 [0.76-1.66],0.557103139580122,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,GPR37,Prosaposin receptor GPR37,Inverse variance weighted,32,1.08 [0.84-1.38],0.558522568076822,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,CXCL16,C-X-C motif chemokine 16,Inverse variance weighted,15,0.88 [0.58-1.34],0.5593358307176,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,CD8A,T-cell surface glycoprotein CD8 alpha chain,Inverse variance weighted,4,1.35 [0.49-3.67],0.559977291127602,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,CD300A,CMRF35-like molecule 8,Inverse variance weighted,35,1.06 [0.87-1.28],0.561750303522307,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,DSG2,Desmoglein-2,Inverse variance weighted,22,1.08 [0.83-1.41],0.56207500260537,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,CD46,Membrane cofactor protein,Inverse variance weighted,2,0.57 [0.08-3.84],0.562307778649761,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,BGLAP,Osteocalcin,Inverse variance weighted,8,0.78 [0.33-1.83],0.56403136634822,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,PILRA,Paired immunoglobulin-like type 2 receptor alpha,Inverse variance weighted,27,1.07 [0.85-1.36],0.564720624125747,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,GPKOW,G-patch domain and KOW motifs-containing protein,Inverse variance weighted,2,1.46 [0.4-5.31],0.565322021081775,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,CLEC7A,C-type lectin domain family 7 member A,Inverse variance weighted,6,1.21 [0.62-2.37],0.568836586413051,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,PNLIPRP1,Inactive pancreatic lipase-related protein 1,Inverse variance weighted,40,0.94 [0.77-1.15],0.571047811545321,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,TFF2,Trefoil factor 2,Inverse variance weighted,16,0.87 [0.53-1.42],0.571391257824013,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,PLAUR,Urokinase plasminogen activator surface receptor,Inverse variance weighted,8,0.82 [0.41-1.63],0.571635228942207,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,SEPTIN8,Septin-8,Inverse variance weighted,4,0.79 [0.35-1.78],0.574151350989639,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,FGA,Fibrinogen alpha chain,Inverse variance weighted,6,1.26 [0.56-2.87],0.575243012896494,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,KIR2DL3,Killer cell immunoglobulin-like receptor 2DL3,Inverse variance weighted,4,0.72 [0.23-2.28],0.575463883651724,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,NEFL,Neurofilament light polypeptide,Inverse variance weighted,6,1.33 [0.49-3.64],0.576534308847641,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,ITIH3,Inter-alpha-trypsin inhibitor heavy chain H3,Inverse variance weighted,22,1.11 [0.77-1.62],0.577042297155795,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,HS6ST2,Heparan-sulfate 6-O-sulfotransferase 2,Inverse variance weighted,12,1.23 [0.59-2.59],0.579090284002602,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,CDH3,Cadherin-3,Inverse variance weighted,10,0.86 [0.52-1.45],0.581018970584108,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,CLEC4D,C-type lectin domain family 4 member D,Inverse variance weighted,9,0.87 [0.53-1.42],0.582050495593187,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,SEMA3G,Semaphorin-3G,Inverse variance weighted,66,1.05 [0.87-1.28],0.586775093523399,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,ADGRE1,Adhesion G protein-coupled receptor E1,Inverse variance weighted,22,1.11 [0.76-1.62],0.587750747547208,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,PHOSPHO1,Phosphoethanolamine/phosphocholine phosphatase,Inverse variance weighted,5,1.23 [0.58-2.6],0.589998802968808,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,TFF3,Trefoil factor 3,Inverse variance weighted,10,0.89 [0.58-1.37],0.591539433145359,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,PON3,Serum paraoxonase/lactonase 3,Inverse variance weighted,12,1.12 [0.74-1.7],0.593427324458018,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,RGMA,Repulsive guidance molecule A,Inverse variance weighted,35,1.06 [0.85-1.34],0.593731945633514,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,INHBC,Inhibin beta C chain,Inverse variance weighted,12,1.14 [0.71-1.82],0.594628680091271,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,CHGB,Secretogranin-1,Inverse variance weighted,7,0.72 [0.22-2.41],0.59660710641506,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,SDC4,Syndecan-4,Inverse variance weighted,35,0.94 [0.73-1.2],0.598822123478023,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,FSHB,Follitropin subunit beta,Wald ratio,1,1.72 [0.23-13.13],0.600889555410257,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,SPINK4,Serine protease inhibitor Kazal-type 4,Inverse variance weighted,14,1.13 [0.71-1.79],0.602131332483175,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,SIGLEC5,Sialic acid-binding Ig-like lectin 5,Wald ratio,1,0.55 [0.06-5.34],0.603018372125327,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,UNC5D,Netrin receptor UNC5D,Wald ratio,1,1.89 [0.17-21.09],0.604223530971755,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,PILRB,Paired immunoglobulin-like type 2 receptor beta,Inverse variance weighted,30,1.04 [0.89-1.23],0.604325513734809,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,CCL14,C-C motif chemokine 14,Inverse variance weighted,17,1.04 [0.89-1.22],0.604481623643923,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,TNFRSF6B,Tumor necrosis factor receptor superfamily member 6B,Inverse variance weighted,24,1.06 [0.84-1.35],0.60499321434039,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,FAM171B,Protein FAM171B,Inverse variance weighted,10,0.85 [0.47-1.56],0.605278875932662,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,CXCL17,C-X-C motif chemokine 17,Inverse variance weighted,6,1.22 [0.57-2.59],0.607280113576062,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,ALCAM,CD166 antigen,Inverse variance weighted,4,0.86 [0.48-1.54],0.609054281213076,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,DDAH1,"N(G),N(G)-dimethylarginine dimethylaminohydrolase 1",Inverse variance weighted,2,1.29 [0.49-3.44],0.609199547652503,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,ANGPTL3,Angiopoietin-related protein 3,Inverse variance weighted,5,1.22 [0.57-2.58],0.610951449510123,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,EPS8L2,Epidermal growth factor receptor kinase substrate 8-like protein 2,Wald ratio,1,0.59 [0.08-4.45],0.610974300733424,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,CD38,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1,Inverse variance weighted,8,0.8 [0.33-1.92],0.611441180341166,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,CDNF,Cerebral dopamine neurotrophic factor,Inverse variance weighted,3,0.73 [0.22-2.43],0.611863705901836,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,MANSC1,MANSC domain-containing protein 1,Inverse variance weighted,15,0.89 [0.57-1.39],0.612027024095754,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,SFRP4,Secreted frizzled-related protein 4,Inverse variance weighted,9,0.8 [0.35-1.87],0.612792381586712,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,ADGRE5,Adhesion G protein-coupled receptor E5,Inverse variance weighted,8,0.79 [0.31-2],0.615658803758077,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,TREM2,Triggering receptor expressed on myeloid cells 2,Inverse variance weighted,35,1.05 [0.88-1.25],0.61655224498635,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,SFRP1,Secreted frizzled-related protein 1,Inverse variance weighted,9,1.18 [0.62-2.24],0.617476276849989,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,CD1C,T-cell surface glycoprotein CD1c,Inverse variance weighted,28,0.92 [0.66-1.28],0.618215698090571,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,PIK3IP1,Phosphoinositide-3-kinase-interacting protein 1,Inverse variance weighted,8,1.23 [0.55-2.77],0.619970933403281,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,ZBTB17,Zinc finger and BTB domain-containing protein 17,Wald ratio,1,1.36 [0.4-4.63],0.621020285137726,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,ULBP2,UL16-binding protein 2,Inverse variance weighted,9,1.13 [0.7-1.8],0.621165576981211,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,ARHGEF5,Rho guanine nucleotide exchange factor 5,Inverse variance weighted,2,1.6 [0.24-10.51],0.623216960264506,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,COL3A1,Collagen alpha-1(III) chain,Inverse variance weighted,5,0.81 [0.34-1.89],0.623308637579182,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,COL1A1,Collagen alpha-1(I) chain,Inverse variance weighted,16,0.89 [0.55-1.43],0.623854797516924,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,ACTN2,Alpha-actinin-2,Inverse variance weighted,4,1.22 [0.55-2.71],0.630085639739427,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,SORBS1,Sorbin and SH3 domain-containing protein 1,Inverse variance weighted,2,2.05 [0.11-37.97],0.630481487847392,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,TPM3,Tropomyosin alpha-3 chain,Wald ratio,1,1.45 [0.32-6.68],0.630917322684754,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,CYB5R2,NADH-cytochrome b5 reductase 2,Inverse variance weighted,2,0.7 [0.16-3.04],0.631268737249138,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Inverse variance weighted,6,0.84 [0.41-1.71],0.631758902876465,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,RBP5,Retinol-binding protein 5,Inverse variance weighted,2,0.7 [0.17-2.95],0.632095521585655,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,FAM3C,Protein FAM3C,Inverse variance weighted,3,1.26 [0.48-3.29],0.633907923126575,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,GRN,Progranulin,Inverse variance weighted,46,0.96 [0.81-1.14],0.636555148525701,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,CDH1,Cadherin-1,Inverse variance weighted,16,1.11 [0.72-1.72],0.63660222270791,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Inverse variance weighted,20,0.88 [0.53-1.47],0.638053189154897,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,IL17D,Interleukin-17D,Inverse variance weighted,2,0.67 [0.12-3.61],0.638493349115106,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,PTPRZ1,Receptor-type tyrosine-protein phosphatase zeta,Inverse variance weighted,16,1.13 [0.69-1.84],0.638907695899901,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,NPTXR,Neuronal pentraxin receptor,Inverse variance weighted,10,0.83 [0.37-1.85],0.648420947116637,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,IL18,Interleukin-18,Inverse variance weighted,26,1.08 [0.78-1.5],0.650146602273187,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,CTSB,Cathepsin B,Inverse variance weighted,28,1.05 [0.85-1.3],0.650481702546381,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,MMP12,Macrophage metalloelastase,Inverse variance weighted,2,1.43 [0.31-6.66],0.652265896879979,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,EBI3_IL27,Interleukin-27,Inverse variance weighted,26,1.06 [0.82-1.36],0.656717042128244,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,TINAGL1,Tubulointerstitial nephritis antigen-like,Inverse variance weighted,13,0.91 [0.6-1.39],0.659260694294499,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,GDNF,Glial cell line-derived neurotrophic factor,Inverse variance weighted,5,1.14 [0.64-2.02],0.659933274875338,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,ADAMTS4,A disintegrin and metalloproteinase with thrombospondin motifs 4,Inverse variance weighted,4,0.81 [0.31-2.09],0.660611814879887,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,NECTIN2,Nectin-2,Inverse variance weighted,3,0.73 [0.17-3.03],0.66142824379942,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,FCRLB,Fc receptor-like B,Inverse variance weighted,10,1.17 [0.59-2.32],0.662726614700851,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,SCG2,Secretogranin-2,Inverse variance weighted,2,1.9 [0.1-34.72],0.663923153446853,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,IL6R,Interleukin-6 receptor subunit alpha,Inverse variance weighted,7,1.14 [0.63-2.04],0.665939054971485,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,SERPING1,Plasma protease C1 inhibitor,Inverse variance weighted,21,1.15 [0.6-2.23],0.667719570816629,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,PGF,Placenta growth factor,Inverse variance weighted,5,0.81 [0.31-2.13],0.668301998366869,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,DCN,Decorin,Inverse variance weighted,2,1.4 [0.3-6.54],0.669384390751787,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,EPHB4,Ephrin type-B receptor 4,Inverse variance weighted,9,0.89 [0.51-1.53],0.669490699900814,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,ATOX1,Copper transport protein ATOX1,Wald ratio,1,1.19 [0.53-2.66],0.669826358192573,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,GM2A,Ganglioside GM2 activator,Inverse variance weighted,2,1.73 [0.13-22.3],0.673426339452877,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,MFAP5,Microfibrillar-associated protein 5,Inverse variance weighted,2,1.26 [0.42-3.77],0.674281604939794,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,CPB1,Carboxypeptidase B,Inverse variance weighted,18,1.08 [0.75-1.57],0.674290982487448,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,LEP,Leptin,Inverse variance weighted,4,0.58 [0.05-7.47],0.677322171613459,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,OSMR,Oncostatin-M-specific receptor subunit beta,Inverse variance weighted,12,1.14 [0.62-2.11],0.678601771375999,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,ABL1,Tyrosine-protein kinase ABL1,Inverse variance weighted,3,0.83 [0.34-2.02],0.678628714822152,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,IFNLR1,Interferon lambda receptor 1,Wald ratio,1,1.4 [0.28-6.91],0.678728112579245,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,GPHA2,Glycoprotein hormone alpha-2,Wald ratio,1,0.64 [0.08-5.32],0.679956834427613,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,PTPRS,Receptor-type tyrosine-protein phosphatase S,Inverse variance weighted,10,1.13 [0.62-2.06],0.680121542515538,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,CD5,T-cell surface glycoprotein CD5,Inverse variance weighted,7,0.87 [0.44-1.7],0.680443578332568,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,CSTB,Cystatin-B,Inverse variance weighted,23,1.04 [0.87-1.24],0.680578102819722,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,EFHD1,EF-hand domain-containing protein D1,Inverse variance weighted,4,1.19 [0.53-2.68],0.681590270436161,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,PIGR,Polymeric immunoglobulin receptor,Inverse variance weighted,10,1.11 [0.68-1.82],0.682234691684755,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,LILRB2,Leukocyte immunoglobulin-like receptor subfamily B member 2,Inverse variance weighted,9,1.15 [0.59-2.26],0.684666935596967,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,LMOD1,Leiomodin-1,Inverse variance weighted,6,1.09 [0.73-1.63],0.68538458701936,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,CRTAM,Cytotoxic and regulatory T-cell molecule,Inverse variance weighted,13,1.12 [0.64-1.96],0.685891385521257,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,PEAR1,Platelet endothelial aggregation receptor 1,Inverse variance weighted,5,1.16 [0.57-2.37],0.686917934612188,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,SCARF1,Scavenger receptor class F member 1,Inverse variance weighted,3,1.47 [0.23-9.5],0.687616454758739,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,PODXL2,Podocalyxin-like protein 2,Inverse variance weighted,17,1.07 [0.76-1.51],0.688266745431805,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,LAIR1,Leukocyte-associated immunoglobulin-like receptor 1,Inverse variance weighted,2,0.72 [0.15-3.54],0.688796257113881,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,GPNMB,Transmembrane glycoprotein NMB,Inverse variance weighted,5,0.95 [0.73-1.23],0.689469877372623,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,PI3,Elafin,Inverse variance weighted,18,0.95 [0.72-1.24],0.689847513937111,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,TIMP1,Metalloproteinase inhibitor 1,Inverse variance weighted,2,0.8 [0.26-2.41],0.690499452383907,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,STX8,Syntaxin-8,Wald ratio,1,0.82 [0.3-2.23],0.692976660540384,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,MFAP4,Microfibril-associated glycoprotein 4,Inverse variance weighted,15,1.11 [0.65-1.9],0.69343001092416,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,EPHA4,Ephrin type-A receptor 4,Inverse variance weighted,5,1.63 [0.14-18.42],0.693680115575022,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,SLITRK2,SLIT and NTRK-like protein 2,Inverse variance weighted,12,1.11 [0.66-1.85],0.693786349434403,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,LTBP3,Latent-transforming growth factor beta-binding protein 3,Inverse variance weighted,16,1.08 [0.73-1.59],0.697221882763096,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,PGA4,Pepsin A-4,Inverse variance weighted,7,1.14 [0.58-2.26],0.69727220703792,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,NPHS1,Nephrin,Inverse variance weighted,15,1.09 [0.7-1.72],0.700465618496117,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,SPON1,Spondin-1,Inverse variance weighted,4,0.84 [0.34-2.08],0.70061740177266,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,TYRP1,"5,6-dihydroxyindole-2-carboxylic acid oxidase",Inverse variance weighted,4,0.86 [0.39-1.87],0.700664380786227,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,SCGB1A1,Uteroglobin,Inverse variance weighted,38,0.95 [0.73-1.23],0.700890015442166,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,GKN1,Gastrokine-1,Inverse variance weighted,3,0.83 [0.33-2.11],0.701102869662635,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,ICAM5,Intercellular adhesion molecule 5,Inverse variance weighted,13,0.9 [0.52-1.55],0.702761673825555,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,LAIR2,Leukocyte-associated immunoglobulin-like receptor 2,Inverse variance weighted,3,0.72 [0.13-4],0.706054912689553,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,IL18BP,Interleukin-18-binding protein,Inverse variance weighted,10,0.89 [0.47-1.66],0.706980808901085,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,ROBO4,Roundabout homolog 4,Inverse variance weighted,3,0.79 [0.22-2.76],0.707149801561465,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,SLITRK1,SLIT and NTRK-like protein 1,Inverse variance weighted,6,1.14 [0.58-2.26],0.708282076328163,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,IL12B,Interleukin-12 subunit beta,Inverse variance weighted,39,1.05 [0.82-1.34],0.709330215958883,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,TG,Thyroglobulin,Inverse variance weighted,36,1.05 [0.82-1.35],0.709598793729522,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,THBS2,Thrombospondin-2,Inverse variance weighted,15,0.93 [0.63-1.37],0.710212840807118,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,RBP7,Retinoid-binding protein 7,Inverse variance weighted,5,1.27 [0.35-4.61],0.711959630610768,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,KLK13,Kallikrein-13,Inverse variance weighted,11,1.11 [0.64-1.93],0.712512461806959,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,WFDC12,WAP four-disulfide core domain protein 12,Inverse variance weighted,56,0.97 [0.84-1.12],0.713078166839831,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,REG1A,Lithostathine-1-alpha,Inverse variance weighted,13,1.07 [0.75-1.52],0.714934040313062,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,PDCD1LG2,Programmed cell death 1 ligand 2,Inverse variance weighted,36,0.96 [0.75-1.22],0.715228175362529,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,RIDA,2-iminobutanoate/2-iminopropanoate deaminase,Inverse variance weighted,6,1.17 [0.49-2.82],0.719724110201529,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,PRND,Prion-like protein doppel,Inverse variance weighted,15,0.93 [0.61-1.41],0.721264049094703,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,SPINK5,Serine protease inhibitor Kazal-type 5,Inverse variance weighted,9,1.22 [0.41-3.64],0.721433981223572,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,NBL1,Neuroblastoma suppressor of tumorigenicity 1,Inverse variance weighted,3,1.47 [0.18-12.18],0.721637814507728,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,FABP6,Gastrotropin,Inverse variance weighted,4,0.84 [0.31-2.23],0.721784340077406,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,ENDOU,Poly(U)-specific endoribonuclease,Inverse variance weighted,22,1.1 [0.65-1.84],0.724504547350858,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,CRH,Corticoliberin,Inverse variance weighted,55,1.04 [0.84-1.28],0.725213682581136,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,B3GNT7,"UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7",Inverse variance weighted,16,1.06 [0.75-1.51],0.726151946130025,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,MYOC,Myocilin,Inverse variance weighted,12,1.11 [0.62-2],0.726782049134241,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,CLEC10A,C-type lectin domain family 10 member A,Inverse variance weighted,17,1.06 [0.78-1.43],0.72687277579951,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,SUSD5,Sushi domain-containing protein 5,Inverse variance weighted,6,1.18 [0.46-3.07],0.729611250433455,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,KLK11,Kallikrein-11,Inverse variance weighted,13,1.13 [0.57-2.2],0.730951913307531,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,DPT,Dermatopontin,Inverse variance weighted,4,1.27 [0.33-4.88],0.731675352493228,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,CA5A,"Carbonic anhydrase 5A, mitochondrial",Inverse variance weighted,4,1.25 [0.35-4.45],0.731767425921419,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,CD86,T-lymphocyte activation antigen CD86,Inverse variance weighted,17,1.06 [0.77-1.44],0.73194166339766,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,WFDC2,WAP four-disulfide core domain protein 2,Inverse variance weighted,4,0.88 [0.43-1.8],0.732397993921844,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,FABP2,"Fatty acid-binding protein, intestinal",Inverse variance weighted,6,1.13 [0.57-2.24],0.733341844076147,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,S100G,Protein S100-G,Inverse variance weighted,4,0.86 [0.36-2.06],0.733509191522139,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,C7,Complement component C7,Inverse variance weighted,26,0.97 [0.82-1.16],0.735882141580061,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,HAVCR1,Hepatitis A virus cellular receptor 1,Inverse variance weighted,21,0.93 [0.59-1.45],0.736437280242255,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,ART3,Ecto-ADP-ribosyltransferase 3,Inverse variance weighted,13,1.08 [0.7-1.65],0.738686249819479,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,MMP10,Stromelysin-2,Wald ratio,1,0.68 [0.07-6.42],0.740250496517038,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,AKAP12,A-kinase anchor protein 12,Wald ratio,1,0.71 [0.09-5.34],0.740805508707847,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,CCN3,CCN family member 3,Inverse variance weighted,17,0.96 [0.74-1.24],0.74285504495668,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,LTBR,Tumor necrosis factor receptor superfamily member 3,Inverse variance weighted,9,0.91 [0.51-1.61],0.744150365145128,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,PTH1R,Parathyroid hormone/parathyroid hormone-related peptide receptor,Inverse variance weighted,17,0.97 [0.83-1.14],0.745595980084655,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,SPINK1,Serine protease inhibitor Kazal-type 1,Inverse variance weighted,5,0.83 [0.26-2.61],0.745800274767716,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,ACTA2,"Actin, aortic smooth muscle",Wald ratio,1,0.79 [0.18-3.39],0.746741842588731,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,THY1,Thy-1 membrane glycoprotein,Wald ratio,1,1.44 [0.16-13.41],0.746874142413444,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,CCL3,C-C motif chemokine 3,Inverse variance weighted,15,0.96 [0.72-1.26],0.747923969257936,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,PPY,Pancreatic prohormone,Inverse variance weighted,23,0.96 [0.75-1.23],0.748276494775898,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,LETM1,Mitochondrial proton/calcium exchanger protein,Inverse variance weighted,2,1.25 [0.32-4.96],0.749264458087308,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,INSL4,Early placenta insulin-like peptide,Inverse variance weighted,4,0.89 [0.44-1.82],0.751252738289614,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,VSTM1,V-set and transmembrane domain-containing protein 1,Inverse variance weighted,3,0.6 [0.02-14.68],0.751358786992876,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,SERPINF1,Pigment epithelium-derived factor,Wald ratio,1,1.43 [0.16-13.17],0.751572919329881,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,TGFB1,Transforming growth factor beta-1 proprotein,Inverse variance weighted,4,1.16 [0.46-2.95],0.751984395974555,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,CD300LG,CMRF35-like molecule 9,Inverse variance weighted,23,1.05 [0.76-1.47],0.752838526486781,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,TDGF1,Teratocarcinoma-derived growth factor 1,Inverse variance weighted,74,1.02 [0.91-1.13],0.755164074289151,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,IL6ST,Interleukin-6 receptor subunit beta,Inverse variance weighted,7,1.1 [0.59-2.07],0.756561734429012,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,GIPC2,PDZ domain-containing protein GIPC2,Inverse variance weighted,2,0.62 [0.03-12.46],0.756765437382714,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,SPINT1,Kunitz-type protease inhibitor 1,Inverse variance weighted,12,0.92 [0.56-1.53],0.756894745900279,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,DTX3,Probable E3 ubiquitin-protein ligase DTX3,Inverse variance weighted,13,1.07 [0.7-1.65],0.757898223525204,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,ASGR2,Asialoglycoprotein receptor 2,Inverse variance weighted,12,1.08 [0.66-1.76],0.759238843534062,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,NOTCH1,Neurogenic locus notch homolog protein 1,Inverse variance weighted,7,1.12 [0.54-2.31],0.759315186543448,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,CD14,Monocyte differentiation antigen CD14,Inverse variance weighted,6,1.11 [0.58-2.12],0.761091526861922,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,EPHA2,Ephrin type-A receptor 2,Inverse variance weighted,3,0.83 [0.25-2.78],0.761152453159813,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,STC1,Stanniocalcin-1,Inverse variance weighted,9,0.91 [0.49-1.69],0.761794279248683,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,RBP2,Retinol-binding protein 2,Inverse variance weighted,5,1.14 [0.49-2.65],0.76294274891159,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,YAP1,Transcriptional coactivator YAP1,Inverse variance weighted,9,0.94 [0.6-1.46],0.768349255184958,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,TGFA,Protransforming growth factor alpha,Inverse variance weighted,9,0.89 [0.41-1.92],0.769225959042851,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,VEGFD,Vascular endothelial growth factor D,Inverse variance weighted,7,0.89 [0.4-1.97],0.772382798397737,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,RNASE10,Inactive ribonuclease-like protein 10,Wald ratio,1,1.41 [0.13-14.75],0.774546034408327,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,CRIP2,Cysteine-rich protein 2,Inverse variance weighted,6,1.13 [0.48-2.7],0.774574686192009,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,ANGPTL4,Angiopoietin-related protein 4,Wald ratio,1,0.73 [0.08-6.36],0.774642894308253,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,CTSZ,Cathepsin Z,Inverse variance weighted,16,0.97 [0.8-1.18],0.774974376444812,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,CLEC6A,C-type lectin domain family 6 member A,Inverse variance weighted,13,1.09 [0.61-1.94],0.775770494559314,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,RCC1,Regulator of chromosome condensation,Wald ratio,1,0.75 [0.1-5.48],0.776370046498478,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,GRP,Gastrin-releasing peptide,Inverse variance weighted,21,0.98 [0.82-1.16],0.776458329010652,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,CCL7,C-C motif chemokine 7,Inverse variance weighted,14,1.06 [0.72-1.56],0.776460691221977,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,EGFL7,Epidermal growth factor-like protein 7,Inverse variance weighted,29,0.96 [0.72-1.27],0.778330593464623,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,MEPE,Matrix extracellular phosphoglycoprotein,Inverse variance weighted,24,0.95 [0.69-1.33],0.779389935627331,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,IGFBP6,Insulin-like growth factor-binding protein 6,Inverse variance weighted,3,1.28 [0.22-7.28],0.781923043013028,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,TIMP2,Metalloproteinase inhibitor 2,Inverse variance weighted,3,0.9 [0.43-1.89],0.784668902882288,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,CD164,Sialomucin core protein 24,Inverse variance weighted,8,0.9 [0.42-1.93],0.785140236609487,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,LAMB1,Laminin subunit beta-1,Inverse variance weighted,21,0.95 [0.67-1.35],0.785598254980655,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,ICOSLG,ICOS ligand,Inverse variance weighted,17,0.93 [0.54-1.59],0.786216347395887,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,CD34,Hematopoietic progenitor cell antigen CD34,Inverse variance weighted,2,1.34 [0.16-10.95],0.786253891023333,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,AGRP,Agouti-related protein,Inverse variance weighted,16,0.96 [0.69-1.32],0.78675533656545,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,GCG,Pro-glucagon,Inverse variance weighted,2,0.83 [0.21-3.23],0.787615405492621,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,CD83,CD83 antigen,Inverse variance weighted,14,0.94 [0.6-1.48],0.787828001163205,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,COLEC12,Collectin-12,Inverse variance weighted,3,0.78 [0.12-5.03],0.792538041172446,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,FCRL6,Fc receptor-like protein 6,Inverse variance weighted,9,1.11 [0.5-2.48],0.794192549371525,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,SPON2,Spondin-2,Inverse variance weighted,3,1.23 [0.25-5.98],0.795215864496466,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,SIRPB1,Signal-regulatory protein beta-1,Inverse variance weighted,7,1.22 [0.27-5.51],0.79571173452407,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,TNFRSF21,Tumor necrosis factor receptor superfamily member 21,Inverse variance weighted,8,0.91 [0.46-1.83],0.796404627122634,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,P4HB,Protein disulfide-isomerase,Inverse variance weighted,4,0.82 [0.19-3.65],0.796641056478938,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,ACVRL1,Serine/threonine-protein kinase receptor R3,Inverse variance weighted,6,1.09 [0.56-2.11],0.797394264070069,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,MMP7,Matrilysin,Wald ratio,1,1.11 [0.49-2.5],0.797415571609907,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,CTSL,Cathepsin L1,Inverse variance weighted,29,0.96 [0.72-1.29],0.797691630211329,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,SPRR3,Small proline-rich protein 3,Inverse variance weighted,6,1.15 [0.4-3.3],0.799919262373592,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,PTPRC,Receptor-type tyrosine-protein phosphatase C,Inverse variance weighted,8,0.93 [0.51-1.67],0.800115679850698,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,NECTIN4,Nectin-4,Inverse variance weighted,4,0.88 [0.32-2.4],0.801253040742991,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,CD27,CD27 antigen,Inverse variance weighted,9,1.09 [0.56-2.12],0.804892587287089,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,PTH,Parathyroid hormone,Inverse variance weighted,11,1.07 [0.63-1.8],0.80583458550029,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,POLR2F,"DNA-directed RNA polymerases I, II, and III subunit RPABC2",Wald ratio,1,1.31 [0.15-11.31],0.807982174225969,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,CST5,Cystatin-D,Inverse variance weighted,29,0.94 [0.57-1.55],0.808925464380056,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,AOC3,Membrane primary amine oxidase,Inverse variance weighted,34,0.98 [0.84-1.14],0.81149728968046,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,AREG,Amphiregulin,Inverse variance weighted,5,1.11 [0.48-2.53],0.812131557794225,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,FGF23,Fibroblast growth factor 23,Inverse variance weighted,15,0.95 [0.63-1.44],0.812718506325011,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,SCG3,Secretogranin-3,Inverse variance weighted,16,1.07 [0.63-1.8],0.813287479497834,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,WFDC1,WAP four-disulfide core domain protein 1,Wald ratio,1,0.77 [0.09-6.82],0.814679197099,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,DKK3,Dickkopf-related protein 3,Inverse variance weighted,14,0.96 [0.71-1.31],0.816428895438078,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,MYBPC1,"Myosin-binding protein C, slow-type",Inverse variance weighted,13,0.94 [0.57-1.57],0.816975148084558,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,CPA4,Carboxypeptidase A4,Inverse variance weighted,9,1.09 [0.53-2.22],0.822362280892154,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,DTNB,Dystrobrevin beta,Inverse variance weighted,2,1.17 [0.31-4.44],0.822420536296568,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,PPP3R1,Calcineurin subunit B type 1,Inverse variance weighted,3,0.89 [0.32-2.46],0.82327729835516,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,PTPRF,Receptor-type tyrosine-protein phosphatase F,Inverse variance weighted,17,1.04 [0.72-1.51],0.82486146888518,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,FGFR2,Fibroblast growth factor receptor 2,Inverse variance weighted,13,0.92 [0.43-1.98],0.824995241943079,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,ERMAP,Erythroid membrane-associated protein,Inverse variance weighted,33,1.02 [0.84-1.25],0.825140629425862,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,LAYN,Layilin,Inverse variance weighted,3,1.15 [0.34-3.9],0.825788125343798,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,AMY2A,Pancreatic alpha-amylase,Inverse variance weighted,28,1.04 [0.74-1.45],0.826404308571982,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,CCL21,C-C motif chemokine 21,Inverse variance weighted,15,1.06 [0.64-1.74],0.828732769770072,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,FSTL3,Follistatin-related protein 3,Inverse variance weighted,3,1.14 [0.34-3.78],0.830783866453677,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,CCL22,C-C motif chemokine 22,Inverse variance weighted,8,1.14 [0.34-3.89],0.831475615177623,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,CD207,C-type lectin domain family 4 member K,Inverse variance weighted,17,0.96 [0.65-1.42],0.832349976134836,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,CD302,CD302 antigen,Inverse variance weighted,11,1.05 [0.69-1.6],0.832426490492319,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,RTN4R,Reticulon-4 receptor,Inverse variance weighted,8,1.07 [0.57-2.01],0.83318384725096,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,NCS1,Neuronal calcium sensor 1,Inverse variance weighted,18,1.04 [0.7-1.56],0.834153565842019,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,KLK4,Kallikrein-4,Inverse variance weighted,5,1.13 [0.36-3.52],0.834376231107532,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,IL4R,Interleukin-4 receptor subunit alpha,Inverse variance weighted,7,1.08 [0.54-2.16],0.835433962889701,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,FGF5,Fibroblast growth factor 5,Inverse variance weighted,18,1.04 [0.72-1.49],0.835801254142625,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,SCGB3A2,Secretoglobin family 3A member 2,Inverse variance weighted,27,1.03 [0.76-1.4],0.836848372188007,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,PAM,Peptidyl-glycine alpha-amidating monooxygenase,Inverse variance weighted,24,1.02 [0.85-1.23],0.839181914393406,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,MIA,Melanoma-derived growth regulatory protein,Inverse variance weighted,14,1.07 [0.53-2.18],0.840836143100249,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,DLK1,Protein delta homolog 1,Inverse variance weighted,10,1.08 [0.5-2.32],0.840952760911546,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,SLAMF1,Signaling lymphocytic activation molecule,Inverse variance weighted,4,0.9 [0.3-2.63],0.841255035901078,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,IL36G,Interleukin-36 gamma,Wald ratio,1,0.85 [0.17-4.34],0.842065633489515,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,FST,Follistatin,Wald ratio,1,1.2 [0.2-7.15],0.842633742057149,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,LPL,Lipoprotein lipase,Inverse variance weighted,8,1.08 [0.5-2.31],0.843127536047798,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,F11R,Junctional adhesion molecule A,Inverse variance weighted,3,0.91 [0.34-2.42],0.843504862905873,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,ERBB4,Receptor tyrosine-protein kinase erbB-4,Inverse variance weighted,15,1.08 [0.51-2.29],0.844111304224801,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,DNMBP,Dynamin-binding protein,Inverse variance weighted,5,0.96 [0.61-1.49],0.844499097021129,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,KLRB1,Killer cell lectin-like receptor subfamily B member 1,Inverse variance weighted,17,0.97 [0.68-1.37],0.845470665116553,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,GCHFR,GTP cyclohydrolase 1 feedback regulatory protein,Inverse variance weighted,3,0.93 [0.42-2.03],0.846313159201269,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,IL17C,Interleukin-17C,Inverse variance weighted,5,1.12 [0.36-3.49],0.847557811688211,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,KLRD1,Natural killer cells antigen CD94,Inverse variance weighted,19,1.03 [0.77-1.38],0.849768930224218,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,INSL5,Insulin-like peptide INSL5,Inverse variance weighted,8,0.92 [0.39-2.17],0.852566523578421,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,GABARAP,Gamma-aminobutyric acid receptor-associated protein,Inverse variance weighted,4,0.89 [0.25-3.12],0.853151053273633,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,EFNB2,Ephrin-B2,Wald ratio,1,0.95 [0.53-1.68],0.855130942245976,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,GPC1,Glypican-1,Inverse variance weighted,28,1.02 [0.79-1.32],0.859292584516411,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,PVR,Poliovirus receptor,Inverse variance weighted,3,1.12 [0.32-3.84],0.861216332306861,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,RARRES1,Retinoic acid receptor responder protein 1,Inverse variance weighted,8,0.94 [0.47-1.88],0.863421150581657,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,CD200,OX-2 membrane glycoprotein,Inverse variance weighted,9,0.93 [0.43-2.04],0.865068612683088,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,CD300E,CMRF35-like molecule 2,Inverse variance weighted,35,1.02 [0.84-1.22],0.865473761075871,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,LTBP2,Latent-transforming growth factor beta-binding protein 2,Inverse variance weighted,12,1.07 [0.5-2.29],0.866126020093031,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,TXNDC15,Thioredoxin domain-containing protein 15,Inverse variance weighted,28,0.98 [0.82-1.18],0.866292869256027,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,LRIG1,Leucine-rich repeats and immunoglobulin-like domains protein 1,Inverse variance weighted,12,0.96 [0.57-1.6],0.86806708933692,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,SLAMF6,SLAM family member 6,Inverse variance weighted,2,0.89 [0.21-3.69],0.868888684086309,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,MXRA8,Matrix remodeling-associated protein 8,Inverse variance weighted,10,1.05 [0.56-1.97],0.869416930102753,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,SORCS2,VPS10 domain-containing receptor SorCS2,Inverse variance weighted,6,1.13 [0.27-4.69],0.870375695296317,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,CRIM1,Cysteine-rich motor neuron 1 protein,Inverse variance weighted,7,1.05 [0.56-1.98],0.87040974147413,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,PAXX,Protein PAXX,Wald ratio,1,0.92 [0.34-2.49],0.870432069204145,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,IL12A_IL12B,Interleukin-12,Inverse variance weighted,56,1.01 [0.87-1.18],0.872866905627241,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,CNTNAP2,Contactin-associated protein-like 2,Inverse variance weighted,11,0.96 [0.56-1.63],0.87463566286835,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,NRP1,Neuropilin-1,Inverse variance weighted,14,0.96 [0.57-1.62],0.875369777546991,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,WFIKKN2,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 2",Inverse variance weighted,40,1.01 [0.85-1.22],0.875543985924146,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,MFGE8,Lactadherin,Inverse variance weighted,15,1.04 [0.61-1.8],0.876414036681765,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,KITLG,Kit ligand,Inverse variance weighted,30,1.02 [0.77-1.36],0.87681033429656,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,RSPO3,R-spondin-3,Inverse variance weighted,5,0.94 [0.44-2.01],0.877212251526241,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,CA9,Carbonic anhydrase 9,Inverse variance weighted,8,1.05 [0.56-1.95],0.878138154928999,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,TNFRSF8,Tumor necrosis factor receptor superfamily member 8,Inverse variance weighted,7,1.08 [0.42-2.74],0.878272967509853,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,CD80,T-lymphocyte activation antigen CD80,Inverse variance weighted,10,0.96 [0.52-1.77],0.884295794319569,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,NPC2,NPC intracellular cholesterol transporter 2,Inverse variance weighted,7,1.05 [0.53-2.1],0.884472670299612,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,FLRT2,Leucine-rich repeat transmembrane protein FLRT2,Inverse variance weighted,17,0.98 [0.74-1.3],0.885361805470408,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,B2M,Beta-2-microglobulin,Inverse variance weighted,7,1.07 [0.44-2.6],0.888023144694316,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,NHLRC3,NHL repeat-containing protein 3,Inverse variance weighted,5,0.94 [0.42-2.13],0.890024159787443,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,TNFRSF1B,Tumor necrosis factor receptor superfamily member 1B,Inverse variance weighted,5,1.09 [0.34-3.5],0.890779187435916,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,CLEC14A,C-type lectin domain family 14 member A,Inverse variance weighted,3,1.06 [0.49-2.29],0.89196417006068,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,TNFRSF13C,Tumor necrosis factor receptor superfamily member 13C,Inverse variance weighted,15,0.95 [0.46-1.96],0.892000309919946,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,RAB6A,Ras-related protein Rab-6A,Inverse variance weighted,27,1.02 [0.82-1.26],0.892433704837395,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,PCDH7,Protocadherin-7,Inverse variance weighted,3,1.2 [0.08-16.94],0.893021547578059,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,SDC1,Syndecan-1,Inverse variance weighted,12,1.03 [0.66-1.61],0.895037668732452,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,CTSO,Cathepsin O,Inverse variance weighted,19,0.98 [0.76-1.27],0.89637714502087,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,FGFR4,Fibroblast growth factor receptor 4,Inverse variance weighted,50,0.99 [0.82-1.2],0.897462808420331,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,CCL18,C-C motif chemokine 18,Inverse variance weighted,19,0.99 [0.85-1.16],0.897737929751239,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,CCL15,C-C motif chemokine 15,Inverse variance weighted,28,1.01 [0.91-1.12],0.900767777718741,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,CPA1,Carboxypeptidase A1,Inverse variance weighted,26,1.02 [0.75-1.38],0.902152750986802,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,QPCT,Glutaminyl-peptide cyclotransferase,Inverse variance weighted,9,1.04 [0.51-2.14],0.907189066613006,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,EGFR,Epidermal growth factor receptor,Inverse variance weighted,8,0.96 [0.47-1.97],0.908103680069207,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,FBLN2,Fibulin-2,Inverse variance weighted,6,1.04 [0.53-2.02],0.909127071837369,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,RNASE4,Ribonuclease 4,Inverse variance weighted,2,0.93 [0.25-3.41],0.910137604734736,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,CANT1,Soluble calcium-activated nucleotidase 1,Inverse variance weighted,8,0.97 [0.6-1.58],0.911181016024703,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,DEFB4A_DEFB4B,Beta-defensin 4A,Inverse variance weighted,7,0.96 [0.51-1.82],0.911400655515101,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,DRAXIN,Draxin,Inverse variance weighted,25,1.02 [0.71-1.48],0.911988015171877,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,XG,Glycoprotein Xg,Inverse variance weighted,2,1.11 [0.16-7.57],0.913414314230665,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,C4BPB,C4b-binding protein beta chain,Inverse variance weighted,21,0.98 [0.62-1.54],0.913707540117015,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,FDX1,"Adrenodoxin, mitochondrial",Wald ratio,1,0.89 [0.11-6.95],0.913957427468139,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,PSAPL1,Proactivator polypeptide-like 1,Inverse variance weighted,50,0.99 [0.8-1.22],0.913972366287119,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,DCTPP1,dCTP pyrophosphatase 1,Inverse variance weighted,5,0.91 [0.15-5.58],0.915638189062687,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,FABP9,Fatty acid-binding protein 9,Inverse variance weighted,48,0.99 [0.83-1.19],0.916792936714251,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,OGFR,Opioid growth factor receptor,Inverse variance weighted,2,1.06 [0.32-3.55],0.918722243207366,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,CD55,Complement decay-accelerating factor,Inverse variance weighted,8,0.97 [0.52-1.81],0.919479485289462,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,ADAM9,Disintegrin and metalloproteinase domain-containing protein 9,Inverse variance weighted,6,1.03 [0.58-1.81],0.921637635150761,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,CST3,Cystatin-C,Inverse variance weighted,3,0.93 [0.23-3.76],0.924506859926962,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,FOLR2,Folate receptor beta,Inverse variance weighted,14,1.02 [0.67-1.56],0.925027250062402,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,CA4,Carbonic anhydrase 4,Inverse variance weighted,25,0.99 [0.83-1.18],0.925253688503407,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,CA14,Carbonic anhydrase 14,Inverse variance weighted,11,1.03 [0.52-2.03],0.927087307722863,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,CLEC5A,C-type lectin domain family 5 member A,Inverse variance weighted,10,0.97 [0.55-1.72],0.927432391596423,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Inverse variance weighted,19,1.01 [0.75-1.36],0.927518927848841,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,VWF,von Willebrand factor,Inverse variance weighted,6,0.96 [0.36-2.55],0.933754171379204,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,CCL17,C-C motif chemokine 17,Inverse variance weighted,27,1.01 [0.83-1.22],0.935121075457762,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,CST7,Cystatin-F,Inverse variance weighted,46,0.99 [0.82-1.2],0.935473748192559,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,APOA2,Apolipoprotein A-II,Inverse variance weighted,15,0.98 [0.64-1.51],0.935606565304299,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,F3,Tissue factor,Inverse variance weighted,13,0.98 [0.57-1.68],0.937609656852488,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,LAG3,Lymphocyte activation gene 3 protein,Inverse variance weighted,11,1.03 [0.53-1.99],0.939285067062236,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,HSPB6,Heat shock protein beta-6,Inverse variance weighted,4,0.96 [0.36-2.6],0.939459065436272,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,BRK1,Protein BRICK1,Inverse variance weighted,10,0.98 [0.62-1.56],0.940077451359459,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,ACAN,Aggrecan core protein,Inverse variance weighted,30,0.99 [0.7-1.39],0.940651464691375,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,ANG,Angiogenin,Inverse variance weighted,9,0.97 [0.4-2.36],0.941003917341844,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,CCDC80,Coiled-coil domain-containing protein 80,Inverse variance weighted,10,1.02 [0.6-1.75],0.941234980939878,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,ADAMTS16,A disintegrin and metalloproteinase with thrombospondin motifs 16,Wald ratio,1,1.12 [0.05-25.19],0.941884915798129,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,TNFRSF19,Tumor necrosis factor receptor superfamily member 19,Inverse variance weighted,10,1.03 [0.51-2.05],0.943389381224515,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,MSR1,Macrophage scavenger receptor types I and II,Inverse variance weighted,18,0.99 [0.69-1.41],0.94379889987307,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,PCSK9,Proprotein convertase subtilisin/kexin type 9,Inverse variance weighted,9,1.02 [0.58-1.8],0.947315068889519,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,MCFD2,Multiple coagulation factor deficiency protein 2,Inverse variance weighted,2,1.04 [0.32-3.38],0.947909234575666,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,ITGAV,Integrin alpha-V,Inverse variance weighted,10,0.98 [0.5-1.93],0.949057767061162,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,CLEC4G,C-type lectin domain family 4 member G,Inverse variance weighted,14,0.98 [0.55-1.75],0.951520699819361,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,EFCAB14,EF-hand calcium-binding domain-containing protein 14,Inverse variance weighted,3,1.07 [0.12-9.67],0.951704938931742,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,OCLN,Occludin,Inverse variance weighted,2,1.05 [0.2-5.42],0.952827179210958,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,C1QTNF1,Complement C1q tumor necrosis factor-related protein 1,Inverse variance weighted,11,0.99 [0.83-1.19],0.953222511940186,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,AMY2B,Alpha-amylase 2B,Inverse variance weighted,28,1.01 [0.73-1.39],0.955828520732076,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,CHRDL1,Chordin-like protein 1,Inverse variance weighted,3,0.97 [0.31-3.05],0.95614667557702,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,PLA2G1B,Phospholipase A2,Inverse variance weighted,20,1.01 [0.68-1.5],0.956848496793756,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,BCHE,Cholinesterase,Inverse variance weighted,38,0.99 [0.79-1.26],0.959769343044593,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,CTRB1,Chymotrypsinogen B,Inverse variance weighted,19,1.01 [0.66-1.55],0.961021344057746,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,F2R,Proteinase-activated receptor 1,Inverse variance weighted,6,1.03 [0.35-3.03],0.961406592961088,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,MUC13,Mucin-13,Inverse variance weighted,3,0.97 [0.23-3.98],0.96149342935046,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,COL6A3,Collagen alpha-3(VI) chain,Inverse variance weighted,3,0.97 [0.33-2.84],0.961642862507363,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,HYOU1,Hypoxia up-regulated protein 1,Inverse variance weighted,17,0.99 [0.57-1.72],0.962474725966593,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,CXCL14,C-X-C motif chemokine 14,Inverse variance weighted,4,0.97 [0.3-3.19],0.96310651044919,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,TIMD4,T-cell immunoglobulin and mucin domain-containing protein 4,Inverse variance weighted,35,0.99 [0.77-1.29],0.963706169363876,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,IL1R1,Interleukin-1 receptor type 1,Inverse variance weighted,14,0.99 [0.57-1.71],0.964190437194697,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,NPY,Pro-neuropeptide Y,Inverse variance weighted,15,1.01 [0.66-1.54],0.96457447284926,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,ORM1,Alpha-1-acid glycoprotein 1,Inverse variance weighted,21,1.01 [0.79-1.28],0.965352463886989,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,LY6D,Lymphocyte antigen 6D,Inverse variance weighted,21,1.01 [0.77-1.32],0.965366215692087,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,CLPS,Colipase,Inverse variance weighted,28,1.01 [0.73-1.39],0.967155863641685,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,JAM3,Junctional adhesion molecule C,Inverse variance weighted,4,0.98 [0.39-2.49],0.970598302932927,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,AGR2,Anterior gradient protein 2 homolog,Inverse variance weighted,2,1.02 [0.35-3],0.971717366476683,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,HS3ST3B1,Heparan sulfate glucosamine 3-O-sulfotransferase 3B1,Inverse variance weighted,6,0.99 [0.5-1.95],0.972930642398344,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,POF1B,Protein POF1B,Inverse variance weighted,4,1.01 [0.47-2.2],0.973579117342001,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,LSP1,Lymphocyte-specific protein 1,Wald ratio,1,1.03 [0.16-6.57],0.973589583692557,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,VIT,Vitrin,Inverse variance weighted,10,1.01 [0.62-1.64],0.974388511095055,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,BCL2,Apoptosis regulator Bcl-2,Inverse variance weighted,5,1.02 [0.3-3.45],0.974571480204693,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,ITGBL1,Integrin beta-like protein 1,Inverse variance weighted,5,0.99 [0.42-2.33],0.976579909747779,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,CCER2,Coiled-coil domain-containing glutamate-rich protein 2,Inverse variance weighted,35,1 [0.81-1.22],0.976676727708153,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,ADAM22,Disintegrin and metalloproteinase domain-containing protein 22,Inverse variance weighted,11,0.99 [0.65-1.52],0.978048867349494,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,ADAM23,Disintegrin and metalloproteinase domain-containing protein 23,Inverse variance weighted,23,1 [0.77-1.29],0.978572829405657,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,GGT5,Glutathione hydrolase 5 proenzyme,Inverse variance weighted,2,1.02 [0.25-4.08],0.979262261792001,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,PALM,Paralemmin-1,Inverse variance weighted,4,1.01 [0.44-2.34],0.979786947558435,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,REG4,Regenerating islet-derived protein 4,Inverse variance weighted,13,0.99 [0.55-1.79],0.981524787470296,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,CXCL9,C-X-C motif chemokine 9,Inverse variance weighted,10,1.01 [0.55-1.86],0.982062263756889,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,IL6,Interleukin-6,Inverse variance weighted,6,1 [0.64-1.58],0.984003177206989,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,NOMO1,Nodal modulator 1,Inverse variance weighted,24,1 [0.85-1.18],0.985682841603273,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,REG1B,Lithostathine-1-beta,Inverse variance weighted,7,1 [0.55-1.78],0.98678246155021,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,DKK4,Dickkopf-related protein 4,Inverse variance weighted,15,1 [0.56-1.77],0.989617746119181,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,LBP,Lipopolysaccharide-binding protein,Inverse variance weighted,17,1 [0.86-1.17],0.989630531390641,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,GSN,Gelsolin,Inverse variance weighted,7,1 [0.55-1.82],0.9897676890185,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,PHLDB1,Pleckstrin homology-like domain family B member 1,Inverse variance weighted,2,0.99 [0.23-4.29],0.989876083215236,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,OSCAR,Osteoclast-associated immunoglobulin-like receptor,Inverse variance weighted,7,0.99 [0.31-3.21],0.989965405699542,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,CKB,Creatine kinase B-type,Inverse variance weighted,11,1 [0.48-2.05],0.989971561194119,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,CFHR2,Complement factor H-related protein 2,Inverse variance weighted,22,1 [0.8-1.25],0.990374760064495,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,NOS3,"Nitric oxide synthase, endothelial",Inverse variance weighted,5,1.01 [0.32-3.21],0.991144572131838,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,NOTCH3,Neurogenic locus notch homolog protein 3,Inverse variance weighted,17,1 [0.63-1.6],0.993289209221088,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,TRIAP1,TP53-regulated inhibitor of apoptosis 1,Inverse variance weighted,9,1 [0.55-1.81],0.99577076241415,trans
Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,LILRB4,Leukocyte immunoglobulin-like receptor subfamily B member 4,Inverse variance weighted,3,1 [0.26-3.87],0.99717741960411,trans
